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Abstract 
English version 
Adequate supply of oxygen to the brain is critical for maintaining normal brain function. Severe 
hypoxia, such as that experienced during high altitude ascent, presents a unique challenge to brain 
oxygen (O2) supply. During high-intensity exercise, hyperventilation-induced hypocapnia leads to 
cerebral vasoconstriction, followed by reductions in cerebral blood flow (CBF), oxygen delivery 
(DO2), and tissue oxygenation. This reduced O2 supply to the brain could potentially account for the 
reduced performance typically observed during exercise in severe hypoxic conditions. The aims of 
this thesis were to document the effect of acute and chronic exposure to hypoxia on CBF control, 
and to determine the role of cerebral DO2 and tissue oxygenation in limiting performance during 
exercise in severe hypoxia.  
 
We assessed CBF, arterial O2 content (CaO2), haemoglobin concentration ([Hb]), partial pressure of 
arterial O2 (PaO2), cerebrovascular CO2 reactivity, ventilatory response to CO2, cerebral 
autoregulation (CA), and estimated cerebral DO2 (CBF ⨉	  CaO2) at sea level (SL), upon ascent to 
5,260 m (ALT1), and following 16 days of acclimatisation to 5,260 m (ALT16). We found an 
increase in CBF despite an elevated cerebrovascular CO2 reactivity at ALT1, which coincided with 
a reduced CA. Meanwhile, PaO2 was greatly decreased despite increased ventilatory drive at ALT1, 
resulting in a concomitant decrease in CaO2. At ALT16, CBF decreased towards SL values, while 
cerebrovascular CO2 reactivity and ventilatory drive were further elevated. Acclimatisation 
increased PaO2, [Hb], and therefore CaO2 at ALT16, but these changes did not improve CA 
compared to ALT1. No differences were observed in cerebral DO2 across SL, ALT1, and ALT16. 
Our findings demonstrate that cerebral DO2 is maintained during both acute and chronic exposure to 
5,260 m, due to the reciprocal changes in CBF and CaO2.  
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We measured middle cerebral artery velocity (MCAv: index of CBF), cerebral DO2, ventilation 
(VE), and performance during incremental cycling to exhaustion and 15km time trial cycling in both 
normoxia and severe hypoxia (11% O2, normobaric), with and without added CO2 to the inspirate 
(CO2 breathing). We found MCAv was higher during exercise in severe hypoxia compared in 
normoxia, while cerebral tissue oxygenation and DO2 were reduced. CO2 breathing was effective in 
preventing the development of hyperventilation-induced hypocapnia during intense exercise in both 
normoxia and hypoxia. As a result, we were able to increase both MCAv and cerebral DO2 during 
exercise in hypoxia with our CO2 breathing setup. However, we concomitantly increased VE and 
PaO2 (and presumably respiratory work) due to the increased hypercapnic stimuli with CO2 
breathing, which subsequently contributed to the cerebral DO2 increase during hypoxic exercise. 
While we effectively restored cerebral DO2 during exercise in hypoxia to normoxic values with CO2 
breathing, we did not observe any improvement in cerebral tissue oxygenation or exercise 
performance. Accordingly, our findings do not support the role of reduced cerebral DO2 in limiting 
exercise performance in severe hypoxia.  
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French version 
Un apport adéquat en oxygène au niveau du cerveau est primordial pour le maintien des fonctions 
cérébrales normales. L’hypoxie sévère, telle qu’expérimentée au cours d’ascensions en haute 
altitude, présente un défi unique pour l’apport cérébral en oxygène (O2). Lors d’exercices à haute 
intensité, l’hypocapnie induite par l’hyperventilation entraîne une vasoconstriction cérébrale suivie 
par une réduction du flux sanguin cérébral (CBF), de l’apport en oxygène (DO2), ainsi que de 
l’oxygénation tissulaire. Cette réduction de l’apport en O2 au cerveau pourrait potentiellement être 
responsable de la diminution de performance observée au cours d’exercices en condition d’hypoxie 
sévère. Les buts de cette thèse étaient de documenter l’effet de l’exposition aiguë et chronique à 
l’hypoxie sur le contrôle du CBF, ainsi que de déterminer le rôle du DO2 cérébral et de 
l’oxygénation tissulaire comme facteurs limitant la performance lors d’exercices en hypoxie sévère. 
 
Nous avons mesuré CBF, le contenu artériel en oxygène (CaO2), la concentration en hémoglobine 
([Hb]), la pression partielle artérielle en O2 (PaO2), la réactivité cérébrovasculaire au CO2, la 
réponse ventilatoire au CO2, et l’autorégulation cérébrale sanguine (CA), et estimé DO2 cérébral 
(CBF x CaO2), au niveau de la mer (SL), au premier jour à 5.260 m (ALT1) et après seize jours 
d’acclimatation à 5.260 m (ALT16). Nous avons trouvé des augmentations du CBF et de la 
réactivité cérébrovasculaire au CO2 après une ascension à 5.260 m. Ces augmentations coïncidaient 
avec une réduction de l’autorégulation cérébrale. Simultanément, la PaO2 était grandement réduite, 
malgré l’augmentation de la ventilation (VE), résultant en une diminution de la CaO2. Après seize 
jours d’acclimatation à 5.260 m, le CBF revenait autour des valeurs observées au niveau de la mer, 
alors que la réactivité cérébrovasculaire au CO2 et la VE augmentaient par rapport à ALT1. 
L’acclimatation augmentait la PaO2, la concentration en hémoglobine, et donc la CaO2, mais 
n’améliorait pas l’autorégulation cérébrale, comparé à ALT1. Aucune différence n’était observée au 
niveau du DO2 cérébral entre SL, ALT1 et ALT16. Nos résultats montrent que le DO2 cérébral est 
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maintenu constant lors d’expositions aiguë et chronique à 5.260m, ce qui s’explique par la 
réciprocité des variations du CBF et de la CaO2.  
 
Nous avons mesuré la vitesse d’écoulement du sang dans l’artère cérébrale moyenne (MCAv : un 
indice du CBF), le DO2 cérébral, la VE et la performance lors d’exercice incrémentaux jusqu’à 
épuisement sur cycloergomètre, ainsi que des contre-la-montres de 15 km en normoxie et en 
hypoxie sévère (11% O2, normobarique) ; avec ajout ou non de CO2 dans le mélange gazeux 
inspiré. Nous avons trouvé que MCAv était plus haute pendant l’exercice hypoxique, comparé à la 
normoxie alors que le DO2 cérébral était réduit. L’ajout de CO2 dans le gaz inspiré était efficace 
pour prévenir l’hypocapnie induite par l’hyperventilation, qui se développe à l’exercice intense, à la 
fois en normoxie et en hypoxie. Nous avons pu augmenter MCAv et le DO2 cérébral pendant 
l’exercice hypoxique, grâce à l’ajout de CO2. Cependant, nous avons augmenté la VE et la PaO2 (et 
probablement le travail respiratoire) à cause de l’augmentation du stimulus hypercapnique. Alors 
que nous avons, grâce à l’ajout de CO2, efficacement restauré le DO2 cérébral au cours de l’exercice 
en hypoxie à des valeurs obtenues en normoxie, nous n’avons observé aucune amélioration dans 
l’oxygénation du tissu cérébral ou de la performance. En conséquence, nos résultats ne soutiennent 
pas le rôle d’un DO2 cérébral réduit comme facteur limitant de la performance en hypoxie sévère. 
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Introduction 
The human brain accounts for ~2% of the total body mass, yet due to its extremely high metabolic 
requirements, it receives ~15% of cardiac output and utilises ~20% of the total body oxygen (O2) 
consumption at rest (Kety & Schmidt, 1948b; Lassen, 1959; Wade & Bishop, 1962). Because of 
this high metabolic demand, the brain is relatively intolerant to hypoxic insults. Adequate supply of 
O2 is critical in maintaining normal brain function, and irreversible neuronal damage can occur if 
the supply of O2 is compromised for more than a few minutes (Panickar & Anderson, 2011). 
Disruption of cerebral blood flow (CBF), as seen during ischaemic stroke, can lead to a cascade of 
adverse consequences such as metabolic impairment, energy failure, free radical production, 
excitotoxicity, altered calcium ion (Ca2+) homeostasis, and activation of proteases (Wexler, 1970; 
Choi, 1988; Martins et al., 1988; Panickar & Norenberg, 2005). Severe disruption in the CBF or O2 
supply can lead to increases in oxidative stress and mitochondrial damage, resulting in necrosis and 
apoptosis-mediated neuronal cell death (Sims & Muyderman, 2010).  
 
High altitude ascent is an endeavour carried out by various groups such as mountaineers, extreme 
sports practitioners (e.g., paragliders and skydivers), porters, trekkers, pilgrims, military personnel, 
rescue workers, miners and scientists alike. Ascending to high altitude often leads to the 
development of acute altitude sickness, which can further develop into life-threatening illnesses like 
high altitude cerebral oedema (Basnyat & Murdoch, 2003). More dramatically, reductions in 
cerebral oxygen delivery (DO2) associated with rapid ascents to extreme altitudes (>8000 m) can 
result in the loss of consciousness within seconds (Luft et al., 1951; Luft & Noell, 1956) and death 
within minutes (Bert, 1943). However, with staged acclimatisation at progressively higher altitudes, 
cerebral DO2 can be maintained well enough for humans to reach the summit of Mount Everest 
(8,848 m) without supplementary O2. This extraordinary feat is made possible due to various 
intrinsic mechanisms that are in place to closely match brain DO2 to metabolic requirements, and 
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highlights the critical role of cerebral DO2 in our abilities to cope with extreme hypoxic conditions. 
How cerebral DO2 is regulated during both acute and chronic exposures to high altitude, and by 
which mechanisms, remain largely unresolved. The first part of this thesis deals with the regulation 
of CBF upon ascent to high altitude and following a period of acclimatisation. In this thesis, the 
term moderate hypoxia will be used to refer to a level of hypoxia equivalent to altitudes between 
~1,500-2,500 m, severe hypoxia will be used to refer to a level of hypoxia equivalent to altitudes 
between ~4,500-6,000 m, and the term extreme hypoxia will be used to refer to a level of hypoxia 
equivalent to altitudes above ~6,000 m. 
 
It is well established that ascent to high altitude is detrimental to one’s aerobic capacity [see (Calbet 
et al., 2002; Calbet et al., 2003; Amann & Kayser, 2009; Calbet & Lundby, 2009) for reviews]. 
However, despite more than a century of research on the detrimental effects of hypoxia on exercise 
performance, the underlying mechanisms remain poorly understood. While the cessation of 
maximal exercise, or the reduction of exercise intensity at the onset of fatigue, implies reduced 
motor recruitment by the central nervous system, the mechanisms responsible for this muscular de-
recruitment remain elusive. During exercise in normoxia and moderate hypoxia, muscle afferents 
appear to play an important role in limiting exercise performance (Amann, 2006; Amann et al., 
2006; Amann & Dempsey, 2008; Amann et al., 2011). Meanwhile, studies indicate that cerebral 
tissue deoxygenation may play a pivotal role in impairing aerobic capacity during exercise in severe 
hypoxic conditions (Kjaer et al., 1999; Amann et al., 2006; Amann et al., 2007b; Subudhi et al., 
2007b; Rasmussen et al., 2010b; Vogiatzis et al., 2011). However, it remains unclear whether 
improving cerebral DO2 and tissue oxygenation would improve performance during exercise in 
severe hypoxia.  
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Mass cerebral DO2 is the product of CBF and arterial O2 content (CaO2). CBF is controlled by 
vascular smooth muscle tone in the arterioles, which are under the influences of chemical, physical, 
neural, and metabolic factors [see (Edvinsson & Krause, 2002; Attwell et al., 2010) for reviews], 
while CaO2 is determined by partial pressure of arterial O2 (PaO2), arterial haemoglobin O2 
saturation (SaO2), and haemoglobin concentration ([Hb]). During severe hypoxia, resting CBF 
increases to protect the brain against reduced PaO2 (Cohen et al., 1967). This CBF response 
depends on the relative degree of prevailing hypoxia (dilating) and associated hyperventilation-
induced hypocapnia (constricting), these being determined by the altitude, the individual’s 
ventilatory response to hypoxia, and acclimatisation state (Dempsey et al., 1974; Forster et al., 
1974; Dempsey & Forster, 1982). Given the scope that is covered by this thesis, a critical 
reappraisal of the current relevant literature is needed. Specifically, this encompasses the effects of 
acute and chronic hypoxia on the chemical, physical, neural, and metabolic control of the cerebral 
blood vessels, and exercise performance limitation in severe hypoxia.  
 
Cerebral blood flow 
The entire capillary network of the brain is covered by astrocyte extensions, surrounding the 
endothelial cells, which constitute the blood-brain barrier (Secher et al., 2008; Alvarez et al., 2013). 
The O2 diffusion distance plays a vital role during changes in local neural activation and associated 
changes in local cerebral O2 consumption. Given that there is no functional or anatomical capillary 
recruitment in the brain (Göbel et al., 1989), an increase in CBF is required to elevate the O2 
pressure gradient (Secher et al., 2008). Further, since all of the brain capillaries are assumed to be 
perfused during rest (Buxton & Frank, 1997), any changes in CBF would be due to changes in 
capillary blood flow velocity mediated by alterations in cerebrovascular resistance [see (Faraci & 
Heistad, 1990; Edvinsson & Krause, 2002) for reviews]. In the face of severe hypoxia, apart from
   14 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Changes in resting cerebral blood flow (CBF) with acute and chronic 
exposure to high altitude. Initial exposure to high altitude (6-8 h) elevates CBF by 
20-57%, which subsequently returned gradually towards sea-level values after ~5 
days of acclimatisation. Modified from Willie et al., (2014b). 
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increasing flow, the cerebral O2 extraction fraction is also elevated in order to meet cerebral 
metabolic rate for O2 (CMRO2) (Kety & Schmidt, 1948a).  
 
During hypoxic exposure, the pattern of the CBF change during both acute and chronic hypoxia can 
be summarised as the net effect of hypoxia-induced vasodilation and hypocapnia-induced 
vasoconstriction in the cerebral blood vessels (Xu & Lamanna, 2006; Brugniaux et al., 2007). 
During initial exposure to severe hypoxia, the vasodilatory drive in the cerebral blood vessels 
typically exceeds that of the constrictor drive, thereby elevating CBF (Figure 1) (Severinghaus et 
al., 1966; Willie et al., 2014a). During acclimatisation, carbon dioxide (CO2) is ‘blown off’ with 
increased ventilation (VE), which lowers the partial pressure of arterial CO2 (PaCO2) and elevates 
PaO2 (Brugniaux et al., 2007), resulting in greater vasoconstrictor drive and restoring of CBF to 
pre-exposure values (Figure 1) (Severinghaus et al., 1966). Therefore, resting CBF at high altitude 
is determined by the severity of hypoxia during acute exposure, which is subsequently modulated 
by the magnitude of increase in ventilatory drive and the associated changes in PaO2 and PaCO2 
during acclimatisation. 
 
Cerebrovascular CO2 reactivity 
Changes in PaCO2 and associated arterial hydrogen ion concentration ([H+]) are potent stimuli for 
altering cerebrovascular resistance and, thus, CBF (Lassen, 1959; Edvinsson & Krause, 2002). A 
rise in PaCO2 (and subsequent respiratory acidosis) leads to vasodilation in the cerebral vessels, 
elevating CBF. Conversely, a drop in PaCO2 (and subsequent respiratory alkalosis) leads to cerebral 
vasoconstriction, lowering CBF. Despite extensive research, the exact mechanisms by which 
PaCO2/[H+] alter cerebrovascular vessel resistance remain poorly understood. In vivo and in vitro 
studies have provided data implicating endogenous mediators in CO2-induced changes in 
cerebrovascular tone, such as nitric oxide, C-natriuretic peptide, prostanoids, and endothelin-1 
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(Eriksson et al., 1983; Kobayashi et al., 1994; Henze et al., 2007; Peebles et al., 2008). These 
endogenous mediators have been attributed to the neighbouring endothelial and neuronal cells, and 
act via second messenger and potassium ion channel activation/hyperpolarising pathways to alter 
intracellular Ca2+ concentration in the vascular smooth muscle, thus eliciting contraction or 
relaxation (Edvinsson & Krause, 2002).  
 
The CBF responsiveness to CO2, termed cerebrovascular CO2 reactivity, provides a useful non-
invasive index of cerebrovascular function (Faraci & Heistad, 1990; Ainslie & Ogoh, 2009). In 
healthy humans, one mmHg rise in PaCO2 elicits 2-8% increase in global CBF as determined by 
transcranial Doppler ultrasound (Peebles et al., 2007; Ainslie & Burgess, 2008; Fan et al., 2010a; 
Battisti-Charbonney et al., 2011), vascular Doppler ultrasound (Sato et al., 2012; Willie et al., 
2012), Fick’s principle (Kety & Schmidt, 1946, 1948a; Peebles et al., 2008), and magnetic 
resonance imaging (MRI) (Noth et al., 2008). Cerebrovascular CO2 reactivity appears to play a 
crucial role in determining basal CBF during both acute and chronic exposures to high altitude 
(Lucas et al., 2011). To date, only a handful of studies have investigated the effect of 
acclimatisation to high altitude on cerebrovascular CO2 reactivity (Table 1). Moreover, 
interpretation of their findings is difficult as the majority of those studies examined the effect of 
high altitude ascent on cerebrovascular CO2 reactivity at only one time point (Fan et al., 2010a; Fan 
et al., 2012a), without controlling for confounding factors such as ascent profile, acclimatisation 
status or smoking (Jansen et al., 1999), or prior exposures to higher altitudes (Ainslie & Burgess, 
2008). Meanwhile others have assessed cerebrovascular function in artificial normobaric hypoxia 
(Poulin et al., 2002; Kolb et al., 2004).  
 
Data from Fan et al., (2010a; 2012a), obtained from the same group of subjects at different stages of 
altitude acclimatisation, indicate that cerebrovascular CO2 reactivity (assessed using a modified 
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rebreathing technique) increases with prolonged exposure to high altitude. In these same subjects, 
Lucas et al., (2011) found cerebrovascular CO2 reactivity (using a steady-state technique) to be 
lower following 14 days at 5,050 m. However, since Lucas et al., (2011) did not carefully control 
the partial pressure of end-tidal O2 (PETO2) at high altitude, the cerebrovascular CO2 reactivities 
reported in that study reflected CBF changes from hypoxic hypocapnia (room air breathing) to 
relative hypercapnic hyperoxia (93% O2 and 7% CO2). Accordingly, the findings by Lucas et al., 
(2011) do not represent true cerebrovascular CO2 reactivity per se. In other cohort studies, Rupp et 
al., (2014) and Villien et al., (2013) found cerebrovascular CO2 reactivity was reduced following 5 
days at 4,350 m, using a steady-state hypoxic hypercapnia method (PETO2: ~55 mmHg). Given the 
differences in background O2 levels and other methodological discrepancies (i.e., steady-state vs. 
rebreathing method) between these studies, it is not surprising that the current literature shows little 
agreement on the effect of high altitude exposure on cerebrovascular CO2 reactivity. For example, 
studies have found cerebrovascular CO2 reactivity to increase (Fan et al., 2010a), decrease (Villien 
et al., 2013; Rupp et al., 2014), or remain unchanged (Jansen et al., 1999) upon early exposure to 
high altitude, whilst acclimatisation either increases (Fan et al., 2012a) or decreases it (Lucas et al., 
2011; Villien et al., 2013; Rupp et al., 2014). Thus, the effect of high altitude ascent and subsequent 
acclimatisation on cerebrovascular CO2 reactivity remains unclear. 
 
 
 
Table 1. Summary of cerebrovascular CO2 reactivity studies at high altitude.	  	  
 Participants Altitude Duration  Method of assessment Cerebrovascular CO2 reactivity Comments 
Jansen et al., 
(1999) 43 subjects  4,243 m Not controlled 
CO2 inhalation  
(0.6-1 l/min) and 
hyperventilation. 
Concentration unknown 
↔ CO2 inhalation 
↑ hyperventilation 
No measurements of end-tidal 
or arterial PCO2. Reactivity 
estimated from cutaneous 
PCO2. Not controlled for 
smoking. 
Ainslie & Burgess 
(2008) 5 subjects 3,840 m Unspecified 
Modified rebreathing & 
hypoxic rebreathing 
↓ modified rebreathing 
↑ hypoxic rebreathing 
Measurements taken following 
9-day ascent to >5,000 m. 
Compared to values obtained at 
1,400m. 
Poulin et al., 
(2002) 10 subjects ~2,800 m  48 h 
Steady-state hyperoxic 
hypercapnia  ↑ 
Simulated altitude in a 
normobaric hypoxic chamber. 
Fan et al., (2010) 17 subjects 5,050 m 2-4 days Modified rebreathing ↑ After 7 days trekking to 5,050 m. 
Lucas et al., 
(2011) 12-17 subjects 5,050 m 
2-4, 7-9, 12-15 
days 
Hyperventilation and 
steady-state hyperoxic 
hypocapnia 
↑ hyperventilation 
 
↓ hyperoxic hypercapnia 
Background O2 level not 
controlled for. 
Fan et al., (2012) 12 subjects 5,050 m 5-11 days Modified rebreathing ↑ After 7 days trekking to 5,050 m. 
Villien et al., 
(2013) 11 subjects 4,350 m 6 days 
Steady-state hypoxic 
hypercapnia ↓  
Rapid ascent with helicopter. 
Background hypoxia used. 
Rupp et al., (2014) 11 subjects 4,350 m 5 days 
Steady-state hypoxic 
hypercapnia and normoxic 
hypocapnia 
↔ normoxic hypocapnia 
 
↓ hypoxic hypercapnia 
Rapid ascent with helicopter. 
Background hypoxia used. 
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Cerebral autoregulation 
As potent as CO2/[H+] are on altering cerebrovascular tone, a decrease in cerebrovascular resistance 
alone cannot increase CBF without sufficient perfusion pressure to maintain the pressure gradient. 
Depending on the severity of change, reductions in mean arterial blood pressure (MAP) have been 
shown to either attenuate or abolish cerebrovascular CO2 reactivity in both dogs and humans 
(Harper & Glass, 1965; Ainslie et al., 2012). Therefore, it seems that the chemical component of 
CBF regulation is intricately linked to perfusion pressure (Carrera et al., 2009). Accordingly, the 
perfusion pressure-blood flow relationship in the brain is critical to our understanding of 
cerebrovascular function changes at high altitude. 
 
Cerebral autoregulation (CA) is a term traditionally used to describe intrinsic, myogenic cellular 
phenomena and neurogenic mechanisms (Paulson et al., 1990; Edvinsson & Krause, 2002), which 
are responsible for adjusting cerebrovascular resistance to maintain CBF constant within a wide 
range of perfusion pressures (~60-150 mmHg, Figure 2) (Lassen, 1959). Early pioneering work by 
Bayliss et al., (1895) demonstrated that cerebral circulation passively follows changes in arterial 
pressure in anaesthetised dogs. Accordingly, they concluded that a rise in MAP increases CBF; 
conversely, a fall in arterial pressure lowers cerebral perfusion. In humans, a reduction of CA was 
observed during CO2 breathing (5%) and has been linked to the cerebrovascular CO2 reactivity 
(Carrera et al., 2009). This observation led the authors to speculate that hypercapnia-induced 
vasodilation might reduce the dynamic range of autoregulation mechanically by lowering the 
vasodilatory reserve, thus limiting the ability of the arterioles to further dilate in response to 
changes in blood pressure (i.e., the pressure-flow relationship becomes more linear and steeper). 
Findings by Carrera et al., (2009) give support to the notion that, despite being long considered to 
be independent of each other, CA and CO2 reactivity might in fact share the same vascular reserve. 
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Figure 2. Cerebral blood flow (CBF) and mean arterial blood 
pressure. Mean values of 11 groups of subjects reported in 7 studies. 
1 and 2, drug-induced severe hypotension; 3 and 4, drug-induced 
moderate hypotension; 5 and 6, normal pregnant women and normal 
young men; 7, drug-induced hypertension; 8, hypertensive toxaemic 
pregnancy; 9 and 10, essential hypertension. From Lassen (1959).  
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Impairments in CA have been reported in both permanent residents and newcomers to high altitude 
(Jansen et al., 2000; Jansen et al., 2007; Ainslie et al., 2008), and appear to persist despite 1–30 
days of high altitude exposure (Levine et al., 1999; Jansen et al., 2000; Ainslie et al., 2008; Iwasaki 
et al., 2011; Ainslie et al., 2012). Jansen et al., (2007) reported a linear relationship between the 
severity of hypoxic stress and the degree of CA loss in high altitude residents (i.e., greater loss of 
CA at higher altitudes), indicating that CA is influenced by the level of hypoxia and does not 
improve with chronic hypoxic exposure. Meanwhile, other CA studies have either omitted 
measurements upon arrival at high altitude (Levine et al., 1999; Cochand et al., 2011; Iwasaki et al., 
2011), or followed slow ascent profiles that allowed for partial acclimatisation prior to initial 
measurements (Jansen et al., 2000; Ainslie et al., 2012). To date, no longitudinal studies have been 
carried out to fully characterise the CA changes across both acute and chronic high altitude 
exposures.  
 
Cerebral metabolism 
The brain is not homogeneous, it is composed of a variety of tissues and discrete structures that 
often function independently or even inversely with respect to one another (Clarke & Sokoloff, 
1999). There is little reason to expect that the perfusion and metabolic rates between these distinct 
brain regions would be similar. At the regional level, changes in CBF are closely coupled with 
glucose utilisation and O2 consumption in the brain (Raichle et al., 1976; Raichle, 1998; Clarke & 
Sokoloff, 1999; Raichle et al., 2001; Vaishnavi et al., 2010). A change in metabolic activity 
associated with regional activation is arguably the main determinant of regional CBF under 
physiological conditions (see section ‘Neurovascular coupling’ below). However, since regional 
changes in cerebral metabolic activities are difficult to quantify, the majority of the literature 
focuses on global cerebral metabolic changes in hypoxia. 
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Using the Kety-Schmidt technique, Møller et al., (2002) found resting cerebral O2 and glucose 
metabolism were unchanged, while resting cerebral metabolic rate of lactate increased slightly 
following 3 weeks at 5,260 m. In that study, they observed a net cerebral lactate efflux at rest, while 
O2-glucose index, lactate-glucose index, and lactate-O2 index (indices of oxidative metabolism) 
tended to be reduced at 5,260 m compared to sea level. Similarly, Overgaard et al., (2012) reported 
no changes in resting CMRO2 in severe hypoxia (FIO2: 0.10), while net cerebral lactate release was 
elevated by ~46% after 10 min of exposure, accounting for ~2% of the energy production in the 
brain. More recently, Ainslie et al., (2014) found global cerebral metabolic rates for O2, glucose, 
and lactate to be unaltered during progressive hypoxia (PaO2: ~35-60 mmHg), while global cerebral 
glucose delivery and net lactate efflux were both elevated. Their data showed a trend for the ratio of 
O2 to glucose uptake by the brain (index of oxidative glucose metabolism) to be decreased with 
increasing hypoxaemia, while the O2 and glucose extraction fractions remained unchanged down to 
70% SaO2. Taken together, it appears that hypoxia increases the lactate release in the resting brain, 
which is suggestive of increased non-oxidative metabolism (i.e., anaerobic glycogenolysis and 
glycolysis). Nevertheless, energy production and cell metabolism appear to remain predominately 
reliant on oxidative metabolism under hypoxic conditions—presumably due to the brain’s ability to 
maintain cerebral DO2 in the face of severe hypoxia (see section ‘Cerebral oxygen delivery’ below). 
However, the contribution of minor substrates such as glutamate and ketones for energy supply to 
the hypoxic brain remains unknown.  
 
Neurovascular coupling 
The close coupling of regional CBF to local substrate utilisation—termed neurovascular coupling—
is the product of the anatomical and metabolic relationship of the neurovascular unit, which is 
comprised of neurons, glial cells, and the cerebral arterioles and capillaries (Willie et al., 2014b). 
Due to this coupling, the cerebral arteriovenous O2 difference at the whole-brain level varies 
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inversely with global CBF during hypercapnia (CO2 inhalation) and hypocapnia (hyperventilation), 
while CMRO2 remains constant (Kety & Schmidt, 1946, 1948a). Further, CBF is regulated to 
ensure appropriate glucose and O2 delivery to the brain in order to meet CMRO2, which can be 
calculated using the Fick’s principle (Strangfeld et al., 1969): 
CMRO2 = CBF ⨉ (a – v)  
Where CMR is the cerebral metabolic rate in µmol/min/g tissue, CBF is cerebral blood flow in 
mL/min/g, and (a – v) is the difference between arterial (a) and cerebral venous (v) substrate 
concentration in µmol/mL.  
 
However, despite this ‘close coupling’ of blood flow and metabolism in the brain, functional MRI 
studies have found increases in regional CBF usually outstrip CMRO2 and adenosine 5’ 
triphosphate (ATP; the currency of energy) consumption by 2-6 fold during sustained neuronal 
activation (Fox & Raichle, 1986; Davis et al., 1998; Hoge et al., 1999; Kim et al., 1999; Lin et al., 
2010; Vafaee et al., 2012). Further, this coupling between CBF and cerebral metabolism can be 
uncoupled using pharmacological means. Specifically, a muscarinic receptor antagonist (Villringer 
& Dirnagl, 1995) and a neuronal nitric oxide synthase inhibitor (Cholet et al., 1996) have been 
shown to abolish the expected CBF increase during somatosensory stimulation, despite elevated 
neuronal (and therefore metabolic) activity. Conversely, activation of acetylcholine-containing fibre 
projection to the cerebral cortex during nucleus basalis stimulation, has been shown to increase 
cortical blood flow without concurrently increasing local glucose metabolism (Vaucher et al., 
1997). These findings of CBF and cerebral metabolism uncoupling give support to possible ‘in-
parallel’ regulatory mechanisms (Magistretti & Pellerin, 1999), whereby synaptic activation and 
subsequent glutamate release leads to: 1) neuronal nitric oxide formation, which contributes to the 
local activity-dependent CBF increase (Attwell et al., 2010); and 2) glutamate reuptake by the 
surrounding astrocytes, which stimulates astrocytic glucose metabolism and lactate production 
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(Magistretti, 1997). With these observations, Magistretti and Pellerin (1999) concluded that while 
CBF and metabolism are linked under physiological conditions, this relationship could be 
uncoupled by selective pharmacological manipulations or during certain pathophysiological 
conditions. 
 
Arterial oxygen content 
The ability to maintain physiological homeostasis in the face of hypoxic stress is vastly 
advantageous, particularly for individuals challenged by changes in barometric pressure and 
associated arterial hypoxaemia (Beall, 2007). Humans have a number of compensatory mechanisms 
to hypoxia, thus enabling communities to live at high altitude. These mechanisms range from fast-
onset responses [within minutes; e.g., elevation of minute ventilation (VE, fast-component) and 
sympathetic activity (Dempsey & Forster, 1982; Xing et al., 2014)], to slower responses [days and 
weeks; e.g., increases in VE (slow-component), haematocrit (Hct), and brain capillary density 
(Dempsey & Forster, 1982; Ainslie & Ogoh, 2009)]. One of the most distinct and rapid 
physiological compensatory responses to hypoxia is the elevation in VE, termed hypoxic ventilatory 
response (HVR, Figure 3). The HVR is initiated within minutes of exposure to hypoxia and 
increases progressively over time before stabilising after ~2 weeks at high altitude (Dempsey & 
Forster, 1982; Sato et al., 1992). This response is primarily mediated by the peripheral 
chemoreceptors (Heymans & Bouckaert, 1930; Forster et al., 1981; Lahiri et al., 1981; Lahiri et al., 
2006), located in the glomus cells of the carotid bodies, at the bifurcation of the common carotid 
arteries (Eyzaguirre & Zapata, 1984). These peripheral chemoreceptors are responsible for eliciting 
the HVR when resting PaO2 drops below 60 mmHg (Dempsey & Forster, 1982). Carotid body 
denervation via unilateral and bilateral carotid body resection attenuates or completely abolishes 
HVR in humans (Wade et al., 1970; Lugliani et al., 1971; Prabhakar & Peng, 2004).
 
   25 
 
 
 
 
 
 
 
 
Figure 3. Effect of time at altitude on hypoxic ventilatory response 
(HVR; mean ± SD). AL1, AL2, and AL3, 30 ± 18, 76 ± 19, and 115 
± 10h, respectively, at 3,810 m altitude. * Different from sea level 
(SL; P<0.05). Modified from Sato et al., (1992). 
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Importantly, increased ventilatory drive and Hct during chronic high altitude exposure improves 
SaO2 and normalises resting CaO2 to sea level values, thus partly alleviating arterial hypoxaemia in 
spite of lowered PaO2. 
 
Given the importance of O2 supply in maintaining normal brain function, it is not surprising that the 
O2 carrying capacity of the blood (i.e., Hct and [Hb]) and the level of O2 in the blood (i.e., PaO2 and 
SaO2) are important determinants of CBF. For example, CBF varies inversely with Hct in many 
species under both acute (i.e., blood transfusion, acute anaemia) and chronic (i.e., erythropoiesis) 
experimental conditions (Jones et al., 1981; Brown et al., 1985; Hudak et al., 1986; Ulatowski et 
al., 1998). A handful of studies have found reducing CaO2 elevates CBF during acute and chronic 
anaemia (Hare, 2004; Gottesman et al., 2012), haemodilution (Brown et al., 1985; Hudak et al., 
1986; Todd et al., 1994; Ulatowski et al., 1998), and carbon monoxide inhalation (Paulson et al., 
1973). Conversely, elevating Hct lowers CBF in haemodialysis patients (Metry et al., 1999). 
Meanwhile, Rebel et al., (2001) found CBF progressively increases with decreasing Hct in 
conscious rats. 
 
A critical consideration in the regulation of cerebral DO2 is whether it is the arterial-tissue PO2 
gradient driving diffusion (i.e., PaO2), or the blood O2 concentration (i.e., CaO2), which plays a 
more important role in CBF control in hypoxia. An elegant study by Jones et al., (1981) 
demonstrated that, by selectively altering Hct and PaO2 in unanaesthetised new-born lambs, the 
relationship between CBF and PaO2 depended on Hct and vice versa; in contrast, the relationship of 
CBF to CaO2 was independent of both Hct and PaO2. From these findings, they concluded that the 
changes in CaO2 are accompanied by reciprocal changes in CBF in order to maintain constant 
cerebral DO2 (Figure 4). Similarly, Roach et al., (1999) found cardiac output and limb blood flow
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Figure 4. Relationship between CBF and CaO2. High 
haematocrit: CBF = 1045.85/CaO2 + 33.99 (R=0.65); Low 
haematocrit: CBF = 1191.67/CaO2 + 25.86 (R=0.88). Modified 
from Jones et al., (1981). 
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during knee extension was elevated when CaO2 was reduced with isovolemic haemodilution, while 
lowering PaO2 with hypoxia had no effect. They concluded that O2 delivery, rather than capillary 
PO2, is the main regulatory goal of vasodilation in the peripheral vasculature. Furthermore, the 
authors speculated that the regulatory mechanisms of CaO2 on blood flow could be due to red blood 
cell ATP release (Ellsworth et al., 1995), O2-sensitive arachidonic acid metabolite release (Harder 
et al., 1996), or a Hb specific effect on scavenging of nitric oxide to elicit vasodilation in the face of 
anaemia (Stamler et al., 1997). These findings indicate that under both physiological and 
pathological conditions, CaO2 rather than PaO2 determines the CBF response during hypoxic 
conditions. This is of particular importance when considering the role of CaO2 on CBF regulation 
during acute and chronic exposure to extreme altitudes. 
 
Cerebral oxygen delivery 
Despite the reduction in environmental PO2 at high altitude and subsequent initial decrease in CaO2, 
cerebral DO2 appears to be well maintained (Wolff, 2000; Wolff et al., 2002). Based on a re-
analysis of the data collected by Severinghaus et al., (1966), Wolff (2000) found cerebral DO2 was 
maintained during the first 8 h of high altitude exposure (3,810 m), largely due to an increase in 
CBF associated with early hypoxic exposure. Furthermore, despite a progressive decline in CBF 
during prolonged high altitude exposure (5 days), cerebral DO2 was maintained due to the increases 
in PaO2 and [Hb] (therefore CaO2) associated with acclimatisation (Wolff, 2000; Wolff et al., 
2002). Grocott et al., (2009) examined the changes in CaO2 and [Hb] in climbers during extreme 
altitude ascent (8,400 m; PaO2: ~30 mmHg). In that study, they found that the increase in [Hb] 
associated with high altitude acclimatisation was sufficient to compensate for the drop in SaO2, 
such that resting CaO2 was maintained until 7,100 m (Figure 5). To date, no studies have examined 
how the CBF and CaO2 interact at a fixed altitude during acute exposure and following 
acclimatisation to high altitude.  
   29 
 
 
 
 
 
 
Figure 5. Changes in mean PaO2, SaO2, [Hb], and CaO2 on Mount Everest. From 
Grocott et al., (2009). 
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Limitation of exercise performance  
Hypoxia limits O2 transport from the air to the muscle mitochondria, thereby compromising the 
body’s capacity to perform work (Calbet & Lundby, 2009). Aerobic exercise capacity is a vital 
determinant of an individual’s ability to thrive at high altitude (Curran et al., 1998), and exposure to 
high altitude poses problems for many physical endeavours. Despite its importance, the 
underpinning mechanisms of reduced aerobic power and exercise performance impairment in 
severe hypoxia (SaO2 < 75 %) are still not well understood. While the lack of O2 is the obvious 
cause, the exact mechanisms by which hypoxia initiates an earlier disengagement from an exercise 
challenge remain unclear.  
 
The brain is responsible for deciding whether to slow down or to stop exercise (Kayser, 2003). 
While various factors such as sensory feedback from the working limbs (Amann et al., 2008; 
Amann et al., 2011), respiratory muscle work (Amann et al., 2007a), circulating metabolites 
(Karlsson et al., 1975; Hogan & Welch, 1984), CaO2 (Amann, 2006; Amann et al., 2006), the 
body’s glycogen stores (Bergstrom et al., 1967; Hermansen et al., 1967), and thermal comfort 
(Nybo & Nielsen, 2001; Nybo et al., 2002), all contributing towards the development of fatigue [see 
(Amann & Calbet, 2008; Dempsey et al., 2008; Nybo, 2008; Amann & Kayser, 2009; Ortenblad et 
al., 2013) for reviews], the cessation of exercise is ultimately initiated by the brain (Kayser, 2003). 
From this perspective, the end-point of increasing fatigue (i.e., exhaustion) is of central nervous 
system origin (Secher et al., 2008).  
 
Aerobic exercise capacity is highly sensitive to changes in SaO2 (Amann & Kayser, 2009), and 
small reductions associated with exercise-induced arterial hypoxaemia impair exercise capacity in 
normoxia [see (Dempsey & Wagner, 1999) for review]. This detrimental effect of arterial 
hypoxaemia on aerobic capacity is amplified during exercise in hypoxia (Kayser et al., 1994; 
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Amann & Calbet, 2008). As Amann & Kayser (2009) noted, this impairment of aerobic capacity 
during both acute and chronic exposure to high altitude has been well documented in both 
moderately and highly trained individuals (Dill et al., 1966; Klausen et al., 1966; Dill et al., 1967; 
Maher et al., 1974; Calbet et al., 2003; Lundby et al., 2004; Lundby et al., 2006). There is a 
performance drop of ~1% for every 100 m ascended from 1,500 m above sea level (Buskirk et al., 
1967; Pugh, 1967). Further, it appears that people with higher aerobic fitness at sea level are more 
adversely affected in hypoxia (Martin & O'Kroy, 1993; Gore et al., 1996; Ferretti et al., 1997; 
Calbet & Lundby, 2009), due to greater reductions in SaO2, CaO2, and therefore mass O2 transport 
(Ekblom et al., 1975; Chapman et al., 1999; Calbet & Lundby, 2009). This reduction in mass O2 
transport ultimately leads to an early onset of muscle fatigue and exhaustion compared to equivalent 
exercise at lower altitudes (Amann & Kayser, 2009).  
 
Peripheral fatigue in hypoxia 
Under normoxic conditions, the major causes of fatigue development during muscle contraction 
have been attributed to muscle contractile apparatus failure and impairment of excitation-
contraction coupling mechanisms associated with excess accumulation of metabolic by-products 
and impaired sarcoplasmic reticulum Ca2+ handling (Merton, 1954; Dawson et al., 1978; Fitch & 
McComas, 1985; MacIntosh et al., 2012; Ortenblad et al., 2013). Accordingly, it was hypothesised 
that greater metabolic disturbance associated with reduced CaO2, at the level of the muscle fibre, 
could be responsible for the reduced exercise performance observed in severe hypoxia (Bylund-
Fellenius et al., 1981; Idstrom et al., 1986). However, evidence from operation Everest II, a 
chamber simulation of a Mount Everest ascent, does not support the idea that the development of 
fatigue during dynamic exercise involving a large muscle mass in severe hypoxia is of muscular 
origin. Data from this chamber study showed that metabolic enzyme activity, oxidative capacity, 
and energy stores in the vastus lateralis to be largely preserved at high altitude (Green et al., 1989), 
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Figure 6. Peripheral quadriceps fatigue (Qtw,pot, potentiated twitch force elicited by 
magnetic nerve stimulation) assessed 2 min following various trials with different 
values for FIO2. * Different from FIO2: 0.15 and 0.30 (P<0.05); † Different from 
FIO2: 0.10, 0.15 and 0.30 (P<0.05). From Amann et al., (2007b).  
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while electrical stimulation elicited full ankle dorsiflexion under extreme hypoxic conditions 
(Garner et al., 1990). Since biochemical, electromyographic, and mechanical signs of muscle 
fatigue at exhaustion are lower compared to normoxia, Verges et al., (2012) summarised that the 
main cause of impaired whole body exercise performance in severe hypoxia is unlikely due to 
muscle metabolic fatigue. Instead, it was proposed by Kayser et al., (1994) that the central nervous 
system might play a primary role in limiting performance under severe hypoxic conditions. 
Supporting this contention, Amann et al., (2007b) found smaller reductions in potentiated 
quadriceps twitch force—index of peripheral fatigue—at the end of constant-load cycling to 
exhaustion (~80% normoxic power output) in severe hypoxia (FIO2: 0.10), compared to normoxia 
and moderate hypoxia (FIO2: 0.15) (Figure 6). From this, they postulated that peripheral muscle 
fatigue is the main determinant of central motor drive and exercise performance in normoxia and 
moderate hypoxia (Amann et al., 2006; Romer et al., 2007), while a hypoxia-sensitive central 
component might play a greater role during high intensity, exhaustive exercise in severe hypoxia.  
 
Following exhaustive constant-load cycling (~50% normoxic power output) in acute hypoxia (FIO2: 
0.105), Amann et al., (2013) found both potentiated quadriceps twitch force and maximal voluntary 
contraction force were reduced compared to pre-exercise values (Figure 7). In contrast, they found 
no sign of peripheral fatigue following an identical bout of exercise in normoxia. Since inspiratory 
muscle work was higher and CaO2 was lower during hypoxic exercise compared to normoxia, the 
authors attributed the development of peripheral fatigue to reduced muscle DO2 and increased 
respiratory work associated with hypoxic exercise (Figures 7 & 8). Increasing respiratory work, 
either by voluntarily increasing the tidal integral of transdiaphragmatic pressure or by hypoxia-
induced hyperventilation, exacerbates diaphragm fatigue during exercise (Babcock et al., 1995; 
Vogiatzis et al., 2008). Diaphragm fatigue (and other respiratory muscle fatigue) augments
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Figure 7. Panel A: Individual data illustrating the effects of constant-load cycling 
exercise (138 ± 14 W; 10.6 ± 0.7 min) on electrically elicited potentiated 
quadriceps twitch force (Qtw,pot; top) and voluntary muscle activation (VA; 
bottom). Panel B: Inspiratory muscle pressure-time production [esophageal 
pressure (Pes) ⨉ respiratory frequency (fR)] during identical constant-load cycling 
exercise. Sea level (CaO2: 19.3 ± 0.7 ml O2/dl) and in acute hypoxia (17.3 ± 9.5 
ml O2/dl) and chronic hypoxia (20.3 ± 1.3 ml O2/dl). * Different from acute 
hypoxia (P<0.05). From Amann et al., (2013).  
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Figure 8. Schematic representation of the effect of hypoxia on central motor drive. Lungs: Hypoxia 
lowers PaO2, thus elevating ventilation and lowering CaO2 and respiratory muscle DO2 (Amann et 
al., 2007a). The combination of increased ventilation and reduced respiratory muscle DO2 
accelerates the development of respiratory muscle fatigue, resulting in activation of respiratory 
muscle metaboreceptors and group III/IV phrenic afferents (Dempsey et al., 2006). Locomotor 
muscles: Increases in both carotid chemoreceptor activity and respiratory metaboreceptor activity, 
elicit vasoconstriction of the locomotor vasculature, thereby lowering limb blood flow (Dempsey et 
al., 2006). The reduced limb blood flow, combined with reduced CaO2 in hypoxia, lowers 
locomotor muscle DO2, augments the accumulation of metabolites, and accelerates the development 
of peripheral fatigue (Amann & Calbet, 2008). Consequently, the increase in peripheral fatigue 
modulates central motor drive via group III/IV muscle afferents (Amann et al., 2006). Brain: 
Increases in central motor drive associated with exercise elevate regional neuronal activity, and 
therefore metabolic requirements (Raichle et al., 1976). These in turn elicit local vasodilation via 
neurovascular coupling, thereby increasing local blood flow and DO2 (Jorgensen et al., 1992a; 
Jorgensen et al., 1992b). The increased ventilatory drive associated with hypoxia exacerbates 
hypocapnia and associated cerebral vasoconstriction. This cerebral vasoconstriction is partly 
alleviated by hypoxaemia-mediated vasodilation and cortical activation-mediated vasodilation 
associated with exercise. The resulting reduction in cerebral blood flow, coupled with reduced 
CaO2, lowers cerebral DO2 and tissue oxygenation (Subudhi et al., 2007b). The subsequent 
reduction cerebral tissue oxygenation, combined with increased group III/IV phrenic and muscle 
afferents discharge, exacerbates the development of central fatigue and lowers central motor drive 
during exercise in hypoxia (Amann & Dempsey, 2008; Amann et al., 2013). 
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metabolite accumulation and activates unmyelinated group IV phrenic afferents (Dempsey et al., 
2006); these in turn increase sympathetic nerve activity (St Croix et al., 2000) and activate 
respiratory muscle metaboreceptors (Hussain et al., 1991; Sheel et al., 2001; Sheel et al., 2002). 
Elevations in sympathetic nerve activity and respiratory muscle metaboreceptor activation elicit 
constriction of the limb muscle vasculature via a supraspinal reflex (Dempsey et al., 2006), which 
redistributes cardiac output from the locomotor muscles to the respiratory muscles (the ‘blood steal’ 
effect) (Harms et al., 1997; Harms et al., 1998). As a result, increasing respiratory work during 
exercise causes earlier respiratory muscle fatigue onset and lowers locomotor muscle blood flow, 
thereby increasing the severity of locomotor muscle fatigue and perceptions of leg discomfort 
(Romer et al., 2006; Taylor & Romer, 2008). These adverse effects of increased respiratory work 
on muscle DO2, muscle fatigue, and perceptions of leg discomfort are amplified by hypoxia 
(Amann et al., 2007a; Verges et al., 2010). Collectively, these findings demonstrate that muscle 
DO2 can be impaired via increased respiratory work and the associated metaboreflex-mediated 
reduction in locomotor limb blood flow during exercise in hypoxia (Figure 8). 
 
A reduction in muscle DO2 in hypoxia leads to a mismatch between O2 requirement and supply 
(Amann & Calbet, 2008). As a consequence, for a given absolute workload, the relative exercise 
intensity in hypoxia is greater than in normoxia (Amann & Calbet, 2008). This increase in relative 
exercise intensity, associated with reduced muscle DO2, elevates type II muscle fibre recruitment 
(Merletti et al., 1990), and lowers the recruitment of fatigue-resistant, O2-dependent type I muscle 
fibres during muscle contractions (Dousset et al., 2001). Consequently, more type II fibres are 
recruited during hypoxic exercise, which accelerates the accumulation of metabolite (e.g., H+ and 
phosphates) (Edwards, 1981; Hogan et al., 1999; Amann et al., 2006). Metabolite accumulation 
disrupts sarcoplasmic reticulum Ca2+ release and uptake pathways (Allen et al., 1995; Dutka et al., 
2005), and inhibits the contractile apparatus (Godt & Nosek, 1989; Stienen et al., 1990; Fryer et al., 
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1995). An elevated metabolite accumulation in hypoxia can lead to early onset of excitation–
contraction coupling failure within the muscle fibre (i.e., muscle fatigue) (Amann & Calbet, 2008). 
The development of locomotor muscle fatigue—termed peripheral fatigue—plays a vital role in 
exercise performance by modulating central motor drive in a dose-dependent manner via group 
III/IV muscle afferent feedback (Figure 8) (Gandevia, 2001; Amann & Dempsey, 2008; Amann et 
al., 2010; Amann, 2011, 2012). 
 
Central fatigue in hypoxia 
It has been proposed that hypoxia of the central nervous system may lead to a reduced central motor 
command, which ultimately limits exercise performance under severe hypoxic conditions (Kayser et 
al., 1994; Amann et al., 2007b; Amann & Calbet, 2008; Amann & Kayser, 2009). It was thought 
that reduced cerebral DO2 and subsequent cerebral tissue deoxygenation might be a major limiting 
factor of exercise performance in hypoxia (Kjaer et al., 1999; Amann et al., 2006; Amann et al., 
2007b; Subudhi et al., 2007b; Rasmussen et al., 2010b; Vogiatzis et al., 2011). The pioneering 
work by Kayser et al., (1994) was the first to demonstrate that exhaustive exercise at 5,050 m could 
be prolonged with a rapid increase in FIO2 (FIO2: 1.0) at the point of maximal exertion, in 
acclimatised subjects during constant-load cycling to exhaustion. This observation has since been 
repeated during both constant-load exercise to exhaustion (Amann et al., 2007b) and incremental 
cycling (Subudhi et al., 2007b; Koglin & Kayser, 2013). These later studies further demonstrated 
that rapid switching to hyperoxia (FIO2: 0.30-0.60) improved performance during exercise in acute 
and chronic hypoxia, while no improvement could be found by increasing FIO2 at exhaustion in 
normoxia (Figures 9 & 10). Since the effect of the FIO2 increase was too quick to reverse the 
metabolic factors associated with peripheral fatigue, Kayser et al., (1994) and others (Amann et al., 
2007b; Subudhi et al., 2007b; Koglin & Kayser, 2013) concluded that the improvement in exercise 
performance was due to cerebral tissue reoxygenation. However, as noted by Subudhi et al.,
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Figure 9. Representative example showing the effects of a rapid increase in FIO2 at 
exhaustion on pedal frequency and endurance time to exhaustion. The arrow indicates 
the point at which the inspirate was switched from normoxia (A; FIO2: 0.21), moderate 
hypoxia (B, FIO2: 0.15), or severe hypoxia (C; FIO2: 0.10) to hyperoxia (FIO2: 0.30). 
From Amann et al., (2007b).  
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Figure 10. Representative changes in cerebral oxyhaemoglobin (HbO2) from a single 
subject performing incremental exercise to maximal exertion at sea level (thick solid 
line), acute hypoxia (thick shaded line), and chronic hypoxia (thin solid line). Arrows 
mark the gas switch to 60% inspired oxygen. The subject could not continue exercise 
after the gas switch at sea level; however, during the hypoxic trials, the gas switch 
improved cerebral oxygenation and maximal exercise performance by 9% and 20% in 
acute hypoxia and chronic hypoxia, respectively. From Subudhi et al., (2007b).  
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(2011b), these conclusions based on rapid O2 switching studies are limited by the fact that the 
improvement of arterial oxygenation is systemic, and thus not localised only to the brain.  
 
During high-intensity exercise, hyperventilation-induced hypocapnia leads to cerebral 
vasoconstriction, which counteracts the hypoxia-induced vasodilation, thereby lowering CBF, 
cerebral DO2 and cerebral oxygenation (Figure 8) (Herholz et al., 1987; Thomas et al., 1989; 
Jorgensen et al., 1992b; Madsen et al., 1993; Subudhi et al., 2007a). An enhanced ventilatory drive 
associated with hypoxia exacerbates the hyperventilation-induced hypocapnia during heavy 
exercise, and further lowers CBF and cerebral oxygenation. Evidence implicating cerebral 
deoxygenation on performance comes from the observation that cerebral deoxygenation precedes 
the development of central fatigue during exercise, which coincides with both reduced cortical 
motor output and increased cerebral metabolism (Secher et al., 2008; Subudhi et al., 2009a; 
Rasmussen et al., 2010a). Under severe hypoxic conditions, several studies have reported a 
relationship between performance and cerebral deoxygenation during various exercise modes such 
as repeated sprints (Smith & Billaut, 2010), incremental exercise (Peltonen et al., 2009; Subudhi et 
al., 2009a; Vogiatzis et al., 2011), and static maximal muscle contraction to exhaustion (Rasmussen 
et al., 2007; Rupp & Perrey, 2009; Goodall et al., 2010). Similarly, exacerbation of the exercise-
induced cerebral deoxygenation with non-selective beta-blockade reduces maximal exercise 
performance under normoxic conditions (Seifert et al., 2009). From these findings, it was 
hypothesised that reduced cerebral DO2 and associated cerebral tissue deoxygenation may be a 
limiting factor of performance during exercise in severe hypoxia (Nybo & Rasmussen, 2007; 
Amann & Dempsey, 2008; Amann & Kayser, 2009). In support of this notion, Goodall et al., 
(2014) found reduced cortical voluntary activation (i.e., index of supraspinal fatigue) and prefrontal 
tissue oxygenation (compared to baseline values) following constant-load cycling in acute hypoxia 
(FIO2: 0.105), while no reductions were observed in normoxia (Figure 11). Interestingly, these 
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Figure 11. Panel A: Representative motor-evoked potentials evoked during 
knee extensor contractions at 50% maximal voluntary contraction before 
exercise in each condition. Note the increase in motor-evoked potential 
amplitude (corticospinal excitability) after acclimatisation. Panel B: Cortical 
voluntary activation measured before (open bars) and immediately after 
(<2.5 min; closed bars) constant-load exercise (131 W) in normoxia, acute 
hypoxia and chronic hypoxia. * Different between pre- vs. post-exercise 
(P<0.05). From Goodall et al., (2014).  
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reductions in post-exercise cortical voluntary activation and prefrontal tissue oxygenation in acute 
hypoxia were abolished after 16 days of acclimatising to 5,260 m, while corticospinal excitability 
was increased twofold compared to pre-exercise values (Figure 11). These findings led the authors 
to conclude that: i) exhaustive exercise in acute hypoxia is associated with the development of 
supraspinal fatigue—termed central fatigue—which is attenuated after a period of high altitude 
acclimatisation, and ii) that the observed reduction in central fatigue with acclimatisation was likely 
due to enhanced corticospinal excitability associated with increased cerebral DO2 and tissue 
oxygenation. 
 
Recently, studies have attempted to investigate the role of cerebral tissue oxygenation on aerobic 
capacity by selectively elevating CBF (therefore cerebral DO2) with CO2 breathing during 
incremental cycling to exhaustion in severe hypoxia (Subudhi et al., 2011b; Siebenmann et al., 
2013). Subudhi et al., (2011b) reported impaired exercise capacity at 1,600 m and 4,875 m 
(hypobaric chamber) where they clamped the subjects’ partial pressure of end-tidal CO2 (PETCO2) 
either at: 1) 50 mmHg throughout incremental exercise or 2): 40 mmHg from ~75% maximal power 
output until exhaustion (Figure 12). They found VE to be greatly elevated (by ~50 L/min) with 
PETCO2 clamping during submaximal exercise intensities (37 and 75% of maximal hypoxic power 
output), compared to room air breathing. Accordingly, they attributed the reduced performance with 
PETCO2 clamping to earlier functional limitation by the respiratory system with CO2 breathing. 
Siebenmann et al., (2013) completed those observations by investigating, at a more moderate 
altitude (3,454 m), the impact of clamping PETCO2 at 40 mmHg on aerobic capacity. These studies 
found clamping PETCO2 increased MCAv (and presumably cerebral DO2) and attenuated the 
decrease in cerebral oxygenation, but slightly decreased maximal power output without affecting 
maximal O2 uptake. However, the subjects studied were either residents of moderate altitude 
(Subudhi et al., 2011b) or low altitude residents following a day spent at high altitude (Siebenmann 
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et al., 2013). These two conditions are known to enhance cerebrovascular and ventilatory 
responsiveness to CO2 (Fan et al., 2010a; Fan et al., 2012a), and thus the acute effect elevating CBF 
(therefore cerebral DO2) during exercise in severe hypoxia in an altitude-naïve population remained 
unclear. Given the importance of aerobic capacity on our ability to thrive in extreme environments, 
the potential role of reduced cerebral DO2 and subsequent cerebral tissue deoxygenation in limiting 
performance in hypoxia warrants further investigation. 
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Figure 12. Control (○) and clamp (●) experiments in normoxia, hypoxia, and follow-up. 
Mean ± SD at 0 W, 25, 50, 75, and 100% of maximal power output. PETCO2 was clamped 
at 50 mmHg in normoxia and hypoxia throughout exercise. In follow-up trials, PETCO2 
was clamped at 40 mmHg from 75% to 100% maximal power output. Clamping increased 
cerebral blood flow velocity (CBFv) and cerebral oxygenation, but decreased maximal 
power output. △TSI, change in tissue saturation index. * Different from control (P<0.05); # 
Non-significant trend (P<0.10). From Subudhi et al., (2011).  
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Aim 
The primary aim of this thesis work was to quantify the changes in CBF control upon exposure to 
high altitude and following a period of acclimatisation. The secondary aim of this thesis work was 
to determine the role of cerebral DO2 and tissue oxygenation for the limits of endurance 
performance during exercise in severe hypoxia in an altitude-naïve population. 
 
 
Hypotheses 
Two novel hypotheses were tested: 
1) The changes in CBF and CaO2 at high altitude are matched as to maintain 
cerebral DO2 constant during initial exposure and following acclimatisation. This 
would be due, in part, to changes in cerebrovascular CO2 reactivity and CA. 
 
2) In altitude-naïve subjects, CO2 breathing during whole-body exercise in severe 
hypoxia selectively increases CBF and cerebral DO2, thereby improving cerebral 
tissue oxygenation and exercise performance. 
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Summary of results 
Article one 
Subudhi AW, Fan JL, Evero O, Bourdillon N, Kayser B, Julian CG, Lovering AT & Roach RC. 
(2014). AltitudeOmics: Effect of ascent and acclimatization to 5,260 m on regional cerebral oxygen 
delivery. Experimental Biology 99, 772-781.  
  
We assessed changes in blood flow in the internal carotid artery (ICA) and vertebral artery (VA) (as 
indexes of global and regional CBF), cerebral DO2, and CaO2 in 21 lowlanders (9 females), at sea 
level (SL), during initial exposure to 5,260m (ALT1), after 16 days of acclimatisation (ALT16), and 
upon re-exposure to altitude following either 7 (POST7) or 21 days (POST21) at low altitude 
(1,525m). Global CBF increased ~70% upon arrival at ALT1 (P<0.05) and returned to SL values at 
ALT16 as a result of changes in cerebral vascular resistance. A reciprocal pattern in CaO2 
maintained global cerebral DO2 across acclimatisation. During acute exposure to high altitude at 
ALT1, DO2 to the posterior cerebral circulation (via VA) was increased by ~25% at ALT1 
(P<0.05), while no difference was observed in DO2 via the ICA (P>0.05).  
 
Contribution: Contributed to the conception and design of the experiment, carried out data 
collection, and assisted in the interpretation of data and manuscript revision. 
 
   48 
Article two 
Fan JL, Subudhi AW, Evero O, Bourdillon N, Kayser B, Lovering AT & Roach RC. (2014). 
AltitudeOmics: Enhanced cerebrovascular reactivity and ventilatory response to CO2 with high 
altitude acclimatisation and re-exposure. Journal of Applied Physiology (1985) 116, 911-918.  
  
We assessed changes in steady-state responses of middle cerebral artery velocity (MCAv), 
cerebrovascular conductance index (CVCi), MAP, and VE to varied levels of CO2 in 21 lowlanders 
(9 females), at sea level (SL), during initial exposure to 5,260m (ALT1), after 16 days of 
acclimatisation (ALT16), and upon re-exposure to altitude following either 7 (POST7) or 21 days 
(POST21) at low altitude (1,525m). In addition, we measured resting pH and bicarbonate 
concentration at these time points. In the non-acclimatised state (ALT1), MCAv and VE responses 
to CO2 were elevated compared to SL (by 79 ± 75% and 14.8 ± 12.3 L/min, respectively, P<0.05). 
Acclimatisation at ALT16 further elevated both MCAv and VE responses to CO2 compared to 
ALT1 (by 89 ± 70% and 48.3 ± 32.0 L/min, respectively, P<0.05). Likewise, both CVCi-CO2 and 
MAP-CO2 slopes were elevated at ALT1 (by 82 ± 79% and 256 ± 265%, respectively, P<0.05), 
while acclimatisation at ALT16 further elevated MAP-CO2 slope by 164 ± 1370%, P<0.05) but not 
CVCi-CO2 slope (P>0.05). The acclimatisation gained for VE responses to CO2 at ALT16 was 
retained by 38% upon re-exposure to altitude at POST7 (P<0.05 vs. ALT1), while no retention was 
observed for the MCAv responses (P>0.05). We found good agreement between steady-state and 
modified rebreathing estimates of MCAv and VE responses to CO2 across all time points (P<0.05, 
pooled data). Furthermore, we found resting bicarbonate concentration correlated with steady-state 
MCAv-CO2 slope (R=-0.771) and VE at 40 mmHg (R=-0.723, P<0.05 for both). 	  
 
Contribution: Contributed to the conception and design of the experiment, carried out data 
collection, and led the analysis, interpretation, writing of the manuscript and the editorial process. 
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Article three 
Subudhi AW, Fan JL, Evero O, Bourdillon N, Kayser B, Julian CG, Lovering AT, Ronney B & 
Roach RC. (2014). AltitudeOmics: Cerebral autoregulation during ascent, acclimatization, and re-
exposure to high altitude and its relation with acute mountain sickness. Journal of Applied 
Physiology (1985) 116, 724-729.  
  
We assessed symptoms of acute mountain sickness (AMS) and dynamic CA during room air 
breathing in 21 lowlanders (9 females) at sea level (SL), during initial exposure to 5,260m (ALT1), 
after 16 days of acclimatisation (ALT16), and upon re-exposure to altitude following either 7 
(POST7) or 21 days (POST21) at low altitude (1,525m). CA was impaired upon arrival at ALT1 
(P<0.05) and did not change with acclimatisation at ALT16 or upon re-exposure at POST7. CA was 
not associated with AMS scores (all R<0.50, P>0.05). 
 
Contribution: Contributed to the conception and design of the experiment, carried out data 
collection, and assisted in the interpretation of data and manuscript revision. 
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Article four 
Fan JL & Kayser B. (2014). Repeated pre-syncope from increased inspired CO2 in a background of 
severe hypoxia: a case report. High Altitude Medicine and Biology 15, 70-77.  
 
We describe a case of experimentally-induced pre-syncope in a healthy young man when exposed 
to increased inspired CO2 in a background of normobaric hypoxia (FIO2: 0.11). Acute severe 
hypoxia was tolerated, but adding CO2 to the inspirate caused pre-syncope symptoms accompanied 
by hypotension and large reductions in both mean and diastolic middle cerebral artery velocity, 
while systolic flow velocity was maintained. The mismatch of cerebral perfusion pressure and 
vascular tone caused unique retrograde CBF at the end of systole and a reduction in cerebral tissue 
oxygenation.  
 
Contribution: Carried out data collection, and led the analysis, interpretation, writing of the 
manuscript and the editorial process. 
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Article five 
Fan JL & Kayser B. (2014). Effect of adding CO2 to hypoxic inspired gas on cerebral blood flow 
velocity and breathing during incremental exercise. PLoS One 8, e81130. 
 
We assessed the effect of CO2 breathing and normobaric hypoxia (FIO2: 0.11) on CBF and 
ventilatory response to exercise during incremental cycling to exhaustion in 10 healthy male 
subjects. During exercise in normoxia, augmenting the fraction of inspired CO2 (FICO2) elevated 
MCAv throughout exercise and lowered both respiratory compensation threshold (RC) onset and VE slope below RC (P<0.05). In hypoxia, MCAv and VE slope below RC during exercise were 
elevated, while the onset of RC occurred at lower exercise intensity (P<0.05). CO2 breathing in 
hypoxia increased VE at RC (P<0.05) but no difference was observed in RC onset, MCAv, or VE 
slope below RC (P>0.05). The VE slope above RC was unchanged with either hypoxia or CO2 
breathing (P>0.05). We found CO2 breathing increased CBF during sub-maximal exercise in 
normoxia, but not in hypoxia, indicating that the ‘normal’ cerebrovascular response to hypercapnia 
is blunted during exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory 
reserve.  
 
Contribution: Carried out data collection, and led the analysis, interpretation, writing of the 
manuscript and the editorial process. 
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Article six 
Fan JL, Bourdillon N & Kayser B. (2014). Effect of end-tidal CO2 clamping on cerebrovascular 
function, oxygenation, and performance during 15-km time trial cycling in severe normobaric 
hypoxia: the role of cerebral O2 delivery. Physiological Reports 1, 1-15.  
 
We assessed the effect of clamping end-tidal PCO2 on CBF, cerebral tissue oxygenation, DO2, and 
exercise performance during 15 km time trial (TT) cycling in normoxia and normobaric hypoxia 
(FIO2: 0.11) in 10 healthy male subjects. During exercise, hypoxia elevated MCAv and lowered 
cerebral concentration of oxyhaemoglobin ([O2Hb]), cerebral DO2 and muscle concentration of 
[O2Hb] (P<0.05). CO2 clamping elevated PETCO2 and MCAv during exercise in both normoxic and 
hypoxic conditions (P<0.05), but had no effect on either cerebral and muscle concentration of 
[O2Hb] (P>0.05). Nevertheless, CO2 clamping elevated cerebral DO2 during TT in both normoxic 
and hypoxic conditions (P<0.05). CO2 clamping restored cerebral DO2 to normoxic values during 
TT in hypoxia and tended to have a greater effect on TT performance in hypoxia compared to 
normoxia (P>0.05). Despite this, post hoc analysis revealed no effect of CO2 clamping on TT 
performance either in normoxia or in hypoxia (P>0.05).  
 
Contribution: Carried out data collection, and led the analysis, interpretation, writing of the 
manuscript and the editorial process. 
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Article seven 
Fan JL, Leiggener C, Rey F & Kayser B. (2012). Effect of inspired CO2 on the ventilatory 
response to high intensity exercise. Respiratory Physiology and Neurobiology 180, 283-288.  
  
We assessed the effect of CO2 breathing on ventilatory response to exercise during incremental 
cycling to exhaustion in 10 healthy male subjects in normoxia. During high-intensity exercise, CO2 
breathing elevated PETCO2 during incremental cycling (P<0.05), while PETO2 remained unchanged 
(P>0.05). During high intensity exercise, CO2 breathing elevated tidal volume at 80, 90 and 100% 
of maximal O2 consumption (P<0.05), while no differences were observed in VE, breathing 
frequency, CO2 production, O2 consumption or power output (P>0.05). CO2 breathing lowered both 
RC and VE slope below RC during incremental cycling (P<0.05). No difference was observed in the VE slope above RC between CO2 breathing and control (P>0.05). 
 
Contribution: Carried out data collection, and led the analysis, interpretation, writing of the 
manuscript and the editorial process. 
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Discussion 
This thesis set out to test two major hypotheses. First, that the changes in CBF and CaO2 at high 
altitude would be sufficient to maintain constant cerebral DO2 during initial exposure and following 
acclimatisation, with these changes possibly mediated by changes in cerebrovascular function. 
Secondly, that the prevention of hypocapnia with CO2 breathing selectively increases CBF and 
cerebral DO2, thereby improving cerebral tissue oxygenation and exercise performance during 
heavy exercise in severe hypoxia.  
 
In agreement with our first hypothesis, we found cerebral DO2 to be maintained during both acute 
and chronic exposure to high altitude. This was primarily mediated by reciprocal changes in global 
CBF and CaO2. Our findings also showed enhanced cerebrovascular CO2 reactivity during acute 
exposure to high altitude, which was further increased with acclimatisation. In agreement with 
previous studies, we found CA to be impaired upon ascent to high altitude, which persisted after 
acclimatisation despite improvements in PaO2 and CaO2. Since the changes in cerebrovascular CO2 
reactivity correlated with the changes in arterial blood acid-base balance across all time points, we 
speculate that the alterations in cerebrovascular function at high altitude might be linked to a 
common mechanism of the arterial buffering capacity.  
 
In contrast to our second hypothesis, we were unable to improve exercise performance by 
preventing the normal hyperventilation-induced hypocapnia and associated cerebral deoxygenation 
during cycling in severe hypoxia. Despite a greater increase in PETCO2 with our CO2 breathing 
setup during hypoxic exercise, we observed only modest elevations in CBF compared to during 
normoxic exercise. We attributed this to an impaired cerebrovascular CO2 reactivity during exercise 
due to an exhausted vasodilatory reserve associated with hypoxia. Nevertheless, we restored 
cerebral DO2 to normoxic values during hypoxic exercise with our setup due to an increase in VE 
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(and therefore PaO2 associated with hypercapnia) coupled with a modest increase in CBF. Since 
these effects did not lead to improved cerebral tissue oxygenation or exercise performance, our 
findings do not support the role of hyperventilation-induced hypocapnia and associated cerebral 
deoxygenation in limiting performance during whole-body exercise in severe hypoxia.  
  
Regulation of cerebral blood flow during high altitude exposure 
The effect of high altitude exposure on resting CBF has been documented using the Kety-Schmidt 
method (Severinghaus et al., 1966; Milledge & Sorensen, 1972; Jensen et al., 1990; Møller et al., 
2002), vascular Doppler ultrasound (Huang et al., 1987; Willie et al., 2014a), and transcranial 
Doppler ultrasound (Baumgartner et al., 1994; Thomas et al., 2008). In his pioneering work, 
Severinghaus et al., (1966) found CBF to be increased by 24% after 6-12 h at 3,810 m, which later 
declined to 13% above sea-level values following 3-5 days of exposure. Subsequent studies have 
added detail to this initial observation, by showing that the increase in CBF peaks after ~1-2 days at 
high altitude, before returning to sea-level values following 1-3 weeks of acclimatisation (Milledge 
& Sorensen, 1972; Huang et al., 1987; Jensen et al., 1990; Baumgartner et al., 1994; Møller et al., 
2002; Willie et al., 2014a). Using vascular Doppler ultrasound, we measured ICA and VA blood 
flow during acute and chronic high altitude exposures, from which we were able to calculate global 
CBF (Subudhi et al., 2014b). Our data extends those previous studies by demonstrating that the 
decline in CBF with acclimatisation to high altitude is offset by a reciprocal elevation in CaO2, thus 
maintaining global cerebral DO2 (Figure 13). Accordingly, our findings demonstrate that the 
intrinsic mechanisms, which regulate CBF reciprocally to the changes in CaO2, are well suited to 
maintain global cerebral DO2 across acclimatisation at 5,260 m. This reciprocal relationship, 
whether evolved or serendipitous, is advantageous for survival in these extreme conditions as it 
mitigates negative consequences of cerebral hypoxaemia. 
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Figure 13. Reciprocal changes in global cerebral blood 
flow (gCBF) and CaO2 maintained global cerebral DO2 
throughout the study. Values expressed as mean ± SD. * 
Different from SL (P<0.05); † Different from ALT1 
(P<0.05). From Subudhi et al., (2014b). 
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Figure 14. Regional DO2 delivery in the vertebral but not in 
the internal carotid artery upon arrival to high altitude 
(ATL1). Values expressed as mean ± SD. Regional DO2 in 
reduced with acclimatisation, but not below SL values. * 
Different from SL (P<0.05); † Different from ALT1 
(P<0.05). From Subudhi et al., (2014b). 
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We found regional differences in CBF responses to acute hypoxia (therefore cerebral DO2), with 
higher VA blood flow upon ascent to 5,260 m (Figure 14). As a result, brain DO2 via the VA was 
elevated upon ascent to high altitude, while ICA DO2 was unchanged (Figure 14). This observation 
supports findings by Ogoh et al., (2013), which showed a 10% increase in VA blood flow during 
acute hypoxic exposure (FIO2: 0.12, PIO2: 86 mmHg), while ICA blood flow was slightly reduced 
due to the constricting effect of relative hypocapnia associated with hypoxia. Similarly, Willie et 
al., (2012) found VA diameter increased by 8% during severe hypoxic exposure (PaO2: 35 mmHg), 
while hypocapnia per se (PETCO2: 15, 20, and 30 mmHg) had no effect. They also found ICA 
diameter to be highly sensitive to changes in PaCO2, but not to hypoxia. In agreement, Sato et al., 
(2012) found the VA blood flow response to hypocapnia to be relatively blunted compared to the 
ICA blood flow response. Together with our observations, these findings are suggestive of a high 
sensitivity of the vertebral vascular bed (and thus VA blood flow) to hypoxia but not to hypocapnia. 
During exposure to hypoxia and associated hypocapnia, such selectivity of VA blood flow 
responses to these blood gas changes may serve to maintain sufficient O2 supply to posterior brain 
regions, given these posterior areas are involved in vital cerebral functions associated with 
homeostasis.  
 
Cerebrovascular CO2 reactivity at high altitude 
During acute and chronic high altitude exposure, the control of CBF is the net result of hypoxia-
induced vasodilation, offsetting the vasoconstriction associated with hyperventilation-induced 
hypocapnia (Brugniaux et al., 2007). With acclimatisation to high altitude, the progressive increase 
in ventilatory drive lowers PaCO2 and elevates PaO2. These arterial blood gas changes alleviate 
hypoxia and exacerbate hyperventilation-induced hypocapnia, thus shifting the balance of the 
cerebrovascular tone in favour of vasoconstriction. It is this hyperventilation-induced hypocapnia 
that is responsible for restoring CBF to sea-level values following initial exposure to high altitude. 
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Accordingly, the cerebrovascular CO2 reactivity plays a pivotal role in regulating CBF at high 
altitude. Fan et al., (2010a; 2012a) found the cerebrovascular CO2 reactivity to be elevated after 1-3 
days and ~7 days at 5,050 m in subjects whom spent 8 days trekking to this altitude (and thus were 
partially acclimatised). Our data extends those observations by showing cerebrovascular CO2 
reactivity was increased during initial exposure to high altitude at ALT1 (<8 hours), in a larger 
cohort rapidly ascending from 1,600 m to 5,260 m (~3 hours) (Figure 15). We found 
cerebrovascular CO2 reactivity to be further elevated following 16 days of acclimatisation to high 
altitude. Our findings, together with the reports by Fan et al., (2010a; 2012a), indicate that 
irrespective of the rate of ascent, cerebrovascular CO2 reactivity is elevated upon initial exposure to 
high altitude, and further elevated with acclimatisation. 
 
An important consideration when examining the changes in cerebrovascular CO2 reactivity is the 
method of assessment. Two methods are commonly used for assessing ventilatory CO2 sensitivity 
and cerebrovascular CO2 reactivity; the modified Read’s rebreathing and the steady-state method. 
The original Read’s method was first described by Read (1967) and was subsequently modified by 
Duffin & McAvoy (1988), which consisted of a period of voluntary hyperventilation followed by 
rebreathing from a 6-L bag filled with 6-7% CO2 in O2. Meanwhile, in the steady-state method 
FICO2 is manipulated to increase PETCO2 in a stepwise manner to a new level, and held constant at 
this new higher PETCO2 until VE reaches a new steady state. At sea level, the steady-state method 
results in higher estimates of cerebrovascular CO2 reactivity (Pandit et al., 2001, 2003, 2007) and 
lower estimates of ventilatory CO2 sensitivity (Tenney et al., 1963; Berkenbosch et al., 1989; 
Jacobi et al., 1989; Fan et al., 2010b) compared to the modified rebreathing test. This discrepancy 
between the two methods has been attributed to the presence of a PCO2 gradient (between alveolar, 
arterial, and cerebrospinal fluid compartments) during the steady-state method, which is supposedly 
abolished or minimised during rebreathing (Berkenbosch et al., 1989). Meanwhile, elevated basal 
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Figure 15. Changes in steady-state estimates of cerebrovascular, cardiovascular, and 
ventilatory responsiveness to CO2 with acclimatisation and reexposure to 5,260 m. Values 
expressed as mean ± SD. * Different from sea-level (SL; P<0.05); † Different from arrival at 
altitude (ALT1; P>0.05); § Different from acclimatisation (ALT16; P<0.05). From Fan et 
al., (2014). 
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VE and subsequent underestimation of the ventilatory CO2 sensitivity has been proposed as another 
possible explanation for lower steady-state estimates (Mohan et al., 1999). In our work, we found 
close agreement between steady-state and rebreathing estimates of CBF and ventilatory response to 
CO2 at sea level and high altitude (Figure 16). Specifically, the trend of changes in steady-state and 
rebreathing estimates of cerebrovascular CO2 reactivity and ventilatory CO2 sensitivity were 
identical upon ascent and following acclimatisation to 5,260 m. These findings support the use of 
both the steady-state method and the modified rebreathing method for the assessment of 
cerebrovascular and ventilatory changes with high altitude ascent. 
 
In contrast to our results, Lucas et al., (2011) found steady-state cerebrovascular CO2 reactivity to 
be increased initially, and lowered subsequently with acclimatisation. However, since they did not 
control PETO2, the cerebrovascular CO2 reactivities reported by Lucas et al., (2011) at 5,050 m 
reflected MCAv changes from hypoxic hypocapnia (room air breathing: PETO2 ~44-48 mmHg, and 
PETCO2: ~26-22 mmHg) to hypercapnic hyperoxia (PETO2 >310 mmHg, and PETCO2 ~30 mmHg), 
and thus do not represent isolated reactivities to CO2. Accordingly, the discrepancies between our 
finding and those by Lucas et al., (2011) can be accounted for by the better control of changes in 
PaO2 and PaCO2 in our study. Indeed, we assessed the cerebrovascular CO2 reactivity over similar 
arterial blood gas ranges (i.e., PaCO2: ~20-40 mmHg, PETO2: >200 mmHg) across all time points, 
thus making comparisons possible. More recently, Rupp et al., (2014) and Villien et al., (2013) 
found, using the same cohort, reduced cerebrovascular CO2 reactivity during steady-state  hypoxic 
hypercapnia following 5 days at 4,350 m. Since hypoxia has been shown to exacerbate the CBF 
response to CO2 (Battisti-Charbonney et al., 2011), the cerebrovascular CO2 reactivities reported by 
Rupp et al., (2014) and Villien et al., (2013) were likely overestimating the ‘true’ sea-level values 
due to the background hypoxia used. Furthermore, the level of background hypoxia used by these 
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Figure 16. Comparison of steady-state and rebreathing estimates 
of cerebrovascular and ventilatory responsiveness to CO2 with 
acclimatisation to 5,260 m. * Significant correlations (P<0.05). 
From Fan et al., (2014) 
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studies (PETO2 ~55 mmHg) was actually slightly hyperoxic compared to room-air breathing at 
4,350 m (reported resting PETO2: ~47-50 mmHg), potentially leading to an underestimation of the 
cerebrovascular CO2 reactivity values at high altitude. These findings highlight the importance of 
selecting appropriate ranges of end-tidal (and therefore arterial) gases when assessing 
cerebrovascular reactivity. Particular care should be taken when choosing the background O2 level 
to ensure identical relative and absolute stimuli between time points, thus avoiding any potential 
confounding effect of hypoxia/hyperoxia on cerebrovascular CO2 reactivity between testing 
sessions.  
 
In contrast to cerebrovascular CO2 reactivity, the CVCi-CO2 reactivity was unaltered with 
acclimatisation at ALT16 (Figure 15). From this perspective, it seems that the major part of the 
increase in cerebrovascular CO2 reactivity following acclimatisation to high altitude may be due to 
an enhanced blood pressure response to CO2. In support, we found the MAP response to CO2 to be 
enhanced upon acute exposure to 5,260 m and further elevated with acclimatisation (Figure 15). 
Under normal conditions, an increase in MAP does not lead to concurrent increases in CBF. This is 
due in part to the presence of CA, which serves to maintain CBF constant within a wide range of 
perfusion pressures. However, an impaired CA associated with high altitude exposure, coupled with 
enhanced MAP-CO2 response, could account for the enhanced cerebrovascular CO2 reactivity with 
acclimatisation, as observed in our study (see section ‘Perfusion pressure and cerebrovascular CO2 
reactivity’ below).  
 
Cerebral autoregulation at high altitude 
It has long been postulated that an impaired CA may be involved in the pathogenesis of AMS, high 
altitude headache and cerebral oedema (Lassen & Harper, 1975; Hackett & Roach, 2001; Van Osta 
et al., 2005; Bailey et al., 2009; Cochand et al., 2011). Previous work by Subudhi et al., (2010; 
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2011a) and Ainslie et al., (2008) found CA impairment preceded the development of AMS during 
hypobaric hypoxia. However, these studies did not find a link between the drop in CA and the 
severity of AMS. In our study, rapid ascent to high altitude increased transfer function coherence 
and gain at ALT1, while phase shift and autoregulation scores were reduced (Figure 17), consistent 
with the classic definition of impaired CA. This impaired CA, already present after less than one 
day of travel from low to high elevation, confirms findings by Subudhi et al., (2010) of reduced CA 
parameters after 4 h in a hypobaric chamber. Our work fills an important gap in the literature 
between studies conducted in laboratories with hypoxic gas mixtures [where normobaric hypoxia 
was achieved in a matter of minutes (Iwasaki et al., 2007; Bailey et al., 2009; Subudhi et al., 2009b; 
Querido et al., 2013)], and studies of trekkers where several days of progressive ascent preceded 
initial high-altitude measurements (Jansen et al., 2000; Van Osta et al., 2005; Ainslie et al., 2008; 
Ainslie et al., 2012). With the exception of the work by Querido et al., (2013), an impaired CA at 
rest in acute hypoxia is a consistent finding in the literature, suggesting that neither the mode nor 
rate of ascent affect the general effect of hypoxia on CA. 
 
We found no improvement in CA with acclimatisation to high altitude despite increased PaO2 
(Figure 17), which by itself is known to improve CA (Ainslie et al., 2008; Subudhi et al., 2010). 
Our longitudinal findings are consistent with numerous cross-sectional studies which have found 
impaired CA at various time points after arrival to high altitude (Jansen et al., 2000; Van Osta et al., 
2005; Ainslie et al., 2008; Cochand et al., 2011; Ainslie et al., 2012), as well as in permanent high-
altitude residents (Jansen et al., 2000; Jansen et al., 2007). We found no correlations between the 
measures of CA and AMS symptom scores at ALT1 (Figure 18). This observation confirms work 
by Subudhi et al., (2010), which showed similar CA impairment in those subjects who developed 
AMS and those who did not, following 10 h of hypobaric hypoxic exposure. Accordingly, we 
conclude that the development of ‘impaired’ CA is a normal adaptive physiological response 
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Figure 17. Arterial blood pressure to cerebral blood flow velocity transfer function metrics 
(mean ± SD from 0 to 0.5 Hz) at sea level (SL), upon arrival at 5,260 m (ALT1), after 16 days 
of acclimatisation (ALT16). Similar impairments in cerebral autoregulation (increased 
coherence and gain and decreased phase shift) from SL were seen in the very low frequency 
(0.02-0.07 Hz; shaded areas) at ALT1 and ALT16 (P<0.05). rad, radians. * Different from SL. 
From Subudhi et al., (2014a). 
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Figure 18 Scatter plots showing no relation (P>0.05) between 
autoregulation indices (ARI), measured at SL (top) and as the 
change (△) from SL to arrival at high altitude (ALT1; bottom), 
and acute mountain sickness symptoms’ scores from the Lake 
Louise Questionnaire (LLQ) at ALT1. From Subudhi et al., 
(2014a). 
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to high altitude exposure, in the absence of pathology. However, since our findings are at odds with 
observations by other studies, which found some association between CA and AMS symptoms 
(Van Osta et al., 2005; Bailey et al., 2009), we cannot completely exclude the possibility that 
alterations in CA might partly contribute to the pathogenesis of AMS during acute exposure to high 
altitude.  
 
Perfusion pressure and cerebrovascular CO2 reactivity 
In a case study, we reported dramatic reductions in MAP during CO2 breathing in background 
hypoxia in a healthy young male subject (Fan & Kayser, 2014). This severe and acute hypotension 
associated with hypercapnia in background hypoxia led to a dramatic reduction in CBF, severe 
prefrontal deoxygenation, and subsequent development of pre-syncope symptoms (Figures 19 & 
20). To the best of our knowledge, this is the first report documenting reduced CBF during a pre-
syncope response triggered by CO2 enriched inspired gas in a background of hypoxia. The 
observation during the second episode of a drop in frontal cortex oxygenation suggests that the pre-
syncope syndrome was accompanied by reduced cerebral oxygen availability (Figure 20). We found 
dramatic reductions in mean and diastolic MCAv during and immediately following CO2 breathing 
in hypoxia (Figure 19). Meanwhile, the reduction in cerebral [O2Hb] followed closely the changes 
in diastolic MCAv (Figure 20), suggesting that diastolic perfusion pressure was the main 
determinant of cerebral DO2. We attribute the observed reduction in CBF and subsequent cerebral 
tissue desaturation to the direct effect of severe hypotension per se. 
 
Our findings are in agreement with an early study by Harper and Glass (1965), who demonstrated 
that reducing MAP to 100 mmHg blunts the cerebrovascular CO2 reactivity (PaCO2 = 80 mmHg) 
by 50% in anaesthetised dogs, while severe hypotension (MAP = 50 mmHg) completely abolished 
the CBF response to hypercapnia. Similarly, Ainslie et al., (2012) found cerebrovascular CO2
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Figure 19. Cerebrovascular and cardiovascular variables during visit one. Cerebral 
vascular resistance (CVR), arterial blood pressure (ABP), total peripheral resistance (TPR), 
cardiac output (Q’), and stroke volume (SV). During exposure to hypoxia + CO2, despite 
increases in HR, mean, systolic and diastolic ABP progressively decrease due to decreases 
in Q’ and SV. From Fan & Kayser (2014).  
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reactivity to be reduced due to a blunted MAP-CO2 response following α and β sympathetic 
blockade at sea level and following ascent to high altitude. Collectively, it appears that blood 
pressure plays an important role in the CBF response to CO2. 
 
What are potential mechanisms for such an effect of CO2 breathing in a background of hypoxia? In 
normoxic conditions, hypercapnia has been shown to elicit a vasodilatory effect on the peripheral 
vasculature in humans (Lennox & Gibbs, 1932; Kontos, 1971; Kontos et al., 1972; Gastaldo et al., 
1974; Ainslie et al., 2005). Hypercapnia (10% CO2) causes an immediate, but transient 
hypotension, which is corrected within 30-40 s from increased sympathetic activity, in anesthetised, 
sino-aortic denervated and vagotomised rats (Takakura et al., 2011). Since inhibition of the retro-
trapezoid nucleus lowers sympathetic nerve activity and attenuated mean MAP recovery at the end 
of the hypercapnic exposure (Takakura et al., 2011), those authors concluded that the compensatory 
increase in sympathetic nerve activity is partly dependent on retro-trapezoid nucleus activation 
during hypercapnic exposure. Similarly, pontine noradrenergic neurons, astrocytes, neurons of the 
nucleus solitary tract and wake-ON orexinergic neurons, have all been shown to be 
hypercapnia/pH-sensitive and linked to sympathetic tone, contributing to peripheral vascular tone 
during hypercapnic exposure (Dean et al., 1989; Dun et al., 2000; Johnson et al., 2008; Allen & 
Barres, 2009). In humans, profound sympathoinhibition has been reported during exposure to 
combined hypoxia and hypercapnia, resulting in vasovagal syncope (Halliwill, 2003). Our finding 
of a reduced ratio between low-to-high frequencies of heart rate variability (index of sympathetic 
activity) is in agreement with that finding (Fan & Kayser, 2014). Furthermore, since our subject’s 
MAP was well maintained during hypercapnic exposure in normoxia, we speculate that, the output 
of the brain regions responsible for the compensatory sympathetic response to hypercapnia might be 
attenuated during exposure to hypoxia.  
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Figure 20. Cerebrovascular and cardiovascular variables during visit two. Cerebral 
vascular resistance (CVR), arterial blood pressure (ABP), total peripheral resistance 
(TPR), cardiac output (Q’), and stroke volume (SV). From Fan & Kayser (2014). 
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In a recent review, Willie et al., (2014b) speculated that CA and cerebrovascular CO2 reactivity 
might be linked, utilising the same vascular reserve. Along the same line, Carrera et al., (2009) 
reported an inverse relationship between the reduction in CA parameters with CO2 breathing (5% 
CO2) and cerebrovascular CO2 reactivity. In our altitude studies, we found the increase in 
cerebrovascular CO2 reactivity was primarily driven by enhanced MAP response to CO2 with 
acclimatisation (Fan et al., 2014), while CA was lowered during both acute and chronic exposures 
to high altitude (Subudhi et al., 2014a). Since the CBF response to CO2 appears to be closely linked 
to perfusion pressure (Harper & Glass, 1965; Ainslie et al., 2012), it seems reasonable to postulate 
that the enhanced cerebrovascular CO2 reactivity observed at high altitude might be due to the 
combined effect of an enhanced MAP response to CO2 and a reduced CA, with the latter increasing 
the compliance of CBF to arterial blood pressure. Together, these findings give support to the role 
of MAP on CBF responses to changes in PaCO2, thus highlighting the dependence of 
cerebrovascular CO2 reactivity on perfusion pressure. 	  
 
CO2 and cerebral blood flow regulation during exercise 
CO2 is a potent vasodilator of the cerebral vessels causing global CBF to increase by 2-4% for a 
given mmHg rise in PaCO2 (Fortune et al., 1992; Sato et al., 2012; Willie et al., 2012), while it 
elicits relatively small changes in limb blood flow of the peripheral vasculature (Lennox & Gibbs, 
1932; Ainslie et al., 2005). Hypercapnia is a useful tool to investigate the role of cerebral DO2 and 
tissue oxygenation on exercise performance as it allows us to selectively increase CBF during 
exercise in severe hypoxia. In our studies, we examined the effect of preventing hyperventilation-
induced hypocapnia (by adding CO2 to inspirate) on CBF, prefrontal oxygenation, cerebral DO2, 
aerobic capacity, and exercise performance during incremental-intensity (Fan & Kayser, 2013) and 
TT cycling (Fan et al., 2013) in normoxia and severe hypoxia (FIO2 = 0.11, equivalent of 5,000 m 
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elevation). Since CO2 increases VE during both rest and exercise, we also examined the effect of 
CO2 breathing on exercise hyperpnoea during incremental cycling in normoxia (Fan et al., 2012b).  
 
During incremental cycling in normoxia, we found MCAv followed the decline in PETCO2 at 
moderate-to-high intensity of exercise (>60% of maximal O2 consumption), which we were able to 
prevent with CO2 breathing (Figure 21). In contrast, we found MCAv to be greatly elevated during 
incremental cycling in hypoxia compare to normoxic conditions, despite a lower PETCO2 
throughout exercise (Figure 21). We observed a ‘plateau’ of CBF at the higher, near-maximal, 
exercise intensities, suggestive of a possible presence of some hypocapnia-induced 
vasoconstriction. Surprisingly, we were unable to elevate MCAv with CO2 breathing during 
incremental exercise in severe hypoxia. During TT cycling, we were able to further elevate CBF by 
clamping PETCO2 with CO2 breathing in normoxia (Figure 22). However, similar to our findings 
during incremental cycling, we found CBF to be elevated in hypoxia compared to normoxic control, 
while clamping PETCO2 elicited only small increases in MCAv during TT cycling in hypoxia. Our 
data demonstrates that during both incremental and TT cycling exercise, hypoxia per se greatly 
elevates CBF, while adding CO2 to the inspirate to prevent the normal drop in PETCO2 elevates 
CBF in normoxia, but by a lesser extent in severe hypoxia.  
 
While controversy remains, there is a large body of literature suggesting that nitric oxide, 
prostanoids and C-natriuretic peptide are involved in the cerebral vasodilatory responses to both 
hypercapnia and hypoxia through a number of intermediate interacting/co-activating pathways 
(Ainslie & Ogoh, 2009). We speculate that if one stimulus, such as hypoxia, is of sufficient 
magnitude to exhaust the cerebral vessels’ capacity to dilate, thereby nearing maximal diameter of 
the vessels, then any further stimuli would have little additional effect on decreasing 
cerebrovascular resistance (i.e., dilating vessel diameter). In such instances, changes in CBF would
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Figure 21. Effect of hypoxia and augmented FICO2 on group respiratory, 
cerebrovascular variables and SpO2 during incremental cycling to exhaustion. Left 
panels: group data in normoxia (mean ± SD); right panels group data in hypoxia. 
From Fan & Kayser (2013).  
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Figure 22. Effect of hypoxia and CO2 clamping on cerebral variables during 15-km time trial cycling. 
Cerebral O2Hb and HHb are expressed as delta changes from normoxia (room air breathing). Left panels, 
group data in normoxia (mean ± SD); right panels group data in hypoxia. ●, normoxia control; ○ normoxia 
CO2 clamp; ■, hypoxia control; □, hypoxia CO2 clamp. From Fan et al., (2013).  
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follow changes in perfusion pressure rather than arterial blood gases, as alluded to by Battisti-
Charbonney et al., (2011). Mardimae et al., (2012) demonstrated a synergistic role of CO2 and 
hypoxia on the control of CBF at rest whereas our results favour a negative effect during exercise, 
whereby the presence of severe hypoxia attenuates the effect of CO2 on cerebrovascular 
resistance—presumably by exhausting the vascular dilatory reserves. In agreement, our data 
indicates that during both incremental and TT cycling in severe hypoxia, the role of CO2 in the 
regulation of cerebrovascular tone appears to be diminished, at least in an unacclimatised 
population. However, we cannot exclude the possibility that there might be regional differences in 
the cerebrovascular response to hypoxia and CO2, which could display additive or synergistic 
relationships. Indeed, regional differences have been observed in vascular ultrasound studies 
whereby the VA blood flow response was found to be higher during hypoxia and lower during both 
hypocapnia and incremental cycling, compared to either ICA or MCA blood flow responses (Sato et 
al., 2011; Sato et al., 2012; Willie et al., 2012). Furthermore, the precise effects of combining 
hypoxia and CO2 on cerebral metabolism are still unknown. Given the limited literature on this 
topic, further studies on the effect of hypoxia, CO2, and acclimatisation status on the regulation of 
cerebrovascular tone and cerebral DO2 during exercise at high altitude are certainly warranted.  
 
Our findings contradict earlier studies in which CBF was significantly elevated by clamping 
PETCO2 with added CO2 during high intensity exercise at 4,875 m [simulated; (Subudhi et al., 
2011b)] and 3,454 m (Siebenmann et al., 2013). Since these studies were conducted in subjects 
living at 1,600 m and in sojourners following one night at high altitude respectively, while the 
subjects in our studies were low altitude residents (~400 m) acutely exposed to normobaric hypoxia 
(~4 min), it is possible that these discrepant findings are due to the differences in acclimatisation 
status between the studies. For example, both acute and chronic high altitude exposures have been 
shown to enhance both the CBF and ventilatory responsiveness to CO2 (Mathew et al., 1983; Fan et 
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al., 2010a; Fan et al., 2012a). This adaptive enhancement of cerebrovascular CO2 reactivity at high 
altitude would certainly account for the greater elevations in CBF with PETCO2 clamping during 
incremental exercise in hypoxia, as reported by Subudhi et al., (2011b) and Siebenmann et al., 
(2013). Furthermore, an enhanced ventilatory CO2 sensitivity would also explain the large increases 
in VE (~50 L/min) reported by Subudhi et al., (2011b) with PETCO2 clamping during hypoxic 
exercise.  
 
Enhanced cortical activation during exercise in hypoxia? 
Functional activation during exercise leads to cerebral hyperperfusion and an associated increase in 
cerebral tissue oxygenation (Ide et al., 1999). Since cerebral function deteriorates when cerebral 
tissue oxygenation drops (Van Lieshout et al., 2003), Quistorff et al., (2008) speculated that the 
cerebral hyperperfusion might serve as an important precaution for brain function deterioration 
during exercise. Therefore, the large elevation in CBF observed during exercise in severe hypoxia is 
likely a protective response, serving to prevent excessive cerebral tissue deoxygenation in the face 
of prevailing hypoxaemia. Alternatively, this progressive increase CBF during TT cycling in severe 
hypoxia, despite relatively stable CaO2 and SaO2, could be due to greater sensorimotor cortex 
activation associated with prolonged exercise in hypoxia. Both blood flow and metabolic rate 
corresponding to the cortical representation of the sensory input are increased during hand 
movement (Raichle et al., 1976). Likewise, early findings showed CBF redistribution to 
sensorimotor cerebral cortex, spinal cord and cerebellum in exercising dogs (Gross et al., 1980). 
Since axillary afferent blockade abolishes the increase in blood flow to the sensorimotor and 
premotor cortices during static handgrip (Friedman et al., 1991) and dynamic hand contraction 
(Friedman et al., 1992), these findings indicate that an increase in cortical activation of 
sensorimotor areas associated with neural input from the working limbs is critical for exercise-
induced increases in CBF. In our studies, we found higher rates of perceived effort (RPE) for a 
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given power output during both incremental and TT cycling in hypoxia when compared to 
normoxia (Fan et al., 2013; Fan & Kayser 2013), thus confirming the report of a direct effect of 
hypoxia on effort perception during exercise in severe hypoxia (Amann & Dempsey, 2008). We 
postulate that increased sensorimotor cortex activation—as indicated by higher RPE—coupled with 
a compensatory cerebral vasodilation in the face of severe hypoxaemia, could at least partially 
account for the elevated CBF observed during exercise in severe hypoxia.  
 
As Rasmussen et al., (2010a) pointed out, since the brain relies largely on oxidative metabolism, a 
minimal mitochondrial O2 tension (PmitoO2) is essential in sustaining adequate cerebral metabolism 
for normal homeostatic function of the brain. Since they observed good correlations between RPE 
with estimated PmitoO2 and cerebral O2-carbohydrate index during cycling exercise in normoxia 
(44%, 81%, and 100% of maximum workload) and hypoxia (44% of maximum workload), they 
concluded that the RPE ratings during 20 min steady-state cycling reflect the state of cerebral 
PmitoO2, regardless of exercise intensity or O2 provision. While this conclusion supports our own 
speculation of a link between RPE and increased cortical activation during exercise in severe 
hypoxia (Fan et al., 2013), we must acknowledge that RPE is a subjective measure that is dependent 
upon both sensory information and cortical output (Rasmussen et al., 2010a). Caution should be 
taken when interpreting these correlations. 
 
Cerebral metabolism during hypoxic exercise 
During steady-state cycling in acute severe hypoxia (FIO2: 0.10), Rasmussen et al., (2010a) found 
both cerebral DO2 and CMRO2 were reduced compared to normoxic conditions. Overgaard et al., 
(2012) examined cerebral lactate turnover during high intensity exercise in hypoxia (70% maximal 
power output) and found a sevenfold increase in cerebral lactate release, as well as elevated cerebral 
lactate uptake and release kinetics, while cerebral glucose uptake tended to be elevated. They also 
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found a 10% reduction in cerebral DO2 during heavy exercise in hypoxia, while cerebral 
arteriovenous differences in glucose and pyruvate concentration were unchanged. From these 
observations they concluded that there is an increase in cerebral lactate oxidation during exercise in 
hypoxia, accounting for up to 33% of total cerebral substrate use. While this increase in cerebral 
lactate uptake and oxidation does not appear to be specific to exercise in hypoxia per se (Volianitis 
et al., 2008), rather as a mechanism of lactate clearance in the face of elevated lactate production, 
such increase in lactate oxidation would spare glucose utilisation in the brain during exercise in 
hypoxia (Quistorff et al., 2008). Since the degree of hypoxia (~10% O2) and the intensity of 
exercise were similar (~140 W versus ~119 W) between our TT study and that by Overgaard et al., 
(2012), it seems reasonable to assume that cerebral lactate uptake and oxidation were also enhanced 
during hypoxic exercise in our subjects.  
 
In acclimatised subjects, Møller et al., (2002) found cerebral DO2 and cerebral oxidative 
metabolism to be preserved during moderate exercise at 5,260 m. They attributed this preservation 
to a compensatory increase in cerebral O2 extraction during exercise at high altitude. Similar to 
acute exposure to hypoxia, they found evidence of increased cerebral lactate uptake during exercise 
following acclimatisation to high altitude. The observed increase in cerebral lactate release by both 
Overgaard et al., (2012) and Møller et al., (2002) could be interpreted as indirect evidence for 
increased non-oxidative metabolism during exercise in hypoxia. Since the rate of glycogenolysis 
relative to glucose utilisation has been shown to reach levels as high as ~290% during anoxia and 
ischaemia compared to normoxia (Lowry et al., 1964; Gross & Ferrendelli, 1980; Harik et al., 
1982), it has been suggested that glycogenolysis might serve as a means to help preserve neuronal 
function during metabolic crisis (Dienel & Cruz, 2006). Further, it is conceivable that hypoxia also 
enhances non-oxidative metabolism during sustained motor cortex activation in order to reduce 
CMRO2 (Vafaee et al., 2012). Whilst speculative, an increase in cerebral non-oxidative metabolism 
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would spare O2 utilisation in the face of reduced brain O2 supply, and thus account for the reduced 
CMRO2 observed by Rasmussen et al., (2010a) during exercise in acute severe hypoxia. 
 
Cerebral oxygenation and performance 
In two of our studies (Fan et al., 2013; Fan & Kayser 2013), increased respiratory drive associated 
with CO2 breathing elevated PETO2 and O2 saturation, which in turn tended to elevate CaO2. 
However, since we did not measure blood gases or prefrontal oxygenation during the incremental 
cycling to exhaustion, we will focus our discussion on the 15km TT study. During TT cycling in 
hypoxia, the modest elevations in both MCAv and CaO2 with CO2 breathing normalised the 
cerebral DO2 to normoxic values (Fan et al., 2013). This finding is further supported by reduced 
cerebral [HHb] and increased cerebral concentration of delta Hb (Figure 22). Accordingly, we 
contend that cerebral DO2 was restored to normoxic levels during the TT in hypoxia using our CO2 
breathing setup. Our data corroborate with those of Subudhi et al., (2011), which showed 
significant increases in cerebral tissue oxygenation with PETCO2 clamping during incremental 
exercise in hypoxia. We also found a tendency for muscle oxygenation to be elevated with CO2 
breathing in hypoxia, presumably due to a slightly higher SaO2 (Figure 23). Since the restoration of 
cerebral DO2 with CO2 breathing in our study was not accompanied by improvements in exercise 
time, motor drive, or mean power output, our data does not support the role of reduced cerebral DO2 
and associated cerebral tissue deoxygenation in limiting performance in hypoxia. It should be 
acknowledged that changes in global cerebral DO2 might not be representative of local changes in 
arterial and/or capillary PO2 in the brain. Therefore it is possible that we were unable to restore DO2 
to the critical brain regions involved in motor recruitment with our CO2 breathing setup. 
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Figure 23. Effect of hypoxia and CO2 clamping on muscle oxygenation during 15-km time trial 
cycling. Muscle O2Hb and HHb are expressed as delta changes from normoxia (room air breathing). 
Left panels, group data in normoxia (mean ± SD); right panels group data in hypoxia. ●, normoxia 
control; ○ normoxia CO2 clamp; ■, hypoxia control; □, hypoxia CO2 clamp. From Fan et al., 
(2013). 
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We cannot exclude the possibility that CO2 breathing during heavy exercise might also introduce 
other confounding factors, which could override the potential benefits of improved cerebral DO2. 
For example, Subudhi et al., (2011b) attributed the reduced exercise capacity with PETCO2 
clamping in hypoxia in their study to increased respiratory muscle work, and associated ‘steal 
effect’ of blood flow from the working limbs, as well as an elevated RPE related to their 
experimental setup. These factors could have out-weighed the benefits of elevated cerebral DO2. 
They found VE to be elevated by ~50 L/min with PETCO2 clamping during incremental cycling in 
hypoxia. Likewise, we found VE to be elevated by ~20 L/min with CO2 breathing during 
incremental and TT cycling in hypoxia (Figures 21 & 24), while the rate of RPE increase was also 
higher with CO2 breathing. As mentioned before, increased respiratory work augments peripheral 
fatigue during exercise and perception of leg discomfort. Accordingly, the detrimental effects of 
enhanced ventilatory drive and respiratory work associated with CO2 breathing could outweigh any 
potential benefits of improved cerebral DO2 and tissue saturation during exercise in hypoxia in our 
studies.  
 
Siebenmann et al., (2013) further argued that CO2 breathing may exacerbate the metabolic acidosis 
associated with heavy exercise, shifting the oxyhaemoglobin curve rightward and lowering SaO2, 
thus limiting maximal O2 consumption. In agreement, we observed a tendency for maximal exercise 
capacity to be impaired with CO2 breathing in hypoxia (Fan & Kayser, 2013). However, contrary to 
Siebenmann et al., (2013), we found O2 saturation to be higher with CO2 breathing in hypoxia 
throughout submaximal exercise intensities (Figure 21), which does not support the notion of a 
limited pulmonary O2 uptake associated with a right-ward shift in the oxyhaemoglobin curve.  
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Figure 24. Effect of hypoxia and CO2 clamping on respiratory variables during 15-km time 
trial cycling. Left panels, group data in normoxia (mean ± SD); right panels group data in 
hypoxia. ●, normoxia control; ○ normoxia CO2 clamp; ■, hypoxia control; □, hypoxia CO2 
clamp. From Fan et al., (2013). 
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Chemoreception of CO2 and exercise hyperpnoea 
The regulation of exercise hyperpnoea has been extensively studied during the past 100 years [see 
(Mateika & Duffin, 1995; Forster, 2000; Ward, 2000; Péronnet & Aguilaniu, 2006; Poon et al., 
2007; Forster et al., 2012) for reviews]. Nevertheless, the role of chemoreception in the regulation 
of exercise hyperpnoea, especially during heavy exercise, remains controversial (Babb et al., 2010; 
Hopker et al., 2011). To date, only a handful of studies have examined the effect on exercise 
hyperpnoea of chemoreceptor stimulation with CO2 breathing alone (Clark et al., 1980; Babb, 1997; 
Babb et al., 2003; Olin et al., 2012) or the combined effect of CO2 breathing with hypoxia 
(Asmussen & Nielsen, 1957). With the exception of Olin et al., (2011) who only reported maximal VE, these studies primarily focused on the effect of CO2 breathing on exercise hyperpnoea during 
low and moderate intensity steady-state exercise. In young sedentary subjects, increased FICO2 (3% 
CO2) has been shown to augment the ventilatory response to exercise (i.e., greater rise in VE) below 
RC (Babb, 1997). Since maximal VE was higher with hypercapnia compared to room-air breathing, 
the author concluded that during near-maximal and maximal exercise in hypercapnia, the 
respiratory system was not limited by the expiratory airflow.  
 
In our work, CO2 breathing did not alter VE during high intensity exercise in normoxia or hypoxia 
(Fan et al., 2012; Fan & Kayser 2013). Findings from these two studies revealed that CO2 breathing 
in normoxia blunts the VE response to incremental exercise (i.e., a lower rise in VE) at lower 
exercise intensities, below RC. Since absolute VE was similar at RC between CO2 breathing and 
control conditions despite occurring at a lower power output with CO2 breathing, we attribute this 
‘blunting’ of the ventilatory response to exercise to an elevated VE at rest with CO2 breathing. 
During moderate-to-high intensity exercise in normoxia (i.e., above RC), we observed no difference 
between room-air and CO2 breathing (Figure 25). Hypoxia alone enhanced the VE rise during 
exercise below RC, and caused RC onset to occur at a lower power output, while hypoxia and CO2 
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breathing further lowered the power output of RC onset and elevated VE at RC (Figure 25). 
Interestingly hypoxia, either alone or in combination with CO2 breathing, had no effect on the VE 
rise during moderate-to-high intensity exercise. Our data agrees with those by Wasserman et al., 
(2011), which showed a dissociation between arterial [H+] and VE during exercise above RC. We 
thus confirm that both hypoxia and hypercapnia can modulate the rate of ventilatory response to 
increasing exercise below RC, presumably through chemoreceptor stimulation. However, these 
chemoreflexes appears to become blunted once the exercise intensity is above RC.  
 
Limitations 
An important methodological consideration when interpreting our findings is the use of transcranial 
Doppler ultrasound to measure MCAv as a representative index of global CBF changes during rest 
and dynamic whole-body exercise in hypoxic conditions. This is based on the assumption that: i) 
the MCA accounts for approximately 80% of the blood flow to the respective hemispheres 
(Lindegaard et al., 1987); ii) changes in MCAv reflex changes in global CBF (Bishop et al., 1986; 
Serrador et al., 2000); iii) the changes in MCAv in response to PaCO2 changes and during 
incremental exercise are comparable to those changes observed in the ICA blood flow (Sato et al., 
2011; Sato et al., 2012); and iii) the diameter of the MCA remains constant during changes in 
arterial blood gases (~25-40 mmHg) and blood pressure (Serrador et al., 2000). In support, MCAv 
has been shown to follow CBF changes during initial exposure to high altitude, when compared 
with the direct Fick’s method (Roy et al., 1968; Milledge & Sorensen, 1972; Møller et al., 2002).  
 
The possibility of large conducting arteries being involved in CBF regulation was first proposed by 
Faraci et al., (1987), who observed changes in feline basilar artery diameter in response to changes 
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Figure 25. Effect of hypoxia and augmented FICO2 on 
respiratory compensation threshold and ventilatory response 
to exercise during incremental cycling to exhaustion. A: 
group data in normoxia (mean ± SD). B: group data in 
hypoxia. * Different from control (P<0.05); † different from 
normoxia (P<0.05); § trend for non-significant difference 
(P<0.10). From Fan & Kayser (2013).  
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in arterial CO2 tension. Accordingly, they concluded that resistances of the large arteries account for 
a third of total vascular resistance in the brain stem. Using transcranial colour-coded Doppler, 
Wilson et al., (2011) found that the diameter of MCA changes depending on the altitude (i.e., 5.30 
mm at 75 m, 5.51 mm at 3,500 m, 5.23 mm at 5,300 m and 9.34 mm at 7,950 m). The data from 
Wilson et al., (2011) demonstrated that the MCA diameter remained relatively unchanged up to 
5,300 m. However, it should be noted that the MCA diameters measured with transcranial colour-
coded Doppler in that study were 80-90% greater than the values obtained using MRI in the same 
subjects. Meanwhile, in contrast to findings by Sato et al., (2012), Willie et al., (2012) found lower 
cerebrovascular CO2 reactivity in the MCAv response compared to ICA blood flow. Those authors 
concluded that this underestimation of cerebrovascular CO2 reactivity was due to dilatation of the 
MCA in hypercapnia. Further, they reported a ~17% change in ICA diameter between extreme 
levels of hypocapnia and hypercapnia (PaCO2: 16-62 mmHg). More recent studies, using 
transcranial colour coded Doppler, found MCA diameter to increase (by 0.6-1.0 mm) during acute 
and chronic exposure to 5,050 m (Imray et al., 2014; Willie et al., 2014a). Taken together, there 
appears to be mounting evidence supporting the role of large conduit arteries in CBF regulation 
during changes arterial blood gases.  
 
Poiseuille’s law states that flow in a circular vessel is proportional to the fourth power of the radius. 
Therefore small changes in MCA diameter would lead to relatively large changes in the estimates of 
CBF obtained using transcranial Doppler ultrasound (Imray et al., 2014). Any MCA dilation with 
hypoxia, CO2 breathing, or exercise would result in an underestimation of the true CBF changes 
assessed with MCAv in our studies. Since we observed increases in CBF during prolonged exercise 
in hypoxia and with CO2 breathing (Fan et al., 2012; Fan et al., 2013; Fan & Kayser 2013), such 
underestimation of CBF would change the size of the effects observed in our studies, but would not 
affect our main conclusions.   
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We used left prefrontal [O2Hb] and [HHb] measured by near-infrared spectroscopy (NIRS) as 
indicators of global cerebral tissue oxygenation, which is a simplification, even though good 
agreements have been found between NIRS and functional MRI measurements of cerebral tissue 
oxygenation levels over various cortices (Kleinschmidt et al., 1996; Strangman et al., 2002). NIRS 
is also subject to bias from skin blood flow variations, since the light traverses the skin and the bone 
layers before entering the tissue of interest. According to Tew et al., (2010), such changes due to 
skin effects can be considered negligible compared to the changes in the brain tissue. 
 
Another limitation of this thesis is that we elevated end-tidal rather than arterial PCO2 during 
incremental cycling to exhaustion. As the end-tidal–arterial PCO2 gradient varies with exercise 
(Jones et al., 1979; Liu et al., 1995), it is possible that we did not elevate PaCO2 to the desired 
levels. In one of our studies (Fan et al., 2013), we measured capillary blood samples as a surrogate 
of arterial measurements, and were able to elevate and maintain capillary PCO2 within 1 mmHg 
throughout exercise under both normoxic and hypoxic conditions. As Mollard et al., (2010) found 
good correlations between pre-warmed capillary earlobe samples and radial artery measurements of 
PaO2 (R2 = 0.99), PaCO2 (R2 = 0.86), and SaO2 (R2 = 0.99) during rest, submaximal, and near 
maximal exercise intensities, we are confident that our protocol was effective in elevating PaCO2. 
Furthermore, using our setup, Siebenmann et al., (2013) were successful in elevating and 
maintaining both end-tidal and arterial PCO2 at around 40 mmHg during incremental exercise in 
hypoxia. We therefore believe it is likely that we were able to sufficiently elevate and maintain 
PaCO2 using our CO2. 
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Further Perspectives 
This thesis attempted to investigate the role of reduced cerebral DO2 and tissue deoxygenation 
associated with hyperventilation-induced hypocapnia on exercise performance in severe hypoxic 
conditions (Fan et al., 2012; Fan et al., 2013; Fan & Kayser 2013). To examine this, we prevented 
the development of hypocapnia with CO2 breathing during incremental-intensity and TT cycling in 
hypoxia in an attempt to selectively increase blood flow (and thus O2 supply) to the brain without 
altering systemic O2 levels. However, the increased ventilatory drive associated with CO2 breathing 
elevated both respiratory work and PaO2, which might have confounded our findings. An 
alternative way to answer our question would be to examine the effects of selectively altering CBF 
and cerebral DO2 using pharmacological means. For example, indomethacin is a reversible 
cyclooxygenase inhibitor, which has been shown to impair the cerebral vessels’ ability to dilate in 
response to hypercapnia and hypoxia via inhibiting prostaglandin synthesis (Parfenova et al., 1994). 
Studies have found that indomethacin lowers resting CBF (by 25-30%) and attenuates 
cerebrovascular CO2 reactivity under normoxic and hypoxic conditions (Eriksson et al., 1983; 
Markus et al., 1994; St Lawrence et al., 2002; Fan et al., 2010a), without affecting cerebral 
metabolism (Hohimer et al., 1985; Kraaier et al., 1992) or systemic vascular functions (Taylor et 
al., 2014). Indomethacin could potentially serve as an ideal tool for selectively reducing CBF and 
thus to investigate the effect of reduced cerebral DO2 on performance during exercise in hypoxia. 
 
Despite our best attempt to quantify the changes in cerebral DO2 and cerebral tissue oxygenation 
during hypoxic exercise, a number of important questions remain unresolved. For example, a 
clinical study in patients with traumatic brain injuries alluded to the notion that brain tissue PO2 
might be determined by variables related to cerebral O2 diffusion, rather than cerebral DO2 and 
metabolism (Rosenthal et al., 2008). Whether this is true in healthy populations and how we might 
measure brain tissue O2 tension in healthy (and intact) exercising humans presents a significant 
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technical issue. Perhaps animal models could be employed to provide direct measures of brain 
tissue O2 tension changes during exercise in severe hypoxia. However, given the inter-species 
differences in physiological responses to exercise (Forster et al., 2012), the applicability of findings 
from animal models of exercise in hypoxia to human performance remains unclear.  
 
As Dienel (2013) aptly pointed out, regional heterogeneity and compartmentalisation of function 
and metabolism is one of the hallmark characteristics of the brain. However, the majority of the 
brain and exercise literature has focused on the brain as a whole. The effect of hypoxia on the brain 
during whole-body exercise on specific brain regions remains largely unknown. Existing techniques 
such as functional MRI, positron emission tomography, electroencephalography, and multi-site 
NIRS could potentially be employed in this area of research. In theory, they would enable the 
assessment of region-specific cortical and other brain areas' activities. Despite the potential 
advantages of these techniques, their practical applications in exercise testing have not been well 
explored, presumably due to the technological and practical limitations as well as the availability 
and financial costs of these systems. Nevertheless, assessment of neuronal activity could be 
undertaken with electroencephalography and NIRS, in order to map out the specific regional 
changes in cortical activity (and therefore metabolism) during dynamic whole-body exercise in 
severe hypoxia. Findings from these studies would provide the groundwork for future 
investigations. Quantifying these cortical activity changes during hypoxic exercise would help us 
identify the specific regions of interest, perhaps even help locate the ‘origin’ of the central fatigue in 
the brain. However, we cannot exclude the possibility that further advancement of neural imagining 
techniques for exercise testing is needed before any breakthrough can be achieved.  
 
Other aspects that have been largely overlooked in this field are the psychological and cognitive 
effects of hypoxia during exercise (Ando et al., 2013) It is conceivable that hypoxia could alter 
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brain processes involved in motivation, both directly and indirectly [e.g., via increased perception 
of dyspnoea (De Peuter et al., 2004; Weinberger & Abu-Hasan, 2009)], which could account for 
some of the detriments in performance. There is no denying that motivation plays a large part in 
sporting performances. Implementing psychological measurements will improve understanding of 
the effect of hypoxia on psychological and cognitive functions, thus providing further insight to the 
mechanisms behind the performance detriments observed during exercise in hypoxia.  
 
Conclusions 
We found cerebral DO2 to be well maintained during acute exposure to high altitude and following 
acclimatisation, which was mediated by reciprocal changes in CBF and CaO2. Our findings showed 
an increase in cerebrovascular CO2 reactivity during acute high altitude exposure, which was further 
elevated with acclimatisation. Since the increase in cerebrovascular CO2 reactivity was abolished 
once we normalised for arterial blood pressure changes, we attribute this to an enhanced systemic 
pressure response with acclimatisation. Our data also showed impaired dynamic CA during 
exposure to high altitude, which persisted following acclimatisation. Such ‘impairment’ in dynamic 
CA would result in a greater change in CBF for any given change in perfusion pressure. Therefore, 
is it conceivable that a reduced CA might facilitate cerebral DO2 in the face of severe arterial 
hypoxaemia during acute and chronic high altitude exposures. Further, since this reduction in CA 
does not appear to be linked with symptoms of acute mountain sickness, we speculate that these 
changes in CA at high altitude are intrinsic consequences of hypoxia in the absence of pathology. 
 
During exercise in normoxia and normobaric hypoxia, we attempted to selectively elevate CBF, 
thus elevating cerebral DO2 and cerebral tissue oxygenation with CO2 breathing during exercise. 
We observed only moderate elevations in CBF with CO2 breathing during both incremental-
intensity and TT cycling exercise in severe hypoxia, which we attributed to an exhausted 
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cerebrovascular dilatory reserve. We were nevertheless able to increase CaO2 with CO2 breathing, 
via increased ventilatory drive. Accordingly, we were able to improve cerebral DO2 during TT 
cycling in hypoxia, restoring it to normoxic values. Since the restoration of cerebral DO2 was not 
accompanied by improvements in either prefrontal oxygenation or exercise performance, our 
findings do not appear to support the role of cerebral DO2 in limiting performance during exercise 
in severe hypoxia. 
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New Findings
 What is the central question of this study?
Hypoxia associated with ascent to high altitude may threaten cerebral oxygen delivery. We
sought to determine whether there are regional changes in the distribution of cerebral blood
flow that might favour oxygen delivery to areas associated with basic homeostatic functions
to promote survival in this extreme environment.
 What is the main finding and its importance?
We show evidence of a ‘brain-sparing’ effect during acute exposure to high altitude, in which
there is a slight increase in relative oxygen delivery to the posterior cerebral circulation.
This may serve to support basic regulatory functions associated with the brainstem and
hypothalamus.
Cerebral hypoxaemia associated with rapid ascent to high altitude can be life threatening; yet,
with proper acclimatization, cerebral function can be maintained well enough for humans to
thrive. We investigated adjustments in global and regional cerebral oxygen delivery (DO2) as 21
healthy volunteers rapidly ascended and acclimatized to 5260 m. Ultrasound indices of cerebral
blood flow in internal carotid and vertebral arteries were measured at sea level, upon arrival at
5260 m (ALT1; atmospheric pressure 409 mmHg) and after 16 days of acclimatization (ALT16).
CerebralDO2 was calculated as the product of arterial oxygen content and flow in each respective
artery and summed to estimate global cerebral bloodflow.Vascular resistanceswere calculated as
the quotient ofmean arterial pressure and respective flows. Global cerebral blood flow increased
by 70% upon arrival at ALT1 (P < 0.001) and returned to sea-level values at ALT16 as a
result of changes in cerebral vascular resistance. A reciprocal pattern in arterial oxygen content
maintained global cerebral DO2 throughout acclimatization, although DO2 to the posterior
cerebral circulation was increased by 25% at ALT1 (P = 0.032). We conclude that cerebral
DO2 is well maintained upon acute exposure and acclimatization to hypoxia, particularly in the
posterior and inferior regions of the brain associated with vital homeostatic functions. This
tight regulation of cerebral DO2 was achieved through integrated adjustments in local vascular
resistances to alter cerebral perfusion during both acute and chronic exposure to hypoxia.
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Introduction
Although the brain represents only about 2% of body
weight, it is a highly metabolic tissue that receives 15%
of cardiac output and accounts for 20% of total body
oxygen consumption at rest (Wade & Bishop, 1962).
Maintenance of cerebral oxygen delivery (DO2) is essential
for vital cerebral functions associated with homeostasis.
In the face of severe hypoxaemia, such as experienced
during rapid ascent to extreme altitudes (>8000 m),
reduction in cerebral DO2 results in loss of consciousness
within seconds (Luft et al. 1951; Luft & Noell, 1956)
and death within minutes (Bert, 1943). However, with
staged acclimatization to progressively higher elevations,
cerebral DO2 can be maintained well enough for humans
to reach the summit of Mount Everest (8848 m) without
supplemental oxygen. The mechanisms responsible for
this remarkable plasticity in cerebralDO2 are complex and
not completely understood.
Cerebral DO2 is the product of cerebral blood flow
(CBF) and arterial oxygen content (CaO2). It is well
established that CBF rises upon acute exposure to
high altitude and returns to near sea-level values with
acclimatization (Severinghaus et al. 1966; Huang et al.
1987; Jensen et al. 1990), while CaO2 decreases in
acute hypoxia and returns to sea-level values with
acclimatization. These opposing CBF and CaO2 responses
to altitude appear to offset one another and maintain
cerebral DO2 throughout acclimatization (Severinghaus
et al. 1966; Wolff et al. 2002). The pattern of CBF
change in response to hypoxia has been attributed
to the relative balance of hypoxic vasodilatation and
hypocapnic vasoconstriction in the brain (Xu&Lamanna,
2006; Brugniaux et al. 2007). During acute, severe
hypoxia, vasodilatation typically exceeds vasoconstriction,
resulting in greater CBF (Mardimae et al. 2012;Willie et al.
2012). With acclimatization, increased ventilatory drive
reduces the arterial partial pressure of CO2 (PaCO2) and
improves the arterial partial pressure of O2 (PaO2), tipping
the balance in favour of vasoconstriction and restoring
CBF to pre-exposure values. Changes in the PaO2/PaCO2
ratio have been shown to account for 40% of the
variation in global CBF over acclimatization (Lucas et al.
2011), with other biochemical (e.g. pH, HCO3−, nitric
oxide) and haematological factors (e.g. haemoglobin,
haematocrit, blood viscosity) presumably accounting for
the rest of the response (Todd et al. 1994; Tomiyama et al.
1999; Severinghaus, 2001) tomaintainglobal cerebralDO2.
Recent data demonstrate that acute normobaric
hypoxia (i.e. breathing hypoxic gas) affects the regional
distribution of CBF within the brain. Data from
positron emission tomography (PET) studies show greater
perfusion of the brainstem, hypothalamus, thalamus and
cerebellum during acute hypoxia, with (Binks et al. 2008)
or without controlled levels of PaCO2 (Buck et al. 1998).
Regional differences in cerebrovascular reactivity to O2
and CO2 have been postulated to control the distribution
of CBF. Vascular Doppler studies of the major tributary
vessels of the brain suggest that a greater percentage
of blood flow may be directed towards the posterior
cerebral circulation, including the brainstem, in response
to controlled levels of hypoxia and hypocapnia (Sato
et al. 2012). From a teleological perspective, this could
help preserve vital homeostatic functions at the expense
of higher cognitive processing; however, it is unclear
whether regional distributionofCBF is affected in a similar
manner in hypobaric hypoxia (i.e. high altitude) or if
it changes with acclimatization, because not all studies
report significant regional differences (Huang et al. 1987;
Willie et al. 2012, 2013).
Despite the importance of O2 supply for cerebral
function, longitudinal studies of cerebral DO2 at high
altitude are sparse. In a secondary analysis of data from
original study by Severinghaus et al. (1966) of CBF
at high altitude, global cerebral DO2 in four subjects
appeared stable and in excess of oxygen demand after
6–12 h and 3–5 days, respectively, of exposure to 3810 m
(Severinghaus, 2001; Wolff et al. 2002). Using similar
methodology (Kety–Schmidt technique), no differences
were found in global cerebral DO2 measured after 5 weeks
at 5260 m and return to sea level (Møller et al. 2002).
Unfortunately, these studies were based on a limited
number of observations, which makes it difficult to detect
small differences, if they existed (type II error), and used
methodology that can only measure global cerebral DO2 .
A more recent magnetic resonance imaging (MRI) study
with a larger sample size reported a tendency towards
elevation of cerebral DO2 after subjects returned from
2 days at 3800m (Smith et al. 2013), but nomeasurements
of regional cerebralDO2 weremade. Based the limited data
to date, it is uncertain whether global or regional cerebral
DO2 varies over time at high altitude.
In this study, we used vascular Doppler technology in
conjunction with arterial blood sampling to allow us to
quantify global and regional changes in CBF and cerebral
DO2 in the field as healthy people rapidly ascended and
acclimatized to high altitude (5260 m). We tested the
hypothesis that upon acute exposure cerebral DO2 would
be maintained to regions of the brain associated with
homeostasis at the expense of other tissues, but that these
changes would normalize with acclimatization.
Methods
Subject recruitment and screening
This study was conducted as part of the AltitudeOmics
project, for which a detailed description of the
protocol is published elsewhere (Subudhi et al. 2014).
Briefly, following institutional ethics approval from
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the Universities of Colorado and Oregon and the US
Department of Defense Human Research Protection
Office, young, healthy, sea-level residents were recruited
from the greater Eugene, OR area (elevation 128 m).
Potential subjects were screened to exclude anyone who
was born or had lived at altitudes >1500 m for longer
than 1 year or had travelled to altitudes >1000 m in the
past 3 months. After obtaining written informed consent,
physical examinations and the Army Physical Fitness Test
(push ups, sit ups and 3.2 km run) were performed to
verify health and fitness status.
Study overview
To evaluate effects of altitude acclimatization on
cerebrovascular haemodynamics, subjects were studied on
three occasions, as follows: (i) at sea level (SL, 130 m);
(ii) upon acute exposure to 5260 m (ALT1); and (iii) after
16 days of acclimatization (ALT16). Specifically,4 weeks
following SL measurements in Eugene, OR, subjects were
flown to La Paz, Bolivia. They spent two nights at low
altitude (Coroico, Bolivia; 1525 m) before being driven
to the Chacaltaya Research Station at 5260 m while
breathing supplemental oxygen. Acute responses to high
altitude were assessed 2–4 h after arrival and cessation
of supplemental oxygen (ALT1). Subjects acclimatized to
altitudes ranging from 3800 to 5260 m over the next
15 days, with amajority of the time (75%) spent at 5250m.
Measurements were repeated on ALT16.
Instrumentation
Subjects were studied in an upright, seated position with
feet on the floor. Arterial blood pressure was monitored
via a fluid-filled pressure transducer (Utah Medical, Salt
Lake City, UT, USA) positioned at heart level and attached
to a 22 gauge catheter in a radial artery. Blood flow
velocity in the left middle cerebral artery (MCAvelocity)
was measured by transcranial Doppler (2 MHz probe,
Spencer Technologies, Seattle, WA, USA; affixed to a
custom-made headset) at depths ranging from 43 to
54 mm. Signal quality was optimized, and an M-mode
screen shot was recorded to facilitate subsequent probe
placements. Arterial saturation was measured on the right
side of the forehead by pulse oximetry (Nellcor N-200,
Mansfield, MA, USA). Limb lead electrodes were used
to measure ECG (ADInstruments BioAmp, Colorado
Springs, CO, USA and Sonosite Micromaxx, Bothell, WA,
USA). Metabolic variables, including expired ventilation
and gas concentrations were assessed via breath-by-breath
(Medgraphics PFX, St Paul, MN, USA and Vacumed
UVM, Ventura, CA, USA) and mixing chamber systems
(Oxigraf O2cap, Mountain View, CA, USA), calibrated
with the same 3 l syringe and known concentrations
of O2 and CO2 prior to each test. Additionally, core
temperature was monitored by telemetry pill (CorTemp
HQInc., Palmetto, FL, USA). Analog data were sampled
and recorded at 200 Hz (ADinstruments Powerlab 16/30,
Colorado Springs, CO, USA).
Cerebral blood flow
After verification of signal quality, resting data were
recorded for 10 min while subjects breathed room air. At
6 min, 2 ml of arterial blood was drawn anaerobically for
blood gas analysis (described in section ‘Cerebral oxygen
delivery’). During the last 4 min of the resting period,
the diameter and blood flow velocities in the left internal
carotid (ICA; 1.5 cm distal to the carotid bifurcation) and
vertebral arteries (VA; between spinous processes of C4
and C5) were recorded over a minimum of five cardiac
cycles by a registered diagnostic sonographer (SonoSite
Micromaxx L25 probe, Bothell, WA, USA). Briefly, vessel
diameter from a longitudinal view was identified and
measured with digital callipers in synchronization with
the ECG trace to identify systole and diastole. Velocity was
measured in the centre of the vessel with an insonation
angle <60 deg and a sample volume maximized for vessel
diameter. The peak velocity trace across cardiac cycles
was used for calculation of mean velocity (time-averaged
peak) and volumetric flow. This procedure was used to
verify accurate tracing of the spectral envelop during
data collection and results in higher values than the
time-averaged mean method (Scho¨ning et al. 1994). All
data were downloaded in DICOM format for verification
of measurements offline (Sante DICOM Editor, Athens,
Greece).
Regional blood flow (in millilitres per minute) in
the ICA and VA (ICAflow and VAflow) was determined
using standard, validatedultrasound techniques (Hoskins,
2008), where:
flow = π × (diameter in centimetres/2)2
× time averaged peak velocity in
centimetres per second × 60 s
Average coefficients of variation determined from three
repeatedmeasurements of ICAandVAflowmeasurements
in seven subjects at SL were 4.0 ± 2.6 and 4.0 ± 2.1%,
respectively.
Global CBF (gCBF) was estimated assuming
symmetrical bilateral flow in the major tributary arteries
of the brain (Ogoh et al. 2013;Willie et al. 2013) as follows:
gCBF = (ICAflow + VAflow) × 2
Regional and global measurements of CBF were also
expressed relative to estimates of cardiac output (%Q˙ )
derived from simultaneous intra-arterial blood pressure
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Table 1. Cardiopulmonary and haematological values
Variable Units SL ALT1 ALT16
Ventilation l min−1 12.05 ± 2.50 (21) 11.93 ± 2.92 (17) 14.88 ± 2.65 (21)∗†
Arterial PO2 mmHg 102.2 ± 5.5 (21) 36.1 ± 2.8 (18)∗ 45.3 ± 3.2 (20)∗†
Arterial PCO2 mmHg 38.1 ± 4.4 (21) 26.5 ± 3.1 (18)∗ 20.9 ± 2.5 (20)∗†
Arterial O2 saturation % 98 ± 1 (21) 76 ± 6 (18)∗ 82 ± 3 (20)∗†
Haemoglobin concentration g dl−1 13.9 ± 1.4 (21) 14.2 ± 1.5 (18)∗ 16.0 ± 2.0 (20)∗†
Arterial O2 content ml dl−1 19.4 ± 1.9 (21) 15.2 ± 2.1 (18)∗ 18.4 ± 2.4 (20)∗†
Heart rate beats min−1 76 ± 12 (21) 90 ± 16 (16)∗ 96 ± 13 (20)∗
Stroke volume ml 91 ± 27 (21) 85 ± 20 (16) 83 ± 21 (20)
Mean arterial blood pressure mmHg 79 ± 8 (21) 76 ± 13 (16) 80 ± 10 (20)
Values are given as means ± SD (n). ∗Different at sea level (SL), and on the 1st and 16th days at 5260 m (ALT1, ALT16, respectively).
†Different from ALT1.
traces (Bogert et al. 2010). Cerebral vascular resistance
index (CVRi) was calculated as follows:
CVRi = meanABP/flow
Cerebral oxygen delivery
Arterial blood was immediately analysed for PaO2 ,
PaCO2 (Siemens RAPIDLab 248, Erlangen, Germany),
haemoglobin concentration ([Hb]), arterial oxygen
saturation (SaO2 ; Radiometer OSM3, Copenhagen,
Denmark) and haematocrit (M24 Centrifuge, LW
Scientific, Lawrenceville, GA, USA). Blood gases
were temperature corrected (Kelman & Nunn, 1966;
Severinghaus, 1966). The CaO2 (vol%) was calculated as
follows:
CaO2 = 1.39 × [Hb] × SaO2 + PaO2 × 0.003
Regional and global cerebral DO2 were calculated as the
products of CaO2 and ICAflow, VAflow and gCBF.
Data analysis
After verification of normality, mixed repeated-measures
ANOVAs were used to analyse the interaction of time by
sex for each variable of interest (α = 0.05). Subsequent
estimation-maximization and multiple-imputation (five
trials) analyses verified negligible effects of missing values
(SPSS 20, IBM, Chicago, IL, USA). Student’s paired t tests
(without imputation of missing values) were used for post
hoc comparisons with the Holm procedure to control
for type I error. A priori power calculations (α = 0.05,
β = 0.20) were integrated into the study design to limit
type II error. Pearson product–moment correlations were
used to describe shared variance between variables. Data
are presented as means ± SD.
Based on the hypothesis that increased CBF may play
a role in the pathogenesis of acute mountain sickness
(AMS; Jensen et al. 1990; Baumgartner et al. 1994,
1999), a secondary analysis was performed to evaluate
potential relationships (Spearman correlations) between
changes in CBF and DO2 with the severity of Lake Louise
Questionnaire symptom scores reported in these subjects
onALT1 (Subudhi et al. 2014). Student’s paired t tests were
used to evaluate differences inCBF andDO2 between those
with severe AMS (Lake Louise Questionnaire symptoms
scores  6, including headache) and those remaining
healthy.
Results
Subject characteristics
Detailed baseline characteristics of the 21 subjects (12
men and nine women; 21 ± 1 years old) participating
in AltitudeOmics are presented elsewhere (Subudhi et al.
InReview).Men exhibitedhigher [Hb],CaO2 andDO2 than
females over the course of the study (all P < 0.05), but as
no interactions in CBF or DO2 were detected throughout
acclimatization, combined data are presented below.
Cerebral blood flow and oxygen delivery
Acute exposure to 5260 m (atmospheric pressure
408 ± 1 mmHg) decreased PaO2 , SaO2 and CaO2 by
66.1 ± 5.4 mmHg, 22 ± 6% and 4.1 ± 1.2 ml dl−1,
respectively (all P < 0.001; Table 1). This severe degree
of hypoxia increased heart rate by 14 ± 11 beats min−1
(P< 0.001)without affectingmean arterial blood pressure
(P= 0.380). Cerebral blood flow increased by 74± 81% in
the ICA (P = 0.018), 59 ± 54% in the VA (P = 0.001) and
69 ± 57% globally (P = 0.003). Respective CVRi values
fell (all P< 0.001; Table 2), allowing a larger percentage of
cardiac output to perfuse the brain (P = 0.010). Increased
ICAflow was characterized by increased ICA velocity
(P = 0.004) without a change in diameter (P = 0.068),
while increased VAflow was explained by an increase in
VA diameter (P = 0.005) without a change in velocity
(P = 0.120). The MCAvelocity was unchanged (P = 0.953).
Increased gCBF offset the decrease in CaO2 to maintain
global cerebral DO2 (Fig. 1), although a small increase in
VADO2 wasobserved (P=0.039;Fig. 2).Observedchanges
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Table 2. Cerebrovascular values
Variable Units SL ALT1 ALT16
ICA diameter cm 0.51 ± 0.08 (21) 0.54 ± 0.07 (16) 0.50 ± 0.07 (20)†
ICA velocity cm s−1 29.8 ± 8.2 (21) 38.9 ± 8.1 (16)∗ 32.1 ± 5.4 (20)†
ICA flow ml min−1 384 ± 197 (21) 556 ± 203 (16)∗ 379 ± 97(20)†
ICA CVRi mmHg ml−1 min−1 0.25 ± 0.12 (21) 0.16 ± 0.09 (16)∗ 0.23 ± 0.07 (19)†
VA diameter cm 0.36 ± 0.06 (20) 0.41 ± 0.06 (16)∗ 0.36 ± 0.06 (19)†
VA velocity cm s−1 21.4 ± 4.4 (20) 24.4 ± 6.4 (16) 19.3 ± 7.1 (19)†
VA flow ml min−1 133 ± 47 (20) 206 ± 98 (16)∗ 122 ± 55 (19)†
VA CVRi mmHg ml−1 min−1 0.66 ± 0.24 (20) 0.46 ± 0.28 (16)∗ 0.84 ± 0.58 (19)†
gCBF ml min−1 1057 ± 413 (20) 1524 ± 456 (16)∗ 981 ± 223 (19)†
gCBF CVRi mmHg ml−1 min−1 0.09 ± 0.03 (20) 0.05 ± 0.02 (16)∗ 0.08 ± 0.02 (19)†
DO2 ICA ml min
−1 75 ± 37 (21) 84 ± 32 (16) 68 ± 19 (19)†
DO2 VA ml min
−1 26 ± 10 (20) 31 ± 16 (16)∗ 22 ± 11 (19)†
DO2 gCBF ml min
−1 206 ± 79 (20) 230 ± 74 (16) 181 ± 51 (19)†
MCA velocity cm s−1 59.5 ± 10.3 (21) 61.1 ± 13.3 (17) 57.7 ± 7.1 (21)
MCA CVRi mmHg cm−1 s−1 1.36 ± 0.25 (21) 1.28 ± 0.32 (17) 1.41 ± 0.24 (20)
ICA%Q˙ % 5.4 ± 2.7 (21) 7.6 ± 2.7 (15)∗ 4.8 ± 1.4 (18)†
VA%Q˙ % 1.9 ± 0.8 (20) 2.6 ± 1.1 (15)∗ 1.5 ± 0.7 (18)†
gCBF%Q˙ % 15.0 ± 5.8 (20) 20.4 ± 6.2 (15)∗ 12.6 ± 3.4 (18)†
Values are given as means ± SD (n). ∗Different at sea level (SL), and on the 1st and 16th days at 5260 m (ALT1, ALT16, respectively).
†Different from ALT1. Abbreviations: ICA, internal carotid artery; CVRi, cerebrovascular resistance index; VA, vertebral artery; gCBF,
global cerebral blood flow; DO2, oxygen delivery; MCA, middle cerebral artery; and Q, cardiac output.
in measures of regional and global CBF and DO2 were
not correlated with Lake Louise Questionnaire symptom
scores of AMS (r = −0.07 to −0.23, P = 0.38–0.78), nor
were they different between those reporting severe AMS
and those remaining healthy (P = 0.57–0.97).
Following acclimatization, a 32 ± 36% rise in
ventilation was accompanied by a 5.5 ± 2.7 mmHg
decrease in PaCO2 and 9.2 ± 4.1 mmHg increase in
PaO2 (ALT1 versus ALT16; all P < 0.001). The values of
SaO2 and [Hb] rose by 6 ± 5% and 1.8 ± 0.9 g dl−1,
respectively, improving CaO2 by 3.1 ± 1.2 ml dl−1 (all
P< 0.001; Table 1). Arterial blood pressure was unaffected
by acclimatization (ALT1 versus ALT16; P = 0.211). The
ICAflow, VAflow and gCBF returned to SL values (SL versus
ALT16; P = 0.810, 0.977 and 0.620, respectively; Table 2).
Respective CVRi values increased as both ICA and VA
diameters decreased from ALT1 to ALT16 (all P < 0.020)
and restored the relative distribution of cardiac output
back to SL values (SL versus ALT16; P = 0.121). Cerebral
DO2 fell fromALT1 to ALT16 (ICADO2 P= 0.028, VADO2
P = 0.020 and global DO2 P = 0.011) as the reductions
in CBF outweighed the increase in CaO2 (Fig. 1); however,
neither global nor regional cerebral DO2 values fell below
that measured at SL (all P > 0.420; Figs 1 and 2).
Discussion
This is the first study to assess regional cerebral oxygen
delivery in the field over a period of acclimatization to high
altitude. Our findings confirm that global cerebral DO2
was preserved across acclimatization through a changing
balance between CBF and CaO2 , but there was a slight
increase in relativeDO2 to theposterior cerebral circulation
during acute exposure. Although changes in CBF and
DO2 were not associated with the incidence or severity
of AMS, regional regulation of CBF may serve to support
vital homeostatic cerebral functions in hypoxia.
Preservation of cerebral oxygen delivery
The increase in CBF upon arrival at high altitude and
decrease back to sea-level values with acclimatization was
opposed by changes in CaO2 (Fig. 1). These responses
preserved cerebralDO2 close to sea-level values and affirm
that components of CaO2 (PaO2 , SaO2 and [Hb]) outweigh
the influence of PaCO2 in regulating CBF in severe hypoxia.
Increased CBF upon arrival at high altitude resulted from
reduced cerebral vascular resistance rather than increased
blood pressure (Tables 1 and 2). Although a reduction
in cerebral vascular resistance is commonly attributed to
dilatation of pial and parenchymal arterioles in the brain
(Fog, 1938), we observed an increased diameter of larger
tributary arteries, supporting a global vascular response
to this degree of hypoxia (Heistad et al. 1978; Faraci
& Heistad, 1990; Willie et al. 2012). The mechanisms
governing hypoxic vasodilatation are complex, involving
local (e.g. astrocyte regulation, nitric oxide) and diffuse
mechanisms (e.g. central chemoreception, autonomic
nervous system), but all stem from a reduction in PaO2
(Severinghaus, 2001; Xu & Lamanna, 2006). When PaO2 is
above60mmHg, little vasodilatation is evident (Mardimae
et al. 2012; Willie et al. 2012). Below this threshold,
the degree of vasodilatation increases exponentially and
outweighs the degree of hypocapnic vasoconstriction
C© 2013 The Authors. Experimental Physiology C© 2013 The Physiological Society
Exp Physiol 99.5 (2014) pp 772–781 777Cerebral oxygen delivery at altitude
(Mardimae et al. 2012; Willie et al. 2012); presumably,
to provide greater blood flow in a time of need. While
the correlation between changes in gCBF and CaO2
was not significant, the change in CaO2 from SL to
ALT1 was similar among all subjects and may not
have afforded an appropriate range of values to detect
the relationship that has previously been shown with
progressive haemodilution (Korosue & Heros, 1992).
Qualitatively, the 70% increase in gCBF was within
the expected range during acute hypocapnic hypoxia
(Severinghaus, 1966, 2001; Jensen et al. 1990; Brugniaux
et al. 2007) and proportional to the 60% reduction in
PaO2 that was responsible for the reduction in CaO2 . This
reciprocal relationship, whether evolved or serendipitous,
Figure 1. Reciprocal changes in global cerebral blood flow
(gCBF) and arterial oxygen content (CaO2 ) maintained global
cerebral oxygen delivery (DO2 ) throughout the study
∗Different from sea level (SL). †Different from arrival at
altitude (ALT1). Abbreviation: ALT16, 16th day at 5260 m.
is advantageous for survival in these extreme conditions
because it mitigates the negative consequences of cerebral
hypoxaemia.
Although increased CBF has been suggested to play
a role in the pathogenesis of AMS (Baumgartner et al.
1994), our results were more similar to those refuting the
hypothesis (Jensen et al. 1990; Baumgartner et al. 1999).
Regional and global CBF and DO2 measurements were
not correlated with AMS symptom scores and did not
differentiate between those with severe AMS and those
who remained healthy after rapid ascent to high altitude.
Nonetheless, our data should be interpreted with caution
because it is possible that increased CBF contributes to
the development of AMS when other, yet to be described,
factors are present.
Increased PaO2 and decreased PaCO2 after 16 days at
high altitude are hallmarks of ventilatory acclimatization
that are addressed elsewhere (Fan et al. 2014). As a
result, PaO2-mediated vasodilatation was reduced and
PaCO2-mediated vasoconstriction was increased, thereby
lowering CBF. Assuming a cerebral O2 reactivity of 3%
CBF %S−1aO2 and a CO2 reactivity of 4% CBF (mmHg
CO2)−2 from a previous duplex ultrasound study (Willie
et al. 2012), we could account for the entire decrease
in gCBF across acclimatization. Specifically, the 5%
increase in SaO2 could be expected to reduce CBF by
15% and the 5.5 mmHg decrease in PaCO2 could be
Figure 2. Regional oxygen delivery (DO2 ) increases in the
vertebral artery (VA) but not in the internal carotid artery
(ICA) on arrival at altitude (ALT1)
Regional DO2 is reduced with acclimatization, but not below
sea-level (SL) values. ∗Different from SL. †Different from ALT1.
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expected to reduce CBF by 22%, thus accounting for
the 36% decrease in gCBF we observed from ALT1
to ALT16 (Table 2). We acknowledge that increased
cerebrovascular CO2 reactivity with acclimatization in
our subjects (Fan et al. 2014) may account for an
even greater proportion of the net effect on CBF at
ALT16. Also, the relative influence of other haematological
factors, such as increased haematocrit and blood viscosity
(Sorensen et al. 1974; Todd et al. 1994; Tomiyama
et al. 1999) from erythropoiesis and plasma volume
contraction, may have contributed to the reduction of
CBF throughout acclimatization (data to be presented
elsewhere). Yet our data suggest that the inherent vascular
reactivities to O2 and CO2 are sufficient to maintain
tight control over cerebral DO2 in hypoxia. Consistent
delivery of oxygen may help to offset the decreased
PO2 gradient (plasma to mitochondria) and support the
cerebral metabolic demand for oxygen at this altitude
(Severinghaus et al. 1966; Møller et al. 2002) to preserve
cerebral function. Together, our data demonstrate that
integratedmechanisms controlling cerebral blood flow are
well suited to preserve global cerebral oxygen delivery at
5260 m.
Regional cerebral oxygen delivery
Weobserved a small increase inDO2 through the posterior
cerebral circulation upon arrival at high altitude (Table 2)
that dissipated with acclimatization. The acute increase
in DO2 was characterized by an increase in VA diameter
and supports recent findings of greater VA (versus ICA)
vasoreactivity during acute hypoxia (Willie et al. 2012;
Ogoh et al. 2013). Of note, Ogoh et al. (2013), showed
that acute hypoxia (15 min) increased VA, but not ICA,
bloodflow.Given that the areas perfused by theVA include
the brainstem and posterior aspects of the thalamus
and hypothalamus, increased blood flow and DO2 to
these regions during acute hypoxia (Buck et al. 1998;
Binks et al. 2008) may be seen as necessary to maintain
vital homeostatic functions (Sheldon et al. 1979; Bilger
& Nehlig, 1993). As increased cardiorespiratory drive
with acclimatization was not associated with a continued
elevation of VA DO2 , we speculate that the increased
VA DO2 during acute hypoxia was protective, to defend
against a potential threat to oxygen supply, rather than
merely to support neuronal metabolic activity associated
with heightened autonomic activity (i.e. neurovascular
coupling). Although such hypothetical explanations for
regional differences in the regulation of CBF and DO2
are intriguing, our results must be interpreted with
caution because measured differences were small and are
not consistently reported in the literature (Huang et al.
1987; Willie et al. 2013). Future studies with more focal
measurements of DO2 (e.g. PET and MRI) and neuronal
activity in key regulatory regions of the brain, as well as
measurements of neurovascular coupling (as an index of
neuronal plasticity) during acute and prolonged hypoxia
are needed to yield further insight into this question.
Brain sparing
Reduced cerebral vascular resistance associated with
vasodilatation upon arrival at altitude can explain the
proportional increase in CBF and greater allocation of
cardiac output. This effect could be magnified if there is
net constriction in other vascular beds at rest. Previous
studies have shown that superior mesenteric and renal
artery blood flow decrease in acute hypoxia and could
allow for greater perfusion of the brain (Greene & Roach,
2004). With acclimatization, cerebral vascular resistance
and blood flow returned to sea-level values. These results
are similar to fetal ‘brain-sparing’ effects (Campbell et al.
1967; Peeters et al. 1979; Sheldon et al. 1979) that are
presumed to preserve vital homeostasis during hypoxia in
utero (Pearce, 2006; Salihagic´-Kadic´ et al. 2006). Similar
effectshave alsobeen shown innewborndogs (Cavazzuti&
Duffy, 1982), piglets (Goplerud et al. 1989) and premature
infants (Daven et al. 1983). The largest response to
hypoxia tends to occur in the brainstem during the
early postnatal period and decreases with age (Bilger &
Nehlig, 1993). We are the first to demonstrate that such
a brain-sparing reaction exists in healthy human adults
exposed to acutehypoxia and recedeswith acclimatization.
Preferential distribution of cardiac output to the brain
upon acute altitude exposure may represent a conserved
mechanism that protects against hypoxic brain damage
in mammals, particularly in brain regions associated
with basic cardiovascular and respiratory control during
periods of acute hypoxia. Measurements of regional
cerebral metabolism are needed to determine whether
brain sparing effectively matches DO2 , or if the increase
in CBF represents a protective form of overcompensation.
Limitations
Our rapid ascent profile in combination with
supplemental oxygen during transport from low to high
altitude was designed to induce an abrupt change in PaO2 ,
similar to that which can be achieved in laboratory studies
with hypoxic gas or hypobaric chambers. As such, our
resultsmust be interpreted in this context and thusmay be
expected to be different from other field studies that have
followedmore traditional progressive ascents (Huang et al.
1987; Jensen et al. 1990; Baumgartner et al. 1994; Willie
et al. 2013).
We used duplex sonography primarily because it is a
non-invasive technique that can be used in field settings.
This technique yields volumetric measurements, in terms
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of millilitres per minute, which, based on first principles,
canbemultipliedbyCaO2 to yieldDO2 .Our lowcoefficients
of variation were in line with a previous study showing
similarity between duplex sonography and both PET and
xenon inhalation methods of measuring gCBF (Scho¨ning
& Scheel, 1996). Nevertheless, we acknowledge that all
these techniques are limited by the lack of an absolute
standard for validating CBF. Our gCBF measurements
were based on unilateral, left-sided measurements of the
ICA and VA, which are the main arteries perfusing the
brain. While left VA flow has been reported to be 20%
higher than the right (Scho¨ning et al. 1994), this was not
expected tohave an effect on globalmeasurements because
ICA flow represents the majority of gCBF (Scho¨ning &
Scheel, 1996). Yet, unilateral VA measurements may have
influenced our finding of increasedVADO2. Future studies
are needed to determine whether brain-sparing effects are
attenuated when independent measurements of left and
right VA flow are summed.
Given that the ICA feeds the MCA, we expected that
changes in ICA flow would be reflected in MCAvelocity.
This was not the case; ICA flow increased by 70%
while MCAvelocity was unchanged throughout the study.
A similar discrepancy between ICA flow and MCAvelocity
has been described previously by Willie et al. (2012)
and argued to support dilatation of the MCA in hypoxia
(Wilson et al. 2011). We calculated that a 12% increase in
MCA diameter could explain the measured discrepancy
between ICAflow and MCAvelocity. This exact degree of
vasodilatation has recently been demonstrated at high
altitude with a colour-coded ultrasound technique (Willie
et al. 2013), yet because additional studies are needed to
clarify artery-specific responses to hypoxia and validate
MCA-diameter measurement techniques, we chose to
refrain from further interpretation of MCAvelocity.
Summary and implications
Overall, our findings highlight the integrative nature of
responses that preserve oxygen delivery to the brain at
high altitude. Regional cerebral vasoreactivity to O2 and
CO2 may favour oxygen delivery to posterior and inferior
regions of the brain during acute hypoxia to sustain
vital cerebral functions associated with homeostasis.
Whether these mechanisms evolved to promote survival
in conditions provoking cerebral hypoxia is not clear
at present, but further research in this area may yield
important insights into human tolerance and adaptation
to chronic states of hypoxaemia.
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Fan JL, Subudhi AW, Evero O, Bourdillon N, Kayser B, Lovering
AT, Roach RC. AltitudeOmics: enhanced cerebrovascular reactivity and
ventilatory response to CO2 with high-altitude acclimatization and reexpo-
sure. J Appl Physiol 116: 911–918, 2014. First published December 19,
2013; doi:10.1152/japplphysiol.00704.2013.—The present study is the
first to examine the effect of high-altitude acclimatization and reex-
posure on the responses of cerebral blood flow and ventilation to CO2.
We also compared the steady-state estimates of these parameters
during acclimatization with the modified rebreathing method. We
assessed changes in steady-state responses of middle cerebral artery
velocity (MCAv), cerebrovascular conductance index (CVCi), and
ventilation (V˙ E) to varied levels of CO2 in 21 lowlanders (9 women;
21 1 years of age) at sea level (SL), during initial exposure to 5,260
m (ALT1), after 16 days of acclimatization (ALT16), and upon
reexposure to altitude following either 7 (POST7) or 21 days
(POST21) at low altitude (1,525 m). In the nonacclimatized state
(ALT1), MCAv and V˙ E responses to CO2 were elevated compared
with those at SL (by 79  75% and 14.8  12.3 l/min, respectively;
P 0.004 and P 0.011). Acclimatization at ALT16 further elevated
both MCAv and V˙ E responses to CO2 compared with ALT1 (by 89 
70% and 48.3  32.0 l/min, respectively; P  0.001). The acclima-
tization gained for V˙ E responses to CO2 at ALT16 was retained by
38% upon reexposure to altitude at POST7 (P  0.004 vs. ALT1),
whereas no retention was observed for the MCAv responses (P 
0.05). We found good agreement between steady-state and modified
rebreathing estimates of MCAv and V˙ E responses to CO2 across all
three time points (P  0.001, pooled data). Regardless of the method
of assessment, altitude acclimatization elevates both the cerebrovas-
cular and ventilatory responsiveness to CO2. Our data further dem-
onstrate that this enhanced ventilatory CO2 response is partly retained
after 7 days at low altitude.
cerebral blood flow; cerebral CO2 reactivity; rebreathing; altitude
acclimatization
THE ABILITY TO MAINTAIN ADEQUATE oxygen transport to the brain
by cerebral blood flow (CBF) in hypoxic environments is vital.
The CBF responsiveness to CO2, termed cerebrovascular CO2
reactivity, provides a useful, noninvasive index of cerebrovas-
cular function (3, 19). To date, only a handful of studies have
investigated the effect of acclimatization to high altitude on
cerebrovascular CO2 reactivity (1, 16, 17, 24, 30, 49). It is
difficult to interpret the findings from these studies due to the
timing of measurements at high altitude (1, 16, 17, 24, 25), the
confounding effects of previous high altitude exposure (1),
artificial normobaric hypoxia (28, 46), and the method used to
assess reactivity (24, 30, 49). Data obtained by Fan et al. (16,
17) on subjects at different stages of altitude acclimatization
suggest that cerebrovascular CO2 reactivity is elevated with
prolonged exposure to high altitude when using a modified
rebreathing technique. In contrast, Lucas et al. (30) reported,
using a steady-state technique (poikilocapnic hypoxia), re-
duced cerebrovascular CO2 reactivity in the same subjects
assessed at the end of a 14-day stay at 5,050 m. More recently,
Rupp et al. (49) reported a reduced cerebrovascular CO2
reactivity during steady-state hypoxic hypercapnia following 5
days at 4,350 m. Thus the effect of altitude acclimatization on
cerebrovascular CO2 reactivity remains unclear.
In addition, it is unknown whether and for how long changes
in cerebrovascular CO2 reactivity from acclimatization persist
after descent. Repetitive 7-mo exposures to high altitude were
reported to improve arterial O2 saturation (SaO2), lower resting
heart rate (HR), and decrease susceptibility to acute mountain
sickness (AMS) upon subsequent reexposures (59). Remark-
ably, these prior exposure adaptations persisted despite a 5-mo
deacclimatization period. The specific effect of high-altitude
reexposure on cerebrovascular and ventilatory responsiveness
to CO2 has yet to be examined.
Changes in cerebrovascular CO2 reactivity with high-alti-
tude acclimatization depend on the method of assessment. At
sea level, the steady-state method results in higher cerebrovas-
cular CO2 reactivity (40–42) and lower ventilatory CO2 sen-
sitivity (6, 18, 23, 55) compared with the modified rebreathing
test. These differences have been attributed to the presence of
a PCO2 gradient (between alveolar, arterial, and cerebrospinal
fluid compartments) during the steady-state method, which is
supposedly abolished or minimized during rebreathing (6).
Meanwhile, elevated basal V˙ E and subsequent underestimation
of the ventilatory CO2 sensitivity has been proposed as one
possible explanation for lower steady-state estimates (34). No
studies have directly compared the steady-state and modified
rebreathing test estimates of cerebrovascular and ventilatory
CO2 responsiveness following ascent or acclimatization to high
altitude.
The purpose of the present study was therefore twofold: first,
we wished to assess the effect of altitude exposure on cerebro-
Address for reprint requests and other correspondence: B. Kayser, ISSUL, Univ.
of Lausanne, 1015 Lausanne Switzerland, (e-mail: Bengt.Kayser@unil.ch).
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vascular and ventilatory responsiveness to CO2 in acute con-
ditions after acclimatization and upon reexposure to high
altitude after a period spent at low altitude; second, we wished
to compare the steady-state and modified rebreathing methods
for assessing the ventilatory and cerebrovascular responsive-
ness to CO2 at high altitude.
METHODS
Subject Recruitment and Screening
This study was conducted as part of the AltitudeOmics project.
Following institutional ethics approval, young (19–23 years old),
healthy, sea-level residents were recruited from the greater Eugene,
Oregon, area (elevation 130 m). Potential subjects were screened to
exclude anyone who was born or had lived at altitudes 1,500 m
for more than 1 year or had traveled to altitudes 1,000 m in the
past 3 mo. A detailed description of subject recruitment proce-
dures, including inclusion and exclusion criteria, has been pre-
sented elsewhere (54).
Ethical Approval
The study was performed according to the Declaration of Helsinki
and was approved by the institutional review boards of the University
of Colorado and the University of Oregon, and by the Human
Research Protection Office of the U.S. Department of Defense. All
participants were informed regarding the procedures of this study, and
written informed consents were obtained prior to participation.
Experimental Design
After familiarization with the experimental procedures outlined
below (visit 1), the subjects underwent experimental trials near sea
level (SL) (130 m; barometric pressure 749 mmHg) and three times at
high altitude (5,260 m, Mt. Chacaltaya, Bolivia; barometric pressure
406 mmHg) on the 1st and 16th days at high altitude (ALT1 and
ALT16, respectively), and again after either 7 (POST7; n  14) or 21
(POST21; n  7) days at low altitude (1,525 m; barometric pressure
639 mmHg). An overview of the entire experimental design and
protocol has been described in detail elsewhere (54).
Experimental Protocol
For each subject, all ALT measurements were carried out around
the same time of day to minimize any confounding effect of circadian
rhythm. Measurements were taken upon arrival at ALT1 to minimize
the influence of AMS. Likewise, no symptoms of AMS were observed
at ALT16 or POST7.
For this study, following 10–15 min of quiet rest in a seated
position, each experimental testing session consisted of 1) instrumen-
tation, 2) 10 min in room air at baseline, and 3) cerebrovascular CO2
reactivity tests. The cerebrovascular CO2 reactivity tests consisted of
1) 10 min with end-tidal PCO2 (PETCO2) clamped at 40 mmHg; 2) 3
min of voluntary hyperventilation to lower PETCO2 to 20 mmHg; 3)
the modified rebreathing test (details below); and 4) 3 min with
PETCO2 clamped at 50 mmHg. The entire cerebrovascular CO2 reac-
tivity protocol was carried out in a background of hyperoxia (end-tidal
PO2 [PETO2] 250 mmHg).
Experimental Setup
Throughout the protocol, the subjects sat upright and breathed
through a mouthpiece attached to a two-way, nonrebreathing valve
(Hans-Rudolph 2700, Hans-Rudolph, Shawnee, KS). The breathing
circuit allowed switching from room air to either an end-tidal clamp-
ing system or a rebreathing system. The end-tidal clamping setup used
in the present study is a modified version of the system previously
described by Olin et al. (39). The setup allowed stabilizing PETCO2 at
40 and 50 mmHg. Throughout the end-tidal PCO2 clamping, we
maintained PETO2 at 250 mmHg by titrating 50% or 100% O2 into
the inspiratory reservoir at SL and ALT, respectively.
Modified Rebreathing Method
The modified rebreathing method is well established for assessing
both ventilatory and cerebrovascular CO2 reactivities (14, 16, 34, 41).
By using hyperoxia (PETO2 250 mmHg) the test minimizes the
output of peripheral chemoreceptors (11, 21), and the ventilatory
response to the modified rebreathing method can thus be interpreted as
the ventilatory CO2 sensitivity primarily from the central chemoreflex.
The details of the modified rebreathing method have been previously
described in Fan al. (16, 17). The rebreathing bag was filled with gas
to achieve inspired PCO2 and PO2 of 0 mmHg and 300 mmHg,
respectively, at each altitude. Subjects were instructed to hyperventi-
late for 3 min (part 2) to lower and then maintain PETCO2 at 20 mmHg
at both sea level and 5,260 m (in background PETO2 250 mmHg).
Subjects were then switched to the rebreathing bag, and following two
initial deep breaths to mix the gas from the bag with that in the
respiratory system, they were instructed to breathe ad libitum (part 3).
The rebreathing tests were terminated when PETCO2 reached 50
mmHg, PETO2 dropped below 200 mmHg, or the subject reached the
end of his or her hypercapnic tolerance.
Measurements
Cerebrovascular variables. Middle cerebral artery velocity (MCAv,
an index of cerebral blood flow) was measured in the left middle cerebral
artery using a 2-MHz pulsed Doppler ultrasound system (ST3; Spen-
cer Technology, Seattle, WA). The Doppler ultrasound probe was
positioned over the left temporal window and held in place with an
adjustable plastic headband (Marc 600 Headframe; Spencer Technol-
ogy). The signal was acquired at depths ranging from 43 to 54 mm.
Signal quality was optimized, and an M-mode screen shot was
recorded to facilitate subsequent probe placements. Peripheral satu-
ration was measured on the right side of the forehead by pulse
oximetry (N-200; Nellcor, Hayward, CA).
Cardiovascular variables. Beat-to-beat mean arterial blood pres-
sure (MAP) was measured from an arterial catheter inserted in a radial
artery, and connected to a calibrated, fluid-filled, disposable pressure
transducer positioned at the level of the heart (DELTRAN II; Utah
Medical, Salt Lake City, UT). HR was determined using three-lead
electrocardiography systems (ADInstruments BioAmp & Micromaxx;
SonoSite, Bothell, WA). Cerebrovascular conductance index (CVCi)
was calculated using the equation CVCi  MCAv/MAP and normal-
ized to values obtained at a PETCO2 of 20 mmHg, and expressed as
percentage change.
Respiratory variables. V˙ E was measured using a pneumotacho-
graph (Universal Ventilation Meter; Vacu·Med, Ventura, CA; Ultima
series; Medgraphics CPX, Minneapolis, MN) and expressed in units
adjusted to body temperature and pressure, saturated (BTPS). PETO2
and PETCO2 were measured using fast-responding gas analyzers(O2Cap Oxygen analyzer; Oxigraf, Mountain View, CA). The pneu-
motachograph was calibrated using a 3-liter syringe (Hans-Rudolph
5530) and the gas analyzers were calibrated using gas mixtures of
known concentrations of O2 and CO2 prior to each testing session.
Arterial blood gas variables. An arterial catheter (20–22 gauge)
was placed into a radial artery and blood samples (2 ml) were taken
over approximately five cardiac cycle periods. Core body temperature
was telemetrically recorded from an ingested pill (CorTemp; HQInc,
Palmetto, FL). All samples were analyzed immediately for arterial pH,
PO2 (PaO2), PCO2 (PaCO2) (Rapidlab 248; Siemens Healthcare Diag-
nostics, Munich, Germany), hemoglobin concentration, and O2 satu-
ration (SaO2) (Radiometer OSM3; Radiometer Medical ApS, Copen-
hagen, Denmark). The blood gas values were analyzed in triplicate
and temperature-corrected (26, 53). Arterial bicarbonate concentration
912 Cerebral Function at Altitude • Fan JL et al.
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([HCO3]) was subsequently calculated using the Henderson-Hassel-
balch equation.
Data Acquisition
All analog data were sampled and recorded at 200 Hz on a personal
computer for off-line analysis (Powerlab 16/30; ADInstruments, Bella
Vista, Australia).
Data Analysis
Steady-state responses. Because the subjects could not tolerate
PETCO2 clamping at 50 mmHg at ALT16, the steady-state MCAv-CO2,
MAP-CO2, and CVCi-CO2 slopes were estimated from the difference
in mean MCAv, MAP, and CVCi at the end of 20 and 40 mmHg
PETCO2 clamping (20-s averages) and plotted against the change in
PaCO2 between these two conditions across all time points (SL, ALT1,
ALT16, POST7, and POST21). The absolute value of V˙ E at clamp 40
mmHg was used as an estimate of steady-state V˙ E responsiveness to
CO2, because voluntary hyperventilation was necessary to reduce
PETCO2 to 20 mmHg.
Modified rebreathing. The rebreathing data were first reduced to
1-s averages across the entire rebreathing period. The V˙ E-CO2 slopes
were analyzed using a specially designed program (Analyse V˙ E
Rebreathing programme rev11; University of Toronto, Toronto, ON,
Canada) as previously described (15, 16, 34). The MCAv-CO2 slopes
were analyzed using a commercially available graphing program
(Prism 5.0d; GraphPad Software, San Diego, CA), whereby segmental
linear regression (least squares fit) was used to estimate the MCAv-
CO2 slope during the modified rebreathing. For comparison, we
plotted the MCAv-CO2 slopes using a sigmoid curve as described by
Battisti-Charbonney et al. (4) using the Prism program. To minimize
the sum of squares for nonlinear regression (Levenberg-Marquardt
algorithm) we used the equation MCAv  a  (b/{1  exp[
(PETCO2  c)/d]}), where MCAv is the dependent variable in cm/s,
PETCO2 is the independent variable in mmHg, a is the minimum
MCAv determined from the mean MCAv of the hypocapnic (hyper-
ventilation) region, b is the maximum MCAv value, c is the midpoint
value of MCAv, and d is the range of the linear portion of the sigmoid
(inverse reflection of the slope of the linear portion).
We found good agreement in the MCAv-CO2 slope obtained from
these two models (R2  0.71). However, due to the range of PETCO2
used in this study, segmental linear regression generally provided
better fit across all conditions, whereas the sigmoidal curve model was
the preferred model for only 12 out of 58 trials. As such, only the
MCAv-CO2 slopes obtained using the segmental linear model are
presented.
Statistical Analysis
Due to logistical impacts on planning and transportation, not all
subjects were able to participate in all high-altitude studies. See the
Figs. 1–3 and Table 1 for complete sample size reporting for each
procedure. Most data are reported as the improvement over the time
of acclimatization (change from ALT1 to ALT16) and as the amount
of that improvement that was retained after time at low altitude,
calculated as % retention (POST7 or POST21 ALT1)/(ALT16
ALT1)·100 (5). The effects of altitude acclimatization and reexposure
(between SL, ALT1, ALT16, POST7, and POST21) on the steady-
state MCAv-CO2 slope, CVCi-CO2 slope, and V˙ E at 40 mmHg were
analyzed using a mixed-model linear regression (IBM SPSS Statistics
version 21; IBM, Armonk, NY). To assess the effects of altitude
acclimatization (between SL, ALT1, and ALT16) on the rebreathing
estimates of MCAv-CO2 and V˙ E-CO2 slopes, we used mixed-model
linear regression analysis (diagonal repeated covariance assumed).
The interactions between variables of interest were assessed using
correlational (Pearson) analysis (IBM SPSS Statistics version 21).
Data are shown as mean  SD. Results were considered significant at
	  0.05. Trends were consider at the 	  0.10 level. A priori power
calculations (	  0.05, 
  0.20) were used to determine sample size
and limit type II error.
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RESULTS
Detailed baseline characteristics of the 21 (9 women; age 21 1
years) subjects participating in AltitudeOmics are presented
elsewhere (54). All 21 subjects completed the protocol at SL.
Due to logistical issues, 4 of 21 subjects were unable to
complete the entire experimental protocol at ALT1. Upon
reexposure to altitude, 14 of 14 subjects completed the protocol
at POST7, and 5 of 7 completed the protocol at POST21. No
comparison was carried out between ALT1 and POST21 due to
the low number of subjects.
Resting Variables
The resting variables across acclimatization and reexposure
have already been reported in detail elsewhere (54) and will not
be reproduced in this paper.
Steady-State Method
Acclimatization. Compared with SL, the steady-state MCAv-
CO2 slope was elevated at ALT1 (by 79  70%; P  0.001),
and was further elevated at ALT16 (by 89  70% vs. ALT1;
P  0.001) (Table 1). Similarly, the steady-state MAP-CO2
slope was elevated at ALT1 (by 0.24  0.23 mmHg/mmHg;
P  0.013) and further elevated at ALT16 (by 0.80  0.46
mmHg/mmHg vs. ALT1; P  0.001). The steady-state CVCi-
CO2 slope was elevated at ALT1 (by 82  79%; P  0.001),
and remained higher at ALT16 (by 93 81%; P 0.001 vs. SL, no
difference with ALT1). V˙ E at 40 mmHg was elevated at ALT1
compared with SL (by 14.8  12.3 l/min; P  0.011), and further
elevated at ALT16 (by 48.3  32.0 l/min vs. ALT1; P  0.001).
Reexposure. Upon reexposure to altitude, it appears that the
acclimatization gained in the steady-state MCAv-CO2 slope
was not retained at POST7 (P  0.145 vs. ALT1). Compared
with ALT16, the steady-state MCAv-CO2 slope was lowered at
both POST7 and POST21 (P  0.029 and P  0.003, respec-
tively), but nevertheless remained higher compared with SL
(P 0.001 and P 0.024, respectively). Similarly, 49% of the
acclimatization gained in the MAP-CO2 slope was retained at
POST7. Specifically, the MAP-CO2 slope remained higher at
POST7 compared with ALT1 (P  0.005). Compared with
ALT16, the MAP-CO2 slope was lowered at both POST7 and
POST21 (P  0.001 for both). Nevertheless, the MAP-CO2
slope was higher at POST7 and POST21 compared with SL
(P  0.001 and P  0.020, respectively). In contrast, no
difference was observed in the CVCi-CO2 slope at POST7
compared with ALT1 or ALT16 (P  0.980 and P  0.804,
respectively), but it remained higher compared with SL (P 
0.001). Likewise, the CVCi-CO2 slope tended to remain higher
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at POST21 compared with SL (P  0.058) but was not
different from ALT16 (P  0.715).
Upon reexposure, the effect of acclimatization on V˙ E at 40
mmHg was retained by 38% at POST7 (P  0.004 vs. ALT1).
Compared with ALT16, V˙ E at 40 mmHg was lower at POST7
and POST21 (P  0.001 and P  0.001, respectively), but
these values remained higher compared with SL (P  0.001
and P  0.001, respectively).
Modified Rebreathing Method
Similar to the steady-state method, the rebreathing MCAv-
CO2 slope was elevated at ALT1 (by 137 117%; P 0.001),
and further elevated at ALT16 (by 35  33% vs. ALT1; P 
0.040) (Table 1). The rebreathing V˙ E-CO2 slope was elevated
at ALT1 compared with SL (by 1.61 1.14 l·min1·mmHg1;
P  0.038), and further elevated at ALT16 (by 2.86  2.61
l·min1·mmHg1 vs. ALT1; P  0.004). The ventilatory
recruitment threshold was lowered at ALT1 (by 4.4  4.0
mmHg; P  0.001 vs. SL) and further lowered at ALT16 (by
4.4  3.2 mmHg vs. ALT1; P  0.001).
Acid-Base Buffering Capacity Correlations
Based on previous findings (16), we performed correlations
between the pooled steady-state data with [HCO3] and found
that resting [HCO3] correlated with the steady-state MCAv-
CO2 slope (R  0.771) and V˙ E at 40 mmHg (R  0.723;
P  0.001 for both) (Fig. 2).
Steady-State vs. Modified Rebreathing
We observed correlations between the steady-state and re-
breathing MCAv-CO2 slope at SL (R  0.609; P  0.003),
ALT1 (R  0.817; P  0.001), and ALT16 (R  0.596; P 
0.007), whereas the pooled MCAv-CO2 slopes (combined SL,
ALT1, and ALT16) between the two methods also correlated
well (R  0.860; P  0.001) (Fig. 3). Likewise, there were
significant correlations between V˙ E at 40 mmHg and the
rebreathing V˙ E-CO2 slope at SL (R  0.476; P  0.029),
ALT1 (R  0.506; P  0.038), and ALT16 (R  0.927; P 
0.001), whereas the pooled ventilatory data across all time
points also correlated (R  0.904; P  0.001).
DISCUSSION
The present study is the first to assess the effect of altitude
acclimatization and reexposure on cerebrovascular CO2 reac-
tivity using both the steady-state and modified rebreathing
methods. We demonstrate that cerebrovascular CO2 reactivity
was elevated immediately upon arrival at 5,260 m and is
further elevated following 16 days of acclimatization regard-
less of the method of assessment. In addition, we found that
cerebrovascular and ventilatory responsiveness to CO2 remains
elevated upon reexposure to altitude, despite 7 or 21 days at
low altitude. Because these changes in cerebrovascular and
ventilatory responsiveness to CO2 correlated with the changes
in resting arterial [HCO3] across all time points, we speculate
that these changes might be partly due to an altered pH
buffering capacity associated with exposure to high altitude.
Our data thus demonstrate that the changes in cerebrovascular
and ventilatory control gained due to altitude acclimatization
over a period of 16 days are partially preserved upon subse-
quent exposure to altitude, at least for up to a period of 3 wk
spent at low altitude.
Effects of Acclimatization on Cerebrovascular CO2
Reactivity
Our findings extend those from Fan et al. (16, 17) by
demonstrating that the MCAv-CO2 slope is elevated upon
arrival at 5,260 m and further elevated following 16 days of
acclimatization (Fig. 1A). Importantly, previous studies by Fan
et al. (16, 17) assessed MCAv-CO2 slope in subjects who spent
8 days ascending to 5,050 m, whereas the subjects in the
present study ascended rapidly to altitude (3 h), thus making
direct comparison difficult. Our findings contradict those of
Lucas et al. (30), who found that the MCAv-CO2 slope was
initially elevated at 5,050 m, but had returned toward sea level
values following 2 wk at 5,050 m. However, because PETO2 was
not controlled, the MCAv-CO2 slopes reported by Lucas et al.
(30) reflect MCAv changes from polkilocapnic hypoxia (room
air breathing at 5,050 m: PETO2～48 mmHg and PETCO2 26–22
mmHg) to hypercapnic hyperoxia (PETO2  310 mmHg and
PETCO2 ～30 mmHg), and thus do not represent isolated reac-
tivity to CO2. Rupp et al. (49) recently found the MCAv
response to steady-state hypoxic hypercapnia (PETO2  55
mmHg) to be reduced following 5 days at 4,350 m. Therefore,
discrepancies between findings by Rupp et al. (49) and those of
the present study can be attributed the differences in PETO2 (55
mmHg vs. 200 mmHg), altitude (4,350 m vs. 5,260 m), and
acclimatization state of the subjects (5 days vs. 16 days). The
results from the present study demonstrate for the first time that
cerebrovascular CO2 reactivity per se is enhanced with accli-
matization to high altitude when studied using a background
level of hyperoxia. Furthermore, discrepancies between studies
Table 1. Cerebrovascular and ventilatory reactivity parameters during the steady-state and modified rebreathing
SL (n  21) ALT1 (n  17) ALT16 (n  20) POST7 (n  14) POST21 (n  5)
Steady-state
MCAv-PaCO2 slope (cm·s1·mmHg1) 1.19  0.42 2.16 1.05* 3.39 0.89*† 2.68 0.88*‡ 2.06 0.57*‡
CVCi-PaCO2 slope (%/mmHg) 3.35  1.21 5.87 2.60* 5.75 1.85* 5.89 1.23* 5.41 1.78*
MAP-PaCO2 slope (l/min) 0.03  0.24 0.28 0.19* 1.06 0.45*† 0.56 0.29*‡ 0.32 0.18*‡
V˙ E at 40 mmHg (l/min) 19.15  4.89 34.06 12.23* 80.05 32.32*† 49.03 13.68*†‡ 43.25 7.56*‡
Modified rebreathing
MCAv-PETCO2 slope (cm·s1·mmHg1) 1.34  0.60 2.95 1.11* 3.67 0.87*† — —
V˙ E-CO2 slope (l·min1·mmHg1) 1.90  0.81 3.49 1.51* 6.28 3.56*† — —
V˙ E recruitment threshold (mmHg) 38.7 3.4 33.7 3.7* 29.2 2.1*† — —
All values are mean  SD. SL, sea level; ALT1, day 1 at high altitude; ALT16, day 16 at high altitude; POST7, reexposure following 7 days at low altitude;
POST21, reexposure following 21 days at low altitude. *Different from SL (P  0.05); †different from ALT1 (P  0.05); ‡different from ALT16 (P  0.05).
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highlight how methodological differences can yield vastly
different results. Thus future studies are warranted to clarify
the effect of hypoxic and hyperoxic background on assessing
cerebrovascular functions at both sea level and following
ascent to high altitude.
Altered Acid-Base Buffering Capacity?
During altitude acclimatization, there is a progressive and
parallel reduction in arterial and cerebrospinal fluid (CSF)
bicarbonate concentration, which serves to compensate for the
changes in pH associated with hyperventilation-induced hypo-
capnia (12, 13, 20). These changes in acid-base buffering
capacity, in both the arterial and CSF compartments, would
lead to a greater rise in arterial and CSF [H] for a given rise
in PaCO2. In support of this notion, lowering CSF bicarbonate
concentration elevates the cerebrovascular CO2 reactivity in an
anesthetized dog model (27), whereas bicarbonate infusion
increases cerebral perfusion pressure in patients with posttrau-
matic head injury (9), elevates cerebral blood volume in
preterm infants (57), and lowers ventilation in healthy exercis-
ing humans at SL (44). As such, it has been suggested that the
MCAv responses to CO2 at high altitude are linked to changes
in arterial acid-base balance (16, 25). In the present study, we
observed concomitant increases in cerebrovascular and venti-
latory responsiveness to CO2 with acclimatization to high
altitude and reexposure (Fig. 1), which occurred in parallel to
the changes in [HCO3] (Fig. 2). While such correlations do not
imply causality, the possible role for acid-base status changes
on cerebrovascular and ventilatory responsiveness to CO2 at
high altitude remains to be further studied.
Interaction Between Cerebrovascular and Ventilatory
Responsiveness to CO2
Interaction between cerebrovascular CO2 reactivity and cen-
tral chemoreceptor activation was first alluded to by Heyman et
al. (22) and has been subsequently expanded upon by others
(10, 16–18, 38, 43, 60–62). It was postulated that changes in
cerebrovascular CO2 reactivity affect the stability of the ven-
tilatory response to CO2 by modulating the degree of H
washout at the level of the central chemoreceptor (38). Ac-
cordingly, a blunted cerebrovascular CO2 reactivity would lead
to less central H washout and subsequently greater central
chemoreceptor activation. Conversely, an enhanced cerebro-
vascular CO2 reactivity would result in lower central [H] and
therefore lower ventilatory CO2 sensitivity. In agreement with
previous altitude studies (16, 17), we observed concomitant
increases cerebrovascular and ventilatory responsiveness to
CO2 (Fig. 1). These findings seem to contradict the modulating
role of cerebrovascular CO2 reactivity on central chemorecep-
tor activation, possibly due to other overriding factors such as
enhanced central chemosensitivity and changes in acid-base
balance associated with ascent to high altitude. Future work is
necessary to further unravel the interaction between the regu-
lation of cerebral blood flow and ventilation.
Going Back Up
Despite the large body of literature regarding high-altitude
acclimatization over the past century, the effect of prior expo-
sure on physiological parameters during subsequent exposures
is not well documented. Most attention has focused on the
effect of a recent altitude exposure on the risk for AMS (7, 31,
45, 51) or the rate of ascent (56). However, the dose of
previous altitude exposure and acclimatization were generally
not controlled in these studies. Wu et al. (59) found a progres-
sive reduction in the incidence of AMS, lower HR, and higher
SpO2 in lowland railroad workers over the course of several
7-mo exposures to high altitude interspersed with 5 mo spent at
low altitude. Similarly, MacNutt et al. (32) found faster rate of
ascent, lower AMS, and higher SpO2 in trekkers with a recent
altitude exposure compared with altitude-naive trekkers, de-
spite a 7- to 30-day deacclimatization period. In the present
study, we compared the cerebrovascular and ventilatory re-
sponsiveness to CO2 with acclimatization and upon reexposure
to 5,260 m following a period of either 7 or 21 days at low
altitude. We found that 38% of the gain in ventilatory response
to CO2 over acclimatization was retained at POST7 (Fig. 1C),
whereas essentially none of the gain in MCAv-CO2 reactivity
over acclimatization was retained at POST7 (Fig. 1A). Regard-
less of the underpinning mechanism(s), our findings suggest
that the effect of previous altitude acclimatization over 16 days
on the ventilatory response to CO2 is partially retained after 7
days at low altitude, whereas it is reversed in the cerebrovas-
cular response to CO2. Our data extend findings by Muza et al.
(36) showing that ventilatory acclimatization gained at 4,300 m
is retained following 8 days spent at low altitude. Because we
found the CVCi-CO2 slope to be consistently elevated by
60–80% across all time points (Fig. 1D), whereas the changes
in MAP-CO2 slope closely follow the changes in MCAv-CO2
slope (Fig. 1B), we speculate that the changes in MCAv-CO2
slope at high altitude can be primarily accounted for by an
enhanced sensitivity of the cerebral vessels to CO2, whereas
the remainder can be attributed to an enhanced perfusion
pressure response.
Steady-State or Modified Rebreathing Method?
There has been much debate over the use of the steady-state
or the modified rebreathing method for the assessment of
cerebrovascular and ventilatory control, and attempts at con-
sensus have produced no uniform agreement [(18, 40), also see
(2, 14) for reviews]. The steady-state ventilatory responses to
CO2 were found to be either similar (34, 37, 40–42, 47) or
lower (6, 18, 23, 55) compared with rebreathing estimates,
whereas steady-state cerebrovascular CO2 reactivity has been
shown to be consistently higher than rebreathing values (18,
40–42). The present study demonstrates that the changes in
cerebrovascular and ventilatory CO2 responsiveness with alti-
tude acclimatization were similar between the steady-state and
the modified rebreathing method (Table 1), possibly due to
tight control of arterial PCO2 and PO2 with our end-tidal clamp-
ing setup. Moreover, we observed strong correlations in
these parameters between the two methods across all time
points (Fig. 3). We therefore conclude that both methods can
be used to assess the changes in cerebrovascular and venti-
latory responses to CO2 with high altitude exposure and
acclimatization, provided that the level of CO2 is compara-
ble across all the conditions, under identical levels of
background O2.
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Limitations
Although the present study provided the opportunity to assess
the effects of acclimatization and reexposure to 5,260 m on
cerebrovascular CO2 reactivity, an important methodological con-
sideration should be acknowledged when interpreting our find-
ings. In the present study, transcranial Doppler ultrasound (TCD)
was used to measure MCAv as an index of global CBF changes
during initial exposure, acclimatization, and subsequent reexpo-
sure to 5,260 m. This is based on the assumption that 1) the MCA
carries approximately upward of 80% of the overall blood flow to
the respective hemisphere (29); 2) changes in MCAv reflect
changes in global CBF (8, 52); 3) the changes in MCAv in
response to PaCO2 changes are comparable to the changes in
internal carotid blood flow (50); and 4) the diameter of the MCA
does not change during the observed changes in arterial blood
gases (52). In support, MCAv has been shown to reflect changes
in CBF assessed with the direct Fick method, at least during initial
exposure to high altitude (33, 35, 48).
Recent findings by Wilson et al. (58) indicate that the
diameter of the MCA, as measured using TCD, varies depend-
ing on the altitude (e.g., 5.30 mm at 75 m, 5.51 mm at 3,500 m,
5.23 mm at 5,300 m, and 9.34 mm at 7,950 m). Importantly,
the results reported by Wilson et al. (58) demonstrate that the
MCA diameter remains relatively unchanged up to 5,300 m. It
should be noted that the MCA diameters measured with TCD
in that study were 80–90% greater than the values obtained
using magnetic resonance imaging in the same subjects. Be-
cause our measurements were carried out in background hy-
peroxia (PETCO2 300 mmHg), it seems unlikely that our
cerebral blood velocity values would be confounded by any
effect of hypoxia-induced vasodilation of the MCA. Further
studies are needed to evaluate MCAv responses to CO2 while
holding PETO2 at consistent levels of hypoxia.
Conclusion
Findings from the present study clearly show that both
cerebrovascular and ventilatory responsiveness to CO2 is ele-
vated upon arrival at high altitude and further elevated with
acclimatization. We demonstrate for the first time that this
effect of high-altitude acclimatization on the ventilatory re-
sponse to CO2 is partially retained after a period at low altitude,
whereas prior acclimatization has no effect on the cerebrovas-
cular response to CO2. Our data suggest that the increased
cerebrovascular CO2 reactivity with acclimatization may be
accounted for by the changes in acid-base balance in the blood
and possibly the CSF compartment.
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Subudhi AW, Fan JL, Evero O, Bourdillon N, Kayser B, Julian
CG, Lovering AT, Panerai RB, Roach RC. AltitudeOmics: cerebral
autoregulation during ascent, acclimatization, and re-exposure to high
altitude and its relation with acute mountain sickness. J Appl Physiol
116: 724–729, 2014. First published December 26, 2013;
doi:10.1152/japplphysiol.00880.2013.—Cerebral autoregulation (CA)
acts to maintain brain blood flow despite fluctuations in perfusion
pressure. Acute hypoxia is thought to impair CA, but it is unclear if
CA is affected by acclimatization or related to the development of
acute mountain sickness (AMS). We assessed changes in CA using
transfer function analysis of spontaneous fluctuations in radial artery
blood pressure (indwelling catheter) and resulting changes in middle
cerebral artery blood flow velocity (transcranial Doppler) in 21 active
individuals at sea level upon arrival at 5,260 m (ALT1), after 16 days
of acclimatization (ALT16), and upon re-exposure to 5,260 m after 7
days at 1,525 m (POST7). The Lake Louise Questionnaire was used
to evaluate AMS symptom severity. CA was impaired upon arrival at
ALT1 (P  0.001) and did not change with acclimatization at ALT16
or upon re-exposure at POST7. CA was not associated with AMS
symptoms (all R  0.50, P  0.05). These findings suggest that
alterations in CA are an intrinsic consequence of hypoxia and are not
directly related to the occurrence or severity of AMS.
transcranial Doppler; cerebral blood flow; cerebral oxygenation;
transfer function analysis; hypoxia
CEREBRAL AUTOREGULATION (CA) is a general term used to
describe dynamic myogenic, neurologic, and metabolic re-
sponses that adjust cerebrovascular resistance to maintain rel-
atively constant cerebral blood flow across a wide range of
perfusion pressures (25). Dynamic CA is said to be impaired if
fluctuations in mean arterial blood pressure (ABP) lead to
concurrent fluctuations in mean cerebral blood flow. Impair-
ments in CA are associated with cerebrovascular disorders (3,
24, 31), yet the relative importance of CA in the development
and course of certain pathologies is unclear.
Our initial interest in CA stemmed from the hypothesis that
impaired CA may be involved in the development of acute
mountain sickness (AMS), high-altitude headache, and cere-
bral edema (5, 7, 9, 16, 37). Conversely, we showed that
impairments in CA upon acute exposure to hypobaric hypoxia
preceded, but were not associated with, the development of
AMS (2, 33, 35). Furthermore, since several cross-sectional
studies demonstrated that impairments in CA persist from 1 to
30 days of high-altitude exposure (1, 2, 11, 12, 17)—when
AMS is not present—and are evident in healthy, permanent
high-altitude residents (12, 13), it seems reasonable to suggest
that a shift in CA may be an inherent and relatively benign
consequence of hypoxemia.
To date, no longitudinal studies have characterized CA and
tested its relation with AMS during acute and chronic high-
altitude exposures. Previous studies have either omitted CA
measurements upon arrival at high altitude (7, 11, 17) or
followed slow ascent profiles that allow for partial acclimati-
zation before initial measurements (1, 12, 39). In this study, we
present novel data from sea-level (SL) residents who rapidly
ascended to high altitude (5,260 m; ALT1), acclimatized for 16
days (ALT16), and were subsequently re-exposed to high
altitude after spending 7 days at low altitude (1,525 m;
POST7). Specifically, we tested the hypotheses that CA would
be: 1) impaired upon rapid ascent to high altitude, 2) unaf-
fected by 16 days of acclimatization, 3) unaffected upon
re-exposure to the same altitude, and 4) unrelated to the
occurrence or severity of AMS.
METHODS
Study overview. This study was conducted as part of the Altitu-
deOmics project. Briefly, institutional ethics approval was obtained
from the Universities of Colorado and Oregon and the U.S. Depart-
ment of Defense Human Research Protection Office. Young, healthy
SL residents were recruited from the greater Eugene, Oregon, area
(elevation 128 m) and screened to exclude anyone who was born or
had lived at altitudes 1,500 m for more than 1 yr or had traveled to
altitudes 1,000 m in the past 3 mo. After obtaining written consent,
physical exams and the Army Physical Fitness Test (push-ups, sit-ups,
and a 3.2-km run) were performed to verify health and fitness status.
Approximately 4 wk following SL measurements in Eugene, Oregon,
subjects were flown to La Paz, Bolivia. They spent two nights at low
altitude (1,525 m in Coroico, Bolivia) before being driven to the
Chacaltaya Research Station at 5,260 m, while breathing supplemen-
tal oxygen. Acute responses to high altitude were assessed 4 h after
arrival and cessation of supplemental oxygen (ALT1). Subjects accli-
matized to altitudes ranging from 3,800 to 5,260 m over the next 15
days, with most of the time (75%) spent at 5,250 m. On the 16th day
(ALT16), measurements were repeated at 5,260 m before subjects
were driven down to Coroico for either 7 or 21 days. Subjects were
driven back to the laboratory at 5,260 m for POST7 or POST21
re-exposure measurements.
This report focuses on novel data regarding resting CA, evaluated
immediately before a series of cerebrovascular, respiratory, and ex-
ercise interventions, as outlined elsewhere (32). We have carefully
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avoided replication of data among reports, except where common
variables were necessary to describe subjects’ basic physiologic status
at the time points of interest [e.g., heart rate (HR), blood pressure,
arterial blood gases].
Subjects. We studied 21 subjects at SL (12 men and nine women;
21 1 yr old). Because of logistical problems upon arrival in Bolivia,
complete data sets were not obtained on the first seven subjects upon
arrival at ALT1. Since the first seven subjects comprised the cohort
studied at POST21, longitudinal assessments of CA were limited to
the remaining 14 subjects who completed the study at POST7.
Physiology protocol. All subjects were familiarized with study
procedures during a practice session at least 48 h before experimental
testing at SL. Subjects followed standardized exercise and dietary
regimens for 24 h before each measurement period. At each time
point, a 22-gauge catheter was inserted into a radial artery at least 1
h before instrumentation. Subjects were seated in an upright position
for 15 min, while sensors were placed to measure physiologic vari-
ables of interest. Limb lead electrodes were used to measure ECG (Bio
Amp; ADInstruments, Colorado Springs, CO). ABP was monitored via a
fluid-filled pressure transducer (Deltran II; Utah Medical Products, Mid-
vale, UT) attached to the radial artery catheter. Core temperature was
recorded telemetrically from an ingested pill (CorTemp; HQInc, Pal-
metto, FL). Cerebral blood flow velocity (CBFv) in the left middle
cerebral artery (MCA) was measured by transcranial Doppler (2 MHz;
Spencer Technologies, Seattle, WA) at depths ranging from 43 to 54
mm. Signal quality was optimized, and an M-mode screen shot was
recorded to facilitate subsequent probe placements and insonation
angles.
After verification of signal quality, resting data were recorded for 6 min,
while subjects breathed room air to assess CA at each altitude. Continuous
analog data [ABP, CBFv, ECG, oxygen (O2), and carbon dioxide (CO2)]
were recorded at 200 Hz (PowerLab 16/30; ADInstruments) for offline
analysis. Core temperature and arterial blood samples (2 ml) were
taken during the last 30 s of measurement periods. Blood samples
were taken from the radial artery catheter, and blood gases were
analyzed for partial pressure of arterial CO2 (PaCO2) and partial
pressure of arterial O2 (PaO2) in triplicate (RAPIDLab 248; Siemens,
Erlangen, Germany) and corrected for body temperature (15, 29).
Acute mountain sickness. Self-reported sections of the Lake Louise
Questionnaire (LLQ) were used to assess AMS on ALT1 and POST7
(12 h after arrival). Moderate and severe AMS was defined as LLQ
3, and LLQ  6, including headache, respectively (27).
Data analysis. Transfer function analyses were used to assess
dynamic CA, based on spontaneous fluctuations in the raw ABP and
CBFv signals, as described previously (33, 34). Briefly, 6-min record-
ings of instantaneous ABP and CBFv were reduced to beat-by-beat
averages, resampled at 5 Hz, and transformed from the time-to-
frequency domain using fast Fourier transformations (512 points/
segment with 40% overlap). The transfer function from mean ABP to
CBFv was expressed in terms of coherence, gain, and phase shift in
the very low frequency range (0.02–0.07 Hz), where dynamic CA is
most active (21, 22), as well as in low (0.07–0.20 Hz) and high
(0.20–0.35 Hz) frequency ranges. All data were used in subsequent
statistical analyses. Reduction in phase shift was considered the
primary criterion for impaired CA, because it signifies shorter delay in
transmission of pressure (ABP) into flow (CBFv) or a reduction in the
ability of the cerebrovascular system to buffer changes in ABP and
maintain consistent blood flow. Yet, since increases in gain (increase
in CBFv relative to a change in ABP) and coherence (linear correla-
tion between ABP and CBFv) may also suggest CA impairment (8,
24, 41), all three transfer function metrics are reported. To address
difficulties in interpreting possible permutations of these three vari-
ables, the inverse transfer function of the resulting gain and phase shift
was used to express results in the time domain as a step function that
could be fitted to one of 10 curves representing a single autoregulation
index (ARI) score (36). An ARI score of zero indicates complete lack
of autoregulation, and nine indicates perfect autoregulation.
Statistics. After calculating descriptive statistics (mean  SD) and
verifying normality (D’Agostino and Pearson tests), variables were
analyzed by repeated-measures ANOVA to evaluate the effect of time
on CA metrics with Fisher’s least significant difference post hoc tests
and the Holm procedure to correct for multiple comparisons ( 
0.05).
Spearman  correlations were run to evaluate relations between CA
metrics and the severity of LLQ symptom scores. Specifically, we
tested the ability of CA assessments, measured at SL and upon arrival
at ALT1, to predict ensuing symptoms of AMS (7). Also, because
AMS classification is dichotomous (i.e., positive vs. negative), we
used receiver-operating characteristic (ROC) analyses (14, 18) to
evaluate the sensitivity (true positive rate) and specificity (true nega-
tive rate) of the ability of ARI scores to detect mild and severe AMS.
The ROC area under the curve (AUC) statistic was used as an
indicator of test accuracy. An AUC of 1.0 signifies a perfect test, with
no chance of false-positive or false-negative results, whereas an AUC
of 0.5 signifies a meaningless test, where the probability of identifying
a true positive result is only 50%.
RESULTS
Effect of rapid ascent to high altitude. At SL, resting
cardiovascular (HR, ABP, CBFv) and CA (coherence, gain,
phase shift, and ARI scores) measurements were characteristic
of young, healthy individuals with intact CA (Table 1 and Fig. 1).
From SL to ALT1, PaO2 and PaCO2 decreased (65% and 26%,
respectively; P  0.001; Table 1). This degree of hypoxia
increased HR (P  0.001) but did not affect mean ABP or
CBFv. Very low frequency power spectral density of ABP and
Table 1. Resting data
Variable SL ALT1 ALT16 POST7
PaO2 mmHg 103  5 36  3* 45  4*† 42  4*†‡
PaCO2 mmHg 37  4 28  2* 21  3*† 24  3*††
HR beats/min 73  9 90  18* 95  12* 85  15*‡
ABP mmHg 77  6 76  14 81  10 76  8
CBFv cm/s 62  9 63  14 59  7 57  9
PSD ABP mmHg2/Hz 11  13 9  4 9  5 6  4
PSD CBFv (cm/s)2/Hz 13  19 14  16 10  6 11  8
Coherence 0.42  0.12 0.64  0.15* 0.70  0.16* 0.55  0.12*‡
Gain %/% 0.64  0.24 0.88  0.35* 0.85  0.25* 0.97  0.33*
Phase shift radians 0.48  0.28 0.17  0.21* 0.27  0.09* 0.25  0.19*
ARI 4.4  1.0 2.8  0.9* 2.8  1.0* 3.3  1.6*
*Different from sea level (SL); †different from arrival at 5,260 m (ALT1); ‡different from after 16 days of acclimatization (ALT16). n  14; mean  SD.
POST7, re-exposure to 5,260 m after 7 days at 1,525 m; PaO2, partial pressure of arterial oxygen; PaCO2, partial pressure of arterial carbon dioxide; HR, heart
rate; ABP, arterial blood pressure; CBFv, cerebral blood flow velocity; PSD, power spectral density; ARI, autoregulation index.
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CBFv was unaltered, but increases in transfer function coher-
ence (P  0.001) and decreases in phase shift (P  0.050) and
ARI score (P  0.001) were consistent (in 13 of 14 subjects)
with the definition of impaired CA at ALT1.
Effect of acclimatization to high altitude. Acclimatization
increased resting PaO2 (27%) and decreased PaCO2 (22%) from
ALT1 to ALT16 (both P 0.001), without affecting HR, ABP,
or CBFv. Measures of CA at ALT16 were unchanged from
ALT1 and remained impaired relative to SL in the very low
frequency range (all P  0.010; Table 1 and Fig. 1).
Effect of re-exposure to high altitude. Resting PaO2 and
PaCO2 at POST7 fell between ALT1 and ALT16 values (all P 
0.050 vs. ALT1 and vs. ALT16), indicating that the degree of
acclimatization achieved at ALT16 was partially maintained at
POST7. Assessments of CA at POST7 were similar to those at
ALT1 and ALT16 and remained impaired relative to SL in the
very low frequency range (P  0.050; Table 1 and Fig. 1).
Association between CA and AMS. Of the 21 subjects, 17
reported symptoms of at least moderate AMS at ALT1 (LLQ
6.4 2.2), 10 of who met the criteria for severe AMS (LLQ
7.8  1.7). Correlations among CA metrics preceding the
development of AMS symptom were weak (all r  0.50, P 
0.050; Fig. 2). The ROC analysis revealed that ARI scores
measured at SL were not sensitive or specific predictors of
moderate (AUC  0.54, P  0.788) or severe (AUC  0.69,
P  0.139) AMS. Additionally, the degree of impairment in
CA (measured as the change in ARI from SL to ALT1) was not
a sensitive or specific predictor of moderate (AUC 0.53, P
0.881) or severe (AUC  0.72, P  0.124) AMS. None of the
14 subjects studied at POST7 reported symptoms of AMS; thus
associations with CA could not be tested.
DISCUSSION
The key findings of this study were that CA, as assessed by
transfer function analysis, is 1) impaired upon rapid ascent to
high altitude, 2) unaffected by acclimatization or 3) subsequent
re-exposure to the same altitude, and 4) not a sensitive or
specific predictor of AMS. Based on our results, we question
whether the so-called impairment in CA that persists at high
altitude is characteristic of pathological insufficiency in cere-
brovascular regulation (16) or alternatively, reflects a relatively
benign relaxation in autoregulation.
Effect of high altitude on CA. This is the first longitudinal
study of CA at high altitude—from rapid ascent through
acclimatization and upon re-exposure after a short period at
low altitude. We show that impairment of CA was a consistent
characteristic across this high-altitude exposure profile.
Increased transfer function coherence and gain, along with
reduced phase shift and ARI score upon rapid ascent, were all
consistent with the classic definition of impaired CA (Table 1)
and outside the normal range of expected variability (6),
implying that changes in ABP were transmitted more readily
into the cerebral circulation as changes in CBFv at high
altitude. Our finding of impaired CA after 1 day of travel
from low to high elevation is consistent with our previous
findings after 4 h in a hypobaric chamber (35) and fills an
important gap in the literature between studies conducted in
laboratories with hypoxic gas mixtures, where normobaric
Fig. 1. Arterial blood pressure to cerebral blood flow velocity transfer function metrics (mean  SD from 0 to 0.5 Hz) at sea level (SL), upon arrival at 5,260
m (ALT1), after 16 days of acclimatization (ALT16), and upon re-exposure to 5,260 m after 7 days at low altitude (POST7). Similar impairments in cerebral
autoregulation (increased coherence and gain and decreased phase shift) from SL were seen in the very low frequency (0.02–0.07 Hz; shaded areas) at ALT1,
ALT16, and POST7 (P  0.05). rad, radians. *Different from SL; &different from ALT16.
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hypoxia was achieved in a matter of minutes (5, 10, 26, 34),
and studies of trekkers, where several days of progressive
ascent preceded initial high-altitude measurements (1, 2, 12,
37). Impaired CA at rest in acute hypoxia is a consistent
finding among all but one study (26), suggesting that neither
the mode nor rate of ascent appears to affect the general
assessment.
By evaluating CA upon initial exposure and after 16 days at
high altitude, we were able to determine if changes in CA
occur with acclimatization, as might be expected with in-
creased PaO2 (2, 35), decreased PaCO2 (19, 23, 26), and further
sympathoexcitation (1). On the contrary, we found no change
in CA over the course of acclimatization (Table 1). Our
longitudinal findings are consistent with other cross-sectional
studies, demonstrating impaired CA at various time points after
arrival at high altitude (1, 2, 7, 11, 12, 37) and in permanent
high-altitude residents (12, 13). These results may indicate that
assessments of CA are less sensitive to changes in PaO2 and
PaCO2 near their respective extremes. Alternatively, a slight
improvement in CA, due to increased PaO2 (2, 35), may have
been masked if the opposing effects of PaCO2 (19, 23, 26)
and/or sympathoexcitation (1) on CA were heightened over
time at altitude. Further testing with manipulation of arterial
gases and sympathetic activity is necessary to determine the
relative influence of arterial gases and neural stimulation on
CA at high altitude, yet impaired CA remains a consistent,
functional consequence across time at high altitude.
As an additional test of the hypothesis that impaired CA is
a consistent response to hypoxemia, we sent subjects down to
low altitude for 7 days and re-evaluated their CA response after
a second rapid ascent back to high altitude. Upon re-exposure,
the measured impairment in CA was similar to that observed
upon the first ascent (ALT1) and after acclimatization
(ALT16). Together, these results demonstrate that impaired
autoregulation was a consistent characteristic of hypoxemia
across our study and imply that slow fluctuations in arterial
pressure were dampened less effectively by the cerebral vas-
culature, regardless of the state of acclimatization. What re-
mains to be determined is if such a tenuous pressure-flow
relation may be potentially harmful.
Relation of CA to AMS. Impairment of CA has been sug-
gested to play a role in the development of AMS by either
permitting cerebral overperfusion and mechanical disruption of
the blood brain barrier (i.e., vasogenic cerebral edema) when
mean ABP is elevated or by cerebral underperfusion and
exacerbation of cerebral hypoxia/ischemia when mean ABP is
lowered (9, 16). In the present study, we found no correlation
between measures of CA and subsequent AMS symptom
scores (Fig. 2), which opposes the notion that lower CA
predisposes people to AMS or conversely, that higher CA
confers protection from AMS. Our additional ROC analyses of
AMS status confirmed that ARI scores were neither sensitive
nor specific indicators for the development of moderate or
severe AMS upon arrival at high altitude. These findings are
congruent with our previous report following the time course
of changes in CA and AMS symptoms over the first 10 h of
exposure to hypobaric hypoxia (35), where we found similar
levels of CA impairments in subjects who eventually devel-
oped AMS or stayed healthy, but are at odds with other studies
showing some association between CA and AMS symptoms
(5, 37). Our data also counter a recent finding that SL assess-
ments of CA predict ensuing severity of AMS (7).
Discrepancies among studies may be explained by the var-
ious methods used to assess CA (transfer function vs. leg cuff;
see Limitations below), the questionnaires used to assess AMS
(LLQ vs. Environmental Symptoms Questionnaire), and the
statistical approach used to evaluate the relation between CA
and AMS (correlation vs. ROC). We acknowledge that caution
should be exercised when interpreting correlations with an
ordinal-level variable, such as the LLQ score, because by
definition, the scale has limited mathematical meaning. For
example, a LLQ score of six does not imply that symptom
severity is exactly twice that of a score of three. Due to the
intrinsic level of measurement, we believe that LLQ scores are
best restricted to dichotomous classification of positive or
negative AMS status and thus place more emphasis on the
negative results of our ROC analysis. We encourage others to
consider this method of analysis for future AMS studies.
Overall, given the similarity in CA responses among indi-
viduals with a wide range of AMS scores, we do not believe
that changes in CA cause AMS. This assertion is supported
further by the complete lack of association between impaired
CA at POST7 when no symptoms of AMS were reported and
previous reports documenting impaired CA in healthy, high-
altitude natives (12, 13). Nonetheless, we must acknowledge
that the alteration in CA upon acute altitude exposure may set
up a tenuous pressure-flow relation that could permit AMS to
develop if other, yet-unidentified factors are present at the
same time.
Fig. 2. Scatter plots showing no relation (P  0.05) between autoregulation
indices (ARI), measured at SL (top) and as the change (	) from SL to arrival
at high altitude (ALT1; bottom), and acute mountain sickness symptoms’
scores from the Lake Louise Questionnaire (LLQ) at ALT1.
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Since impairment of CA appears to be a consistent physio-
logical response in hypoxic environments and unrelated to
AMS status, it is tempting to speculate that the underlying
change in the cerebral pressure-flow relation may actually
promote successful acclimatization or adaptation to chronic
states of hypoxemia (4). It is possible that impairment of CA
could promote cerebral oxygen delivery in a time of need,
since it allows greater cerebral perfusion for a given increase in
ABP. This potentially beneficial consequence of impaired CA
during hypoxemic stress might outweigh the relative risk of
reduced cerebral perfusion if ABP were to drop. We therefore
raise the possibility that the term “impaired CA” may be a
misnomer, because it implies an association with pathology
that has yet to be substantiated in acute or chronic hypoxemia.
We suggest that “relaxation of CA” might be a more accurate
term to describe changes in the cerebral pressure-flow relation
from normoxia to hypoxia in the absence of pathology.
Limitations. One major limitation affecting the field is the
lack of a gold-standard method to assess CA. We have chosen
to evaluate rhythmical fluctuations in CA via transfer function
analysis, primarily because we believe it captures the natural
cerebral pressure-flow relation over time and thus has greater
practical relevance over methods that induce larger, more
abrupt changes in ABP, as with leg-cuff inflation/deflation,
rapid tilting, or more sustained changes in ABP, such as with
pharmaceutical interventions. Still, we acknowledge that trans-
fer function analysis of resting data monitors relatively subtle
fluctuations in ABP and CBFv, which if amplified, may not
show impairment in CA (39). These factors may limit the
generalizability of resting CA assessments and lead to an
overstatement of the clinical relevance of the findings. Addi-
tionally, there are no universal standards for the parameter
settings used in transfer function analysis or interpretation of
subsequent results, which makes comparisons among studies
problematic. Future work is needed to clarify differences in
methods used to assess CA in hypoxemic states and evaluate if
these changes are generalizable to clinical settings.
Most CA studies rely on transcranial Doppler measurements
of flow velocity and assume that vessel diameter is unchanged;
yet, there is evidence to suggest that this assumption may be
invalid at extreme altitudes (39, 40). Dilation of the MCA at
ALT1 may explain why MCA velocity did not follow the
expected increase in CBF upon acute exposure to high altitude
(30). We do not believe potential MCA dilation affected our
interpretation, because the phase shift—our primary criterion
for assessing changes in CA—measures the relative timing of
oscillations in ABP and CBFv and thus is largely independent
of absolute flow. However, since small changes in diameter can
have profound effects on flow (flow  radius4), future studies
must consider the use of continuous flow measurements, in-
stead of velocity measurements, to assess CA accurately in
hypoxia.
Finally, our measurements of CA were limited to the MCA
and relied on pressure measurements taken in the radial artery.
Since regional differences in cerebrovascular regulation have
been reported recently (20, 28, 38), more specific measure-
ments of regional pressure and flow are needed to characterize
CA fully.
Conclusions. Our data demonstrate that the initial impair-
ment of CA upon acute exposure to high altitude is invariant
with acclimatization and re-exposure, suggesting that relax-
ation in the regulation of the cerebral pressure-flow relation is
a characteristic response to hypoxia that is unaffected by the
degree of acclimatization. Since changes in CA do not follow
the progression and resolution of AMS, we question the clin-
ical relevance of impaired CA at high altitude.
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Case Reports
Repeated Pre-Syncope from Increased Inspired
CO2 in a Background of Severe Hypoxia
Jui-Lin Fan1,2 and Bengt Kayser1
Abstract
Fan, Jui-Lin, and Bengt Kayser. Repeated pre-syncope from increased inspired CO2 in a background of severe
hypoxia. High Alt Med Biol. 15:70–77, 2014.—We describe a case of experimentally induced pre-syncope in a
healthy young man when exposed to increased inspired CO2 in a background of hypoxia. Acute severe hypoxia
(FIO2 = 0.10) was tolerated, but adding CO2 to the inspirate caused pre-syncope symptoms accompanied by
hypotension and large reductions in both mean and diastolic middle cerebral artery velocity, while systolic flow
velocity was maintained. The mismatch of cerebral perfusion pressure and vascular tone caused unique ret-
rograde cerebral blood flow at the end of systole and a reduction in cerebral tissue oxygenation. We speculate
that this occurrence of pre-syncope was due to hypoxia-induced inhibition of brain regions responsible for
compensatory sympathetic activity to relative hypercapnia.
Key Words: vasovagal syncope, hypoxia, hypercapnia
Introduction
Syncope is defined as a transient loss of conscious-ness followed by rapid recovery, and it accounts for a
significant portion of emergency department visits and hos-
pital admissions (Kapoor, 1990; Kapoor and Brant, 1992; Van
Lieshout et al., 2003). Vasovagal or reflex syncope is the most
common type of syncope in both young and elderly subjects
(Ganzeboom et al., 2003; Serletis et al., 2006; Tan and Parry,
2008; Van Lieshout et al., 2003) and is preceded by pre-
syncope signs (epigastric discomfort, nausea, sweating, desire
to change position), with a gradual decline in vascular tone,
bradycardia, and hypotension (Kapoor, 2002; Van Lieshout
et al., 2003). The pathophysiology of the hypotension/brady-
cardia reflex in vasovagal syncope is not completely under-
stood, but changes in sympathetic tone are believed to be
critical in the peripheral vasodilation preceding syncope
(Kapoor, 1990; Kapoor and Brant, 1992; Van Lieshout et al.,
2003; Wang et al., 1996). While the hypotension underscores
the role of cardiovascular regulation in the development of va-
sovagal syncope, the subsequent loss of consciousness is ulti-
mately the result of cerebral hypo-perfusion (Ganzeboom et al.,
2003; Serletis et al., 2006; Tan and Parry, 2008; Van Lieshout
et al., 2003). As such, it is of interest to monitor the response of
cerebral blood flow (CBF) while observing such events.
Syncope is well documented during acute exposure to
hypoxia (Nicholas et al., 1992; Sagawa et al., 1997; Wes-
tendorp et al., 1997; Kapoor, 2002; Roche et al., 2002; Van
Lieshout et al., 2003; Halliwill and Minson, 2004), while high
altitude acclimatization appears to be rather protective
against syncope at high altitude (Thomas et al., 2010). In this
case report, we present novel data from two trials of acute
exposure to severe hypoxia in combination with relative
hypercapnia. We observed pre-syncope symptoms accom-
panied by hypotension, cerebral hypo-perfusion, and cerebral
tissue desaturation in a 21-year old male, when inspired CO2
tension was increased in a background of hypoxia equivalent
to an altitude of 5000 m.
Methods
Subject details
The subject was one of a group of volunteers participating
in a study designed to examine the effect of inspired CO2 on
exercise capacity in hypoxia. He was a 21-year-old healthy
nonsmoking physically active male (BMI = 23.2, Vo2max =
45 mL/kg/min), with no known medical conditions, not tak-
ing any regular medication, and no history of syncope. He
abstained from caffeine for 12 h and from heavy exercise and
alcohol for 24 h prior to the experiments. The experiments
1Faculty of Biology and Medicine, Institute of Sports Sciences, and 2Lemanic Doctoral School of Neuroscience, University of Lausanne,
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were carried out under consistent laboratory conditions
(temperature 22.3 – 0.5C, humidity 27– 7%, barometric
pressure 725– 4 mmHg). Two medical practitioners were
present during the experimental sessions. The study was
approved by the Research Ethical Committee of the Uni-
versity Hospitals of Geneva and conformed to the standards
set by the Declaration of Helsinki.
Consent
Written informed consent was obtained from the subject
for publication of this case report.
Measurements
The following variables were recorded continuously: bi-
lateral systolic, diastolic and mean middle cerebral artery
velocity (MCAv, transcranial Doppler ultrasound, ST3,
Spencer Technology, Seattle, USA; monitoring probe
(2 MHz) power: 50%, depth: 57 mm); heart rate (HR), car-
diac output (Q’), stroke volume (SV), total peripheral resis-
tance (TPR), beat-to-beat systolic, diastolic and mean
arterial blood pressure (ABP, finger plethysmography,
Finometer-MIDI, Finapress Medical Systems, Amsterdam,
Netherlands); peripheral O2 saturation (Spo2; Rad-7, Masi-
mo, Irvine, USA); breath-by-breath ventilation (V’E), partial
pressure of end-tidal O2 (Peto2) and CO2 (Petco2) (Med-
graphics CPX, Loma Linda, USA). Cerebrovascular resis-
tance (CVR) was estimated by dividing mean MCAv by
mean ABP. Beat-to-beat heart rate variability was analyzed
with dedicated software (Kubios, version 2.1, freely available
at http://kubios.uef.fi). We analyzed the HR data separately
during the normoxia, hypoxia, and CO2 + hypoxia epochs,
and when symptoms were maximal, just after coming off the
mouthpiece. Because of the nonstationary characteristics of
the data, we removed trend components prior to analysis
using the smoothing priors algorithm with a lambda of 500, as
recommended by the software manufacturer. The data were
analyzed in the frequency domain using a fast Fourier
transformation and a Welch window of 256 with a 50%
window overlap. We report, as a rough index of sympathetic
versus parasympathetic activity, the LF/HF (ratio between
low frequency (0.04–0.15 Hz) and high frequency (0.15–
0.4 Hz) power, unit less).
Experimental protocol
The original protocol foresaw, with the subject seated on a
cycle-ergometer, 4 min of normoxia baseline measurements,
2–3 min of hypoxia, followed by 4 min of increased inspired
CO2, to bring Petco2 back to normoxic resting levels, before
starting an incremental exercise protocol.
Throughout the experimental sessions, the subject wore a
nose-clip and breathed through a mouthpiece attached to a
low resistance one-way non-rebreathing valve (Hans-
Rudolph 2700, Kansas City, USA). The hypoxia and added
CO2 to the inspirate were achieved using a modified gas
mixing system (Altitrainer, SMTec, Nyon, Switzerland),
described in detail by Fan et al., (2013). For this experiment
Fio2 was set at either 0.21 or 0.10 (in Geneva the equivalent
of an altitude of about 5000 m) during normoxia and hyp-
oxia conditions, respectively. Under feedback of on-screen
Petco2 (Datex infrared CO2 analyzer, Helsinki, Finland),
Fico2 was continuously adapted as to bring Petco2 to its
target value of 40–45 mmHg. The subject was unaware of the
rationale of the study and was not informed to what gas
mixture he was breathing.
Results
The subject attended the laboratory on four occasions. On
the first two visits, he successfully completed incremental
maximal cycling tests (30 w/min ramp) in conditions of
normoxia and normoxia +CO2 without any adverse events.
On the third occasion, the subject was seated on the cycle
ergometer in preparation of the next test, breathing room-air
for 4 min. He was then switched to hypoxia for 3 min, fol-
lowed by increased inspired CO2 in hypoxia. After 134 sec,
pre-syncope symptoms prompted the subject to come off the
mouthpiece and request the session to be aborted. The subject
reported symptoms of dizziness, blurry vision, and nausea.
We invited the subject to come back to the laboratory on
another occasion, this time adding the measurement of oxy-
(O2Hb) and deoxygenated hemoglobin (HHb) over the left
frontal cortex with near-infrared spectroscopy (index of brain
tissue oxygenation; NIRS, Oxymon Mk-II, Artinis, Zetten,
Netherlands), expressed as absolute changes from baseline
room-air breathing. The experiments were performed at the
same time of the day. On the second occasion, the subject was
left on hypoxia for more than 4 min before switching to in-
creased inspired CO2 to exclude that he was not simply de-
veloping a vasovagal reaction to hypoxia. The subject
indicated that he was fine, after which he was switched to
added CO2. Following 55 sec of breathing CO2-enriched
hypoxic gas, the subject indicated that pre-syncope symp-
toms were developing again and came off the mouthpiece,
requesting the experiment to be aborted. We then excluded
the subject from further participation.
Table 1 shows the values for the measured and derived
variables during the different epochs of the two episodes of
hypoxic+CO2, as well as the data from the normoxic +CO2
visit for reference (means over 20 sec at the end of each
epoch). Hypoxia alone lowered Peto2, Petco2, and Spo2
during the two episodes by 51–58 mmHg, 3–4 mmHg, and
18%–19 %, respectively (Fig. 1 and 2). At the same time,
hypoxia lowered mean ABP, systolic ABP, diastolic ABP,
TPR, and HR by 12–20 mmHg, 15–35 mmHg, 11–17 mmHg,
23%–18%, and 12–9 b/min, while V’E, mean, systolic and
diastolic MCAv (mean of left and right MCAv), Q’, and SV
remained relatively unchanged with hypoxia (Fig. 1 and 2).
At the end of the period of added CO2 in hypoxia, when
pre-syncope developed, mean, systolic and diastolic ABP
were further lowered by 9–18 mmHg, 14–30 mmHg, and
3–15 mmHg, respectively (Fig. 2). SV dropped by 27–26 mL
with inspired CO2 in hypoxia compared to normoxia, while
HR remained relatively unchanged compared to hypoxia only
(Figs. 1 and 2). Mean and diastolic MCAv had now dropped
by 15%–20% and 51%–55%, respectively, compared to
normoxia, while both systolic MCAv and CVR remained
relatively unchanged (Figs. 1 and 2). During breathing CO2
enriched gas in hypoxia, we observed a reduced cardiac cycle
time, which was predominantly mediated by a reduced time
in diastole (Fig. 3). Inspired CO2 elevated V’E and Spo2 by
8.1 L/min and 4%, respectively (Table 1). When pre-syncope
symptoms were strongest (when the subject came off the
mouthpiece), there was bradycardia and hypotension (Figs. 1
and 2). We observed a distinct triphasic pattern in the MCAv
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FIG. 1. Cerebrovacsular and cardiovascular variables during visit one. Middle cerebral artery velocity (MCAv), cerebral
vascular resistance (CVR), arterial blood pressure (ABP), total peripheral resistance (TPR), cardiac output (Q’ _Q), stroke
volume (SV), heart rate (HR), and peripheral O2 saturation (Spo2). During exposure to hypoxia+CO2 despite increases in
HR, mean, systolic and diastolic ABP progressively decrease due to decreases in Q’ and SV. This reduction in ABP causes
declines in mean and diastolic MCAv, while systolic MCAv is maintained. The mean, systolic, and diastolic ABP continued
to decline following the hypoxia +CO2 exposure, despite the subject coming off the mouthpiece.
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FIG. 2. Cerebrovascular and cardiovascular variables during visit two. Middle cerebral artery velocity (MCAv), cerebral
hemoglobin concentration (Hb), cerebral vascular resistance (CVR), arterial blood pressure (ABP), total peripheral resis-
tance (TPR), cardiac output (Q’), stroke volume (SV), heart rate (HR), and peripheral O2 saturation (SpO2).
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traces, which resulted in slight retrograde blood flow at the
end of systole (Fig. 3). During the first visit, the HRV index
LF/HF was 4.6 during normoxia, 4.7 during hypoxia, 0.9
during hypoxia +CO2, and 1.2 after the subject came off the
mouthpiece. During the second visit, LF/HF was 6.3 during
normoxia, 2.2 during hypoxia, 2.7 during hypoxia+CO2, and
1.3 after the subject came off the mouthpiece.
Discussion
We report the sudden development of pre-syncope symp-
toms in a healthy 21-year old male during acute exposure to
inspired CO2 in a background of severe hypoxia. The pre-
syncope symptoms were accompanied by bradycardia,
hypotension, cerebral hypo-perfusion, and cerebral tissue
deoxygenation. The observed changes in vital signs, HRV
index LF/HF, and development of symptoms seems coherent
with a vasovagal reaction.
The mechanisms involved in acute hypoxia syncope are
complex. The increased susceptibility to syncope in hypoxia
has been attributed to a reduced baroreflex sensitivity (Ni-
cholas, 1992; Sagawa et al., 1997; Roche et al., 2002; Kle-
menc and Golja, 2011), which is further compounded by
greater cardiac output decline and withdrawal of sympathetic
vasoconstrictive tone during orthostatic stress in hypoxia,
resulting in greater hypotension (Wang et al., 1996; Van
Lieshout et al., 2003). Westendorp et al., (1997) proposed
that an enhanced vasodilatory response to epinephrine during
hypoxia (Blauw et al., 1995) would lead to greater sympa-
thetic withdrawal as well as elevated parasympathetic ac-
tivity. They further proposed that an increase in atrial
natriuretic peptide during hypoxemia might attenuate the
carotid baroreflex-mediated cardiac acceleration and inhibit
sympathetic nervous activity, thus further increasing the risk
of syncope in hypoxia.
To the best of our knowledge, this is the first report
documenting reduced CBF during a pre-syncope response
triggered by CO2-enriched inspired gas in a background of
hypoxia. The observation during the second episode of a
drop in frontal cortex oxygenation suggests that the pre-
syncope syndrome was accompanied by reduced cerebral
oxygen availability (Fig. 2). We found dramatic reductions
in mean and diastolic MCAv during and immediately
following hypoxia +CO2 exposure (Fig. 1). Meanwhile,
the reduction in cerebral O2Hb followed closely to the
changes in diastolic MCAv (Fig. 2), suggesting that dia-
stolic perfusion pressure is the main determinant of cere-
bral O2 delivery. Vasovagal syncope typically involves
both central and peripheral mechanisms. However, since
severe and uncompensated hypotension, below the
threshold of cerebral autoregulation, leads to cerebral
hypo-perfusion ( Skinhoj and Strandgaard, 1973; Chillon
and Baumbach, 1997), while hypotension per se blunts the
CBF responsiveness to CO2 during both normoxic and
hypoxic conditions ( Harper and Glass, 1965; Ainslie et al.,
2012), we attribute the observed reduction in CBF and
subsequent cerebral tissue deoxygenation to the direct ef-
fect of severe hypotension per se.
According to Van Lieshout et al., (2003), when a pre-
syncope progresses, it is the fall in mean ABP below the
FIG. 3. Middle cerebral artery velocity traces during hypoxia (A) and immediately following hypoxia +CO2 exposure (B).
The velocity trace immediately following hypoxia +CO2 exhibits a distinct triphasic flow pattern, characterized by large
flow during systole, followed by retrograde flow at the end of systole and small flow during diastole. The white horizontal
line denotes zero flow.
PRE-SYNCOPE IN HYPOXIA 75
lower limit of cerebral autoregulation that reduces cerebral
perfusion and oxygenation, leading to unconsciousness. In
the present case, we observed dramatic reductions in mean
ABP with increased inspired CO2 in background hypoxia,
which persisted for some time following the exposure (Fig.
1). In addition to this drop in ABP, we observed a distinct
triphasic flow pattern in the CBF velocity waveform, char-
acterized by large flow during systole, followed by a distinct
retrograde flow at the end of systole, and very little flow
during diastole (Fig. 3). Since CO2 is a potent vasodilator of
the cerebral vasculature, we reasoned that the reduction in
mean ABP associated with increased inspired CO2 would
lead to a greater mismatch of cerebral perfusion pressure and
vascular tone (i.e., impairment of cerebral autoregulation).
This mismatch of cerebral perfusion pressure and vascular
tone could potentially account for the retrograde flow ob-
served in our subject.
What are potential mechanisms for such an effect of in-
creased inspired CO2 in a background of hypoxia? In nor-
moxic conditions, hypercapnia has been shown to elicit a
vasodilatory effect on the peripheral vasculature in humans
(Lennox and Gibbs, 1932; Kontos, 1971; Kontos et al., 1972;
Gastaldo et al., 1974; Ainslie et al., 2005). Hypercapnia (10%
CO2) causes an immediate, but transient hypotension, which
is corrected within 30–40 sec from increased sympathetic
activity, in anesthetized, sino-aortic denervated and vagoto-
mized rats (Takakura et al., 2011). Since inhibition of the
retro-trapezoid nucleus (RTN) lowers sympathetic nerve
activity and attenuates mean ABP recovery at the end of the
hypercapnic exposure (Takakura et al., 2011), those authors
concluded that the compensatory increase in sympathetic
nerve activity is partly dependent on RTN activation during
hypercapnic exposure. Similarly, pontine noradrenergic
neurons, astrocytes, neurons of the nucleus solitary tract, and
wake-ON orexinergic neurons, have all been shown to be
hypercapnia/pH-sensitive and linked to sympathetic tone,
contributing to peripheral vascular tone during hypercapnic
exposure (Dean et al., 1989; Dun et al., 2000; Johnson
et al., 2008; Allen and Barres, 2009). In humans, profound
sympatho-inhibition has been reported during exposure to
combined hypoxia and hypercapnia, resulting in vasovagal
syncope (Halliwill, 2003). Our data of reduced LF/HF (Table
1) are in agreement with that finding. Furthermore, since our
subject’s ABP was well maintained during hypercapnic ex-
posure in normoxia (Table 1), we speculate that the output of
the brain regions responsible for compensatory sympathetic
response to hypercapnia might be attenuated during exposure
to hypoxia.
An alternative explanation is a blunted peripheral che-
moreflex response to severe hypoxia, which might increase
an individual’s susceptibility to hypoxia-induced syncope
due to greater central hypoxic depression associated with
greater arterial desaturation. We observed Spo2 of 78–80% at
the end of a 3–4 min exposure to hypoxia (Table 1), at the
lower end of the 77%–91% range typically observed in our
laboratory using this setup (Fan et al., 2013; Fan and Kayser,
2013). Since cerebral O2Hb was relatively well maintained
during hypoxia and decreased only at the onset of hypoten-
sion during hypoxia +CO2 (Fig. 2), it seems unlikely that a
blunted hypoxic ventilatory response and associated arterial
(and presumably cerebral) desaturation was responsible of
the pre-syncope observed in our case report. Nevertheless,
due to a lack of a more prolonged hypoxic control trial, we
cannot fully exclude the possibility that hypoxia alone was
responsible for the development of pre-syncope observed in
this report.
Implications
The present case report, together with previous findings,
highlights the increased risk of syncope for climbers and
trekkers upon rapid ascent to high altitude. Accordingly,
particular care should be taken during postural changes,
whereby impaired compensatory mechanisms, coupled with
reduced arterial and cerebral tissue oxygenation associated
with hypoxic exposure, would lead to greater risk of hypo-
tension and subsequently greater cerebral hypo-perfusion/
tissue deoxygenation during orthostatic challenges.
Conclusions
We present a case of repeated pre-syncope during exposure
to relative hypercapnia in a background of severe hypoxia.
The development of hypotension suggests an impaired
compensatory sympathetic response to an increase in Paco2,
leading to reduced venous return, decreased stroke volume,
and a drop in cardiac output. The resultant mismatch of
perfusion pressure and cerebrovascular tone caused a dis-
tinctive triphasic flow pattern in the brain, characterized by a
unique retrograde flow at the end of systole. Since the subject
exhibited no adverse response to CO2 during normoxic
conditions, we speculate that sympatho-inhibition and sub-
sequent loss of systemic vascular tone was responsible for the
development of pre-syncope.
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Abstract
Hypoxia increases the ventilatory response to exercise, which leads to hyperventilation-induced hypocapnia and
subsequent reduction in cerebral blood flow (CBF). We studied the effects of adding CO2 to a hypoxic inspired gas on CBF
during heavy exercise in an altitude naı¨ve population. We hypothesized that augmented inspired CO2 and hypoxia would
exert synergistic effects on increasing CBF during exercise, which would improve exercise capacity compared to hypocapnic
hypoxia. We also examined the responsiveness of CO2 and O2 chemoreception on the regulation ventilation (V
:
E) during
incremental exercise. We measured middle cerebral artery velocity (MCAv; index of CBF), V
:
E, end-tidal PCO2, respiratory
compensation threshold (RC) and ventilatory response to exercise (V
:
E slope) in ten healthy men during incremental cycling
to exhaustion in normoxia and hypoxia (FIO2 = 0.10) with and without augmenting the fraction of inspired CO2 (FICO2).
During exercise in normoxia, augmenting FICO2 elevated MCAv throughout exercise and lowered both RC onset andV
:
E
slope below RC (P,0.05). In hypoxia, MCAv and V
:
E slope below RC during exercise were elevated, while the onset of RC
occurred at lower exercise intensity (P,0.05). Augmenting FICO2 in hypoxia increased V
:
E at RC (P,0.05) but no difference
was observed in RC onset, MCAv, or V
:
E slope below RC (P.0.05). The V
:
E slope above RC was unchanged with either
hypoxia or augmented FICO2 (P.0.05). We found augmenting FICO2 increased CBF during sub-maximal exercise in
normoxia, but not in hypoxia, indicating that the ‘normal’ cerebrovascular response to hypercapnia is blunted during
exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory reserve. This finding may explain the lack of
improvement of exercise capacity in hypoxia with augmented CO2. Our data further indicate that, during exercise below RC,
chemoreception is responsive, while above RC the ventilatory response to CO2 is blunted.
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Introduction
At high intensities of exercise in normoxia, above the respiratory
compensation threshold (RC), hyperventilation-induced hypocap-
nia constricts the cerebral vessels, thereby reducing cerebral blood
flow (CBF) and lowering cerebral oxygen delivery [1–3]. In
conditions of hypoxia, in spite of hypoxic vasodilation, the
hypocapnia-induced limitation of CBF at high exercise intensities
is further aggravated due to a greater ventilatory drive. Such a
limitation of CBF might lead to inadequate cerebral O2 delivery,
triggering early motor drive withdrawal, thus limiting exercise
performance in hypoxia [4,5]. In support, several studies found a
relationship between performance and cerebral deoxygenation in
hypoxia using various exercise modes such as repeated sprints [6],
incremental exercise [7,8], and static maximal muscle contraction
to exhaustion [9–12]. Similarly, under normoxic conditions,
exacerbation of exercise induced cerebral deoxygenation, by
administering a non-selective beta-blocker, is accompanied by
impaired maximal exercise performance [13]. This has led to the
hypothesis that an exaggerated hyperventilation-induced hypo-
capnia and subsequent reduction in CBF during heavy exercise
might account, in part, for the impaired performance in hypoxia.
Recently, studies have assessed the effect of preventing the
normal drop in end-tidal PCO2 on CBF and exercise performance
in normoxia [14] and hypoxia [15,16]. Subudhi et al., [15]
reported impaired exercise capacity at 1,600 m and 4,875 m
(hypobaric chamber) when they clamped end-tidal PCO2
(PETCO2) either: 1) at 50 mmHg throughout incremental exercise
or 2): at 40 mmHg from ,75% maximal work rate until
exhaustion. Siebenmann et al., [16] completed those observations
by investigating, at a more moderate altitude (3,454 m), the
impact of clamping PETCO2 at 40 mmHg, on performance. Both
of these studies found clamping PETCO2 increased MCAv and
attenuated the decrease in cerebral oxygenation, but slightly
decreased peak power output without affecting maximal oxygen
uptake. Subudhi et al., [15] found ventilation (V
:
E) was elevated
(by ,50 L/min) during submaximal exercise intensities (37 and
75% of maximal hypoxic work rate) with PETCO2 clamping,
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e81130
compared to without added CO2. As such, they attributed the
reduced performance with CO2 clamping to earlier functional
limitation by the respiratory system associated with CO2
breathing. Since these studies were carried out in subjects living
at moderate altitude [15] and in low altitude residents following a
day spent at high altitude[16], respectively, both conditions
accompanied by enhanced cerebrovascular and ventilatory
responsiveness to CO2 [17,18], the acute effect of augmented
FICO2 and hypoxia on CBF during exercise in an altitude-naı¨ve
population remained unclear.
For climbing 8,000 m peaks, a strong ventilatory response at
altitude is believed to be a factor for success [19], but increases the
risk of brain damage because of excessive hyperventilation-
induced cerebral hypoxemia [20]. By contrast, Bernardi et al.,
[21] found that acclimatized elite climbers with a smaller
ventilatory response to hypoxia at 5,200 m were more successful
climbing to extreme altitude (Everest and K2), perhaps due to a
greater ventilatory reserve (difference between maximal voluntary
ventilation and effective minute ventilation) at these altitudes.
Therefore, the effect of augmenting FICO2 on ventilation during
exercise is of interest, particularly in the presence of enhanced
ventilatory drive associated with hypoxia.
We tested the hypotheses that, in non-altitude acclimatized
subjects, increasing PETCO2 during incremental exercise in
normobaric hypoxia would: i) further augment CBF during
exercise in hypoxia and improve exercise capacity; and ii)
exacerbate the increase in ventilation at sub-maximal exercise
intensities but not at maximal effort.
Methods
Ethics
The study was approved by the Research Ethical Committee of
the University Hospitals of Geneva and conformed to the
standards set by the Declaration of Helsinki. All subjects were
informed regarding the procedures of this study, and informed
signed consent was given prior to participation.
Subjects
Ten healthy male subjects with a mean age of 2463 yr (mean6
SD), a body mass index of 22.762.4 kg/m2 and V
:
O2max of
58.3610.5 ml/min/kg participated in this study. Subjects were
non-smokers, had no previous history of cardiovascular, cerebro-
vascular, or respiratory disease and were not taking any
medication. All the subjects were residents of Geneva, Switzerland
(,400 m) and partook in regular exercise (3–6 h per week); none
were acclimatized to altitude (i.e., they had not travelled to
altitudes .1,000 m in the past 2 months).
Experimental design
The subjects visited the laboratory on five occasions. After a full
familiarization with the experimental procedures outlined below
(visit one), subjects underwent four experimental exercise trials in a
randomized, single-blind and balanced fashion (to prevent order
effects), with a 3-day washout period between each experimental
session, consisting of the following conditions: i) control normoxia
(ambient air, 389 m); ii) augmented FICO2 in normoxia; iii)
control hypoxia (normobaric simulated altitude, 5,000 m); and iv)
augmented FICO2 in hypoxia. Before each experimental session,
the subjects were asked to abstain from caffeine for 12 h and heavy
exercise, and from alcohol for 24 h. Each experimental testing
session comprised 20 min instrumentation followed by a 4 min
resting baseline collection with the subject breathing room-air and
seated on an electronically braked cycle ergometer (Ergoselect
100, Ergoline GmbH, Bitz, Germany). During the hypoxia and
augmented FICO2 trials, the subjects were then switched to a gas
mixing system (described below), breathing the respective gas
mixtures for an additional 4 min resting baseline (condition
baseline) prior to the incremental cycling test.
Exercise test
The subjects were instructed to begin cycling at 0 watts at a
pedaling rate of 70 rpm. The work rate was increased by 0.5 watts
every second (30 W/min) thereafter until the subject reached
voluntary exhaustion. Throughout each experimental session, the
subjects wore a nose-clip and breathed through a mouthpiece
attached to a low resistance one-way non-rebreathing valve (Hans-
Rudolph 2700, Kansas City, USA). The hypoxia and augmented
FICO2 were achieved using a modified gas mixing system
(Altitrainer, SMTec, Nyon, Switzerland), which has been previ-
ously described in detail [14]. In brief, additional CO2 was bled
into the inspired gas mixture under constant feedback of on-screen
PETCO2 and FICO2 was constantly adapted as to keep PETCO2
to a target value of approximately 45 mmHg during both
normoxia and hypoxia. The FIO2 was held constant at either
0.21 (normoxia, ambient air) or 0.10 (hypoxia). The subjects
breathed through the same circuit in all four conditions and were
kept unaware to what gas mixture they were breathing and were
naive to the rationale of the study. For each subject the
experiments were carried out at the same time of day under
consistent laboratory conditions (temperature 22.360.5uC, hu-
midity 2767%, barometric pressure 72564 mmHg).
Measurements
Respiratory variables. Gas exchange was monitored on a
breath-by-breath basis (Medgraphics CPX, Loma Linda, USA)
measuring flow at the mouth with a Pitot tube and the fractions of
inspired and expired O2 and CO2 with fast responding gas
analyzers (infrared and paramagnetic) integrated in the system.
Ventilation (V
:
E) was derived from the flow signal and expressed in
body temperature and pressure saturated (BTPS) and L/min,
respectively. The partial pressure of end-tidal O2 (PETO2), CO2
(PETCO2), O2 consumption (V
:
O2) and CO2 production (V
:
CO2)
were calculated by the gas analysis system. Prior to each
experimental session the system was calibrated using a 3-L syringe
(M9474, Medikro Oy, Finland) and precision gas mixtures of
known O2 and CO2 concentrations.
Cerebrovascular and cardiovascular variables. Bilateral
middle cerebral artery blood flow velocities (MCAv: as index of
CBF) were measured in the middle cerebral arteries using a 2-
MHz pulsed Doppler ultrasound system (ST3, Spencer technol-
ogy, Seattle, USA). The Doppler ultrasound probes were
positioned over the temporal windows and held firmly in place
with an adjustable headband (Marc 600 Headframe, Spencer
technology, Seattle, USA). The signals were at depths ranging
from 43 to 54 mm. Signal quality was optimized and an M-mode
screen shot was recorded to facilitate subsequent probe place-
ments. In our hands, day-to-day reproducibility of MCAv has a
coefficient of variation of ,10%. The bilateral MCAv were
averaged to represent an index of global CBF during rest and
exercise. Heart rate was measured using a thoracic belt and
recorded directly onto a PC via a wireless receiver pod (PC-POD,
Suunto, Vantaa, Finland). Peripheral O2 saturation (SpO2) was
measured from the right ear lobe using pulse oximetry (Satlite,
Datex, Helsinki, Finland, and ML320 Oximeter Pod, ADInstru-
ments, Bella Vista, Australia). Blood pressure was measured with
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an automated arm sphygmomanometer (Ergoselect 100, Ergoline
GmbH, Bitz, Germany).
Perceived exertion. During exercise, the subjects were asked
to score their perceived exercise exertion on the 0–10 Borg scale
every minute [22].
Data and statistical analysis
Respiratory compensation threshold and ventilatory
response to exercise. The respiratory compensation threshold
(RC) was obtained using the v-slope method previously described
by Beaver et al., [23]. The assessment of the ventilatory response
to exercise (i.e., the slope of V
:
E rise during exercise: V
:
E-slope to
power output) has been previously described [24,25]. In brief,
breath-by-breath V
:
E points were plotted against mechanical
power output and a least squares regression was used to determine
the V
:
E-slope to exercise above and below RC.
Statistical analysis. Resting values were obtained by aver-
aging the data obtained in the last two minutes of the four minutes
resting periods just prior to exercise. For the incremental exercise,
we took the last 20 sec of every 10% increase in exercise intensity
until exhaustion (100%). We then averaged all of the 20 sec
segments of the data to obtain a single mean value for each variable
during all four experimental conditions. The effects of hypoxia and
augmenting FICO2 on cardiorespiratory and cerebrovascular
responses at rest were assessed using two-way repeated-measures
ANOVA with a-level of P,0.05 (IBM SPSS Statistics version
21.0, IBM Corporation, Armonk, USA). Likewise, two-way
repeated measure ANOVA was used to assess the effects of
hypoxia and augmenting FICO2 on these variables during
incremental exercise. For significant interactions between hypoxia
and augmenting FICO2, four pairwise comparisons (Bonferroni
corrected) were performed to isolate the effect of hypoxia and
augmenting FICO2 on the dependent measures within subjects
with a a-level of 0.0125, indicated where appropriate with the
superscript B. Trends were considered when P,0.10. All data are
reported as means 6 SD.
Results
All ten subjects completed the experimental protocol. Due to
poor gas exchange traces, one subject had to repeat the augmented
FICO2 in hypoxia trial. Two subjects had to repeat their control
normoxia trials, as they initially did not maintain a pedaling rate of
70 rpm during high intensity exercise. One subject reported
respiratory dyspnea during exercise in augmented FICO2, in
hypoxia, while another reported a mild headache lasting 20 min
following the control hypoxia trial. No other subjects reported any
side effects such as headache or dyspnea following the experi-
ments. Due to poor blood pressure signals during exercise, we
were unable to carry out repeated-measures ANOVA analysis on
the MAP data during exercise.
Resting variables (Table 1)
MCAv: Hypoxia had no effect on resting MCAv (hypoxia:
P = 0.790 vs. normoxia), while augmenting FICO2 elevated
MCAv by 25621% during both normoxic and hypoxic conditions
(CO2: P = 0.001, interaction: P = 0.681).
Ventilatory variables. Resting PETCO2 was lower with
hypoxia (hypoxia: P = 0.001), while it was higher with augmented
FICO2 (CO2: P,0.001, interaction: P = 0.224). There was an
interaction between the effects of hypoxia and augmenting FICO2
on resting PETO2 (interaction: P = 0.004). Post-hoc analysis shows
that PETO2 was lowered with hypoxia during both control and
augmented FICO2 conditions (P,0.001
B vs. normoxia for both),
while augmenting FICO2 elevated resting PETCO2 by a greater
extent in normoxia (by 2065 mm Hg, P,0.001B vs. control
normoxia) compared to in hypoxia (by 1064 mm Hg, P,0.001B
vs. control hypoxia). Resting V
:
E was elevated by hypoxia
(P = 0.008 vs. normoxia) and augmented FICO2 (CO2:
P,0.001, interaction: P = 0.848). There was an interaction
between the effect of hypoxia and augmenting FICO2 on V
:
CO2
(interaction: P = 0.003). Post-hoc t-tests showed that hypoxia
elevated V
:
CO2 during control (P,0.001
B vs. control normoxia)
but not during augmented FICO2 (P = 0.832
B vs. augmented
FICO2 in normoxia). Accordingly, V
:
CO2 appeared to be lower
with augmented FICO2 in hypoxia (P,0.001
B vs. control hypoxia)
but not in normoxia (P = 0.131B vs. control normoxia). No
differences were observed in V
:
O2 with either hypoxia or
augmented FICO2 (main effects: P = 0.217 & P = 0.127, respec-
tively, interaction: P = 0.575).
Cardiovascular variables. Hypoxia elevated resting HR
(hypoxia: P,0.001 vs. normoxia); there was a slight but non-
significant tendency for augmenting FICO2 to attenuate this
increase in HR (CO2: P = 0.886, interaction: P = 0.059). The effect
of hypoxia and augmented FICO2 on resting SpO2 interacted with
each other (interaction: P = 0.004). Specifically, post-hoc analysis
found SpO2 to be lower with hypoxia during both control and
augmented FICO2 conditions (P,0.001
B vs. normoxia for both).
Meanwhile, augmenting FICO2 selectively elevated resting SpO2
in hypoxia (P,0.001B vs. control hypoxia), but not in normoxia
(P = 0.615B vs. control normoxia). No changes were observed in
resting MAP with either hypoxia or augmenting FICO2 (main
effects: P = 0.809 and P = 0.123, respectively, interaction:
P = 0.370).
Exercise
Performance. Hypoxia lowered maximal exercise capacity
by 26% (251615 W vs. 338621 W, hypoxia vs. normoxia,
hypoxia: P = 0.001), whereas there was a tendency for maximal
exercise capacity to be lowered with augmented FICO2 (CO2:
P = 0.091, interaction: P = 0.397). Specifically, maximal exercise
capacity tended to be lower by 4% in normoxia (332666 W vs.
345666 W, augmented FICO2 vs. control, P = 0.052
B), while no
trend was observed in hypoxia (248648 W vs. 256648 W,
P = 0.252B).
Ventilatory variables (Fig. 1A, 1B & 2A–D). During
incremental exercise, the effect of augmenting FICO2 on PETCO2
was greater in hypoxia compared to normoxia (interaction:
P,0.001). Post-hoc analysis revealed that throughout exercise,
hypoxia lowered PETCO2 during control by a greater extent than
during augmented FICO2 (1063 mmHg vs. 563 mmHg,
P,0.001B vs. normoxia for both). Meanwhile, augmenting FICO2
elevated PETCO2 by a lesser extent in normoxia compared to in
hypoxia (863 mmHg vs. 1463 mmHg, P,0.001B vs. control for
both). In contrast, hypoxia blunted the effect of augmenting
FICO2 on PETO2 (interaction: P,0.001). Post-hoc comparisons
found hypoxia lowered PETO2 by 4962 mmHg during control
and by 5464 mmHg during augmented FICO2 conditions
(P,0.001B vs. normoxia for both). Furthermore, augmenting
FICO2 increased PETO2 by 1563 mmHg in normoxia and by
1063 mmHg in hypoxia (P,0.001B vs. control for both).
During incremental exercise, both hypoxia and augmenting
FICO2 elevated V
:
E (main effect: P,0.001 for both, interaction:
P = 0.188). At exhaustion, V
:
E reached 74612% of estimated
maximal voluntary ventilation (MVV) in normoxia and 69611%
in hypoxia [26].
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MCAv (Fig. 1C, 2E & 2F). During incremental exercise,
there was a significant interaction between the effect of hypoxia
and augmenting FICO2 (interaction: P = 0.010). Post-hoc analysis
revealed that hypoxia elevated MCAv during control (P = 0.002B
vs. control normoxia), but not during augmented FICO2 condition
(P = 0.429B vs. augmented FICO2 in normoxia). Meanwhile,
augmenting FICO2 selectively elevated MCAv during incremental
exercise in normoxia (P,0.001B vs. control normoxia), but not in
hypoxia (P = 0.145B vs. control hypoxia).
Oxygen saturation (Fig. 1D, 2G & 2H). The effect of
augmenting FICO2 on SpO2 during exercise was enhanced in
hypoxia (interaction: P,0.001). As such, post-hoc analysis showed
that hypoxia lowered SpO2 by 2666% during control condition
(P,0.001B vs. control normoxia) and by 1566% during
augmented FICO2 condition (P,0.001
B vs. augmented FICO2
in normoxia). Meanwhile, augmenting FICO2 elevated SpO2 by
1265% in hypoxia (P,0.001B vs. control hypoxia), but not in
normoxia (P = 0.615B vs. control normoxia).
Metabolism (Fig. 1E, 1F & 3A–D). Hypoxia lowered both
V
:
O2 and V
:
CO2 throughout exercise (hypoxia: P,0.001 vs.
normoxia for both), while augmented FICO2 had no effect on
these variables (CO2: P = 0.628 & P = 0.544, respectively, inter-
action: P = 0.954 & P = 0.304).
Cardiovascular variables (Fig. 1G, 3E & 3F). During
exercise, the effect of hypoxia on HR was offset by the effect of
augmenting FICO2 (interaction: P = 0.003). Accordingly, post-hoc
t-tests found HR to be higher with hypoxia during control
(P = 0.001B vs. control normoxia), but not during the augmented
FICO2 (P = 0.360
B vs. augmented FICO2 in normoxia). There
were trends for augmenting FICO2 to elevate HR during exercise
in normoxia (P = 0.075B vs. control normoxia) and lower HR in
hypoxia (P = 0.019B vs. control hypoxia).
Rate of perceived exertion (Fig. 1H, 3G & 3H). There was
an interaction between effects of hypoxia and augmenting FICO2
on RPE (interaction: P = 0.045). As a result, a post-hoc t-tests
found a tendency for RPE to be elevated with augmented FICO2
in normoxia (P = 0.038B vs. control normoxia), but not in hypoxia
(P = 0.598B vs. control hypoxia). Hypoxia had no effect on RPE
during control or augmenting FICO2 (P = 0.735
B & P = 0.180B vs.
normoxia, respectively).
RC and V
:
E-slope to exercise (Fig. 4 & 5). During
exercise, the onset of RC occurred at lower power output in
hypoxia compared to in normoxia (by 86636 W, Hypoxia:
P,0.001). Likewise, the onset of RC occurred at lower power
output with augmenting FICO2 compared to control conditions
(CO2: P = 0.015; interaction: P = 0.176). Meanwhile, there was an
interaction between the effect of hypoxia and augmenting FICO2
on V
:
E at RC (interaction: P = 0.021). Post-hoc analysis revealed
that hypoxia tended to elevate V
:
E at RC under the augmented
FICO2 condition (P = 0.027
B vs. augmented FICO2 in normoxia),
but not during the control condition (P = 0.112B vs. control
normoxia). Augmenting FICO2 selectively increased V
:
E at RC in
hypoxia (by 23.95621.70 L/min, P = 0.007B vs. control hypoxia),
but not in normoxia (P = 0.847B vs. control normoxia). The effect
of hypoxia and augmenting FICO2 interacted with each other on
the V
:
E-slope to exercise (the slope of V
:
E rise against power) below
RC (interaction: P = 0.043). As such, hypoxia elevated the V
:
E
slope to exercise below RC during both control (by 30613%,
P,0.001B vs. control normoxia) and augmented FICO2 condition
(by 93678%, P = 0.001B vs. augmented FICO2 in normoxia).
Augmenting FICO2 lowered the V
:
E slope below RC during
normoxia (by 27614%, P = 0.001B vs. control normoxia), but not
during hypoxia (P = 0.786B vs. control hypoxia). In contrast, no
differences were observed in the V
:
E slope to exercise above RC
with either hypoxia or augmenting FICO2 (hypoxia: P = 0.256,
CO2: P = 0.155, interaction: P = 0.585).
Discussion
Augmenting FICO2 elevated CBF during incremental exercise
in normoxia, but, unexpectedly, it did not during hypoxia.
Furthermore, we found no improvement in exercise capacity with
Table 1. Effect of hypoxia and augmented FICO2 on resting respiratory, cerebrovascular and cardiovascular variables.
Normoxia Hypoxia
Control
Augmented
FICO2 Control
Augmented
FICO2
Ventilatory
PETCO2 (mmHg) 36 6 3 43 6 2* 32 6 2
{ 40 6 2*{
PETO2 (mmHg) 96 6 4 116 6 4* 45 6 3
{ 55 6 3*{
V
:
E (L/min) 11.6 6 1.8 24.1 6 5.1* 16.5 6 2.4
{ 28.5 6 5.5*{
V
:
O2 (ml/min) 350 6 64 394 6 63 346 6 91 375 6 75
V
:
CO2 (ml/min) 320 6 67 285 6 51 444 6 85
{ 282 6 66*
Cerebrovascular
MCAv (cm/s) 54 6 10 67 6 10* 54 6 12 66 6 16*
Cardiovascular
HR (b/min) 70 6 7 74 6 13 88 6 7 84 6 7*
MAP (mmHg) 90 6 7 99 6 11 90 6 14 100 6 9
SpO2 (%) 97 6 1 98 6 1 85 6 5
{ 91 6 3*{
Values are mean 6 SD.
*different from control (P,0.05);
{different from normoxia (P,0.05).
N = 10 for all variables except VO2 and VCO2 where N= 9.
doi:10.1371/journal.pone.0081130.t001
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augmented FICO2 during either normoxia or hypoxia. While the
roles of hypercapnia and hypoxia in the regulation of CBF during
rest have been extensively studied, their effects on cerebrovascular
control during exercise are less well documented [see [27] for
review]. During exercise, studies have found enhanced CBF
response to hypercapnia [28], while the CBF response to
hypocapnia remained unchanged [29]. During incremental
exercise, we observed higher MCAv during both control hypoxia
and augmented FICO2 in normoxia (Fig. 1C). However, in
contrast to the findings by Subudhi et al., [15], we observed no
further increase in MCAv with augmented FICO2 in hypoxia. The
discrepancies between these findings could potentially be account-
ed for by the differences in the experimental setup and/or the level
of hypercapnia achieved. In the study by Subudhi et al., [15],
Figure 1. Effect of hypoxia and augmented FICO2 on mean respiratory, cerebrovascular, metabolic and cardiac variables and
perceived effort of exertion during incremental cycling to exhaustion. Values expressed as mean 6 SD. * different from control (P,0.05);
{ different from normoxia (P,0.05); 1 trend for a difference (P,0.10).
doi:10.1371/journal.pone.0081130.g001
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Figure 2. Effect of hypoxia and augmented FICO2 on group respiratory, cerebrovascular variables and peripheral O2 saturation
during incremental cycling to exhaustion. Left panels: group data in normoxia (mean 6 SD); right panels: group data in hypoxia. Note: these
graphs are only intended for visualizing the changes in physiological parameters during incremental cycling. Statistical analyses were carried out
using the average variable during the exercise session (see Figure 1).
doi:10.1371/journal.pone.0081130.g002
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Figure 3. Effect of hypoxia and augmented FICO2 on metabolic variables, heart rate, and perceived effort of exertion during
incremental cycling to exhaustion. Left panels: group data in normoxia (mean6 SD); right panels: group data in hypoxia. Note: these graphs are
only intended for visualizing the changes in physiological parameters during incremental cycling. Statistical analyses were carried out using the
average variable during the exercise session (see Figure 1).
doi:10.1371/journal.pone.0081130.g003
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PETCO2 was clamped at 50 mmHg throughout exercise, while
our subjects’ PETCO2 were on average, ,46 and ,43 mmHg in
normoxia and hypoxia respectively (Fig. 1A), reaching ,53 and
,47 mmHg at maximal exercise intensity (Fig. 2A & 2B).
Meanwhile, using our Altitrainer setup, Siebenmann et al., [16]
were able to increase MCAv during incremental exercise in
moderate hypobaric hypoxia (3,454 m) by clamping PETCO2 at
40 mmHg in altitude sojourners. We deem it unlikely that
differences in experimental setup are sufficient to account for
these discrepant findings between the three studies. An alternative
explanation is the potential influence of (partial) altitude acclima-
tization [30]. Subudhi et al., [15] examined the effect of CO2
clamping on competitive cyclists living and training at 1,650 m,
therefore already acclimatized to exercise at moderate altitude.
Likewise, the subjects in Siebenmann et al., [16] had spent one
night at altitude. In contrast, the subjects in our study had not
been exposed to altitude .1000 m in the 2 months prior the
study. Since acclimatization to altitude augments the cerebrovas-
cular responsiveness to CO2 [17], the increase in CBF observed by
both Subudhi et al., [15] and Siebenmann et al., [16] may
therefore be due to a partial state of acclimatization to altitude.
Cerebral O2 delivery and performance in hypoxia
Contrary to our first hypothesis, augmenting FICO2 during
incremental exercise in normobaric hypoxia failed to improve
aerobic exercise capacity. This finding corroborates recent
findings in milder (hypobaric) hypoxic conditions [15,16]. The
relationship between cerebral deoxygenation and exercise perfor-
mance in normoxia [13] and hypoxia [6–12] is therefore unlikely
to be causally related to the loss of aerobic capacity in hypoxia.
However, it cannot be excluded that augmenting FICO2
introduces limits that overrule the potential benefit of improved
cerebral CO2 delivery. Siebenmann et al., [16] argued that
inspired CO2 may exacerbate the metabolic acidosis associated
with heavy exercise, shifting the oxyhemoglobin curve rightward,
decreasing SaO2, thus limiting peak V
:
O2. In agreement, our
results show a reduction in average heart rate in hypoxia (Fig. 1G)
and a tendency for maximal exercise capacity to be actually
impaired with augmented FICO2 (P = 0.091), as also reported
elsewhere [15,16]. In agreement with Subudhi et al., [15], we
found the participants’ RPE to increase more rapidly with
augmented FICO2 in normoxia (Fig. 3G), in parallel with the
increase in ventilation (Fig. 2C). But contrary to Siebenmann et
al., [16], our findings of higher SpO2 with augmented FICO2 in
hypoxia throughout submaximal exercise intensities, and similar
SpO2 at exhaustion (Fig. 2H), which exclude a right-ward shift in
the oxyhemoglobin curve would have limited pulmonary oxygen
uptake.
Limits to cerebral vasodilation
While controversy remains, there is a large body of literature
suggesting that nitric oxide, prostanoids and C-natriuretic peptide
are involved in the cerebral vasodilatory responses to both
hypercapnia and hypoxia through a number of intermediate
interacting/co-activating pathways [31]. We speculate that if one
chemical stimulus, such as hypoxia, is of sufficient magnitude to
exhaust the cerebral vessels’ capacity to vasodilate, thereby
reaching maximal diameter of the vessels, then any additional
stimuli would have no further effect on cerebrovascular resistance.
Our data indicate that the CBF response to hypoxia is enhanced
during exercise compared to rest, while adding CO2 to the
inspired gas during exercise only elevates CBF during normoxia,
Figure 4. Effect of hypoxia and augmented FICO2 on respiratory compensation threshold and ventilatory response to exercise
during incremental cycling to exhaustion. Values expressed as mean 6 SD. * different from control (P,0.05); { different from normoxia
(P,0.05); 1 trend for a difference (P,0.10).
doi:10.1371/journal.pone.0081130.g004
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but not during severe hypoxia (Fig. 1C). The ‘normal’ cerebro-
vascular reactivity to hypercapnia thus appears to be abolished
during exercise in severe hypoxia (Fig. 2F). In support, we found
no difference between the MCAv values between augmented
FICO2 in normoxia and control hypoxia (P = 0.193). Such
exhaustion of the cerebral vessels’ vasodilatory reserve would
account for the lack of change in MCAv with augmented FICO2
during sub-maximal exercise in hypoxia. Mardimae et al., [32]
demonstrated a synergistic role of CO2 and hypoxia on the control
of CBF at rest whereas our results would favor a negative effect,
whereby the presence of severe hypoxia appears to attenuate the
effect of hypercapnia on the cerebral vessels. Our data indicates
that during incremental exercise in hypoxia, the role of
hypercapnia in the regulation of cerebrovascular tone appears to
be diminished – at least in an unacclimatized population.
However, we cannot exclude the possibility that there might be
regional differences in the cerebral vessel response to hypoxia and
hypercapnia, which could display additive or synergistic interac-
tions between the two chemical stimuli. Furthermore, the effect of
combining hypoxia and hypercapnia on cerebral metabolism is
unknown. Given the limited literature on this topic, further studies
on the effect of hypoxia, hypercapnia and acclimatization status on
regulation of cerebrovascular tone and therefore cerebral O2
delivery during exercise in altitude is certainly warranted.
Chemoreception and exercise hyperpnea
The regulation of exercise hyperpnea has been extensively
studied during the past 100 years [see [33–37] for reviews].
Nevertheless, the role of chemoreception in the regulation of
exercise hyperpnea, especially during heavy exercise remains
controversial [38,39]. To date, only a handful of studies have
examined the effect of chemoreceptor stimulation with CO2 alone
[3,14,25,40,41] or the combined effects of hypoxia and hypercap-
nia on exercise hyperpnea [42]. Our second hypothesis stated that
increasing PETCO2 and decreasing PETO2 would stimulate the
chemoreceptors and lead to an increase in the ventilatory response
to exercise. We found that hypoxia and augmented FICO2 had an
additive effect on exercise hyperpnea below the RC threshold
(Fig. 4C). As reported before in conditions of normoxia [14],
adding CO2 to the inspirate during normoxic and hypoxic
conditions indeed increased ventilation at rest and during
incremental exercise (Table 1 & Fig. 5). However, at higher
intensities, above the RC threshold, this effect progressively
lessened, in spite of a progressive increase in PETCO2, again
similarly to what we found before in normoxia [14]. Hypoxia per se
augmented the ventilatory response to incremental exercise (the
rate of ventilation increase during exercise) below the RC
threshold, while augmented FICO2 attenuated this rate of increase
(Fig. 5). Hypoxia shifted the RC threshold to lower exercise
intensities, which is further exacerbated with augmented FICO2
(Fig. 4A & 5B). No differences were observed in the slope of the
ventilatory response to exercise above the RC threshold between
any of the conditions (Fig. 4D). We thus confirm that below the
RC threshold both hypoxia and hypercapnia can modulate the
rate of ventilatory response to increasing exercise, presumably
through chemoreceptor stimulation. However, once above the
ventilatory compensation threshold, the chemoreflex ventilatory
responses are blunted.
Siebenmann et al., [16] suggested that, during heavy exercise in
hypoxia, the hyperventilation-induced hypocapnia might attenu-
ate ventilatory drive and limit the ventilatory response to exercise.
They further speculated that the mechanical constraints associated
with high intensity exercise ventilation may be reduced in
hypobaric hypoxia, while at the same time hypocapnia would be
more pronounced, so that a blunting effect of hypocapnia on V
:
E
would persist or become more pronounced. Since we performed
our experiments in normobaric conditions our results were not
influenced by differences in air density, neglecting the small
increases in N2 and CO2 in exchange of O2 in our inspirates. In
our young and active, but not-athletic subjects, mechanical
limitation would seem unlikely since maximal ventilation only
reached,70% of estimated MVV with augmented FICO2 both in
normoxia and hypoxia.
Methodological considerations
Although the present study provided the opportunity to
examine the effects of augmented FICO2 on CBF response and
exercise capacity during incremental exercise in hypoxia, an
important limitation of the present study, as of many other studies,
is the assumption that MCAv represents global CBF changes. Sato
et al., [43] recently found that blood flow in the middle cerebral
and internal carotid arteries declined from moderate (60%
V
:
O2max) to high intensity exercise (80% V
:
O2max), whilst blood
flow in the vertebral artery continued to increase at the higher
intensities. This led Vogiatzis et al., [11] to suggest that vertebral
artery blood flow may compensate for reductions of MCA blood
flow during near-maximal or maximal exercise. However, since
the relative contribution of the internal carotid artery (and
Figure 5. Effect of hypoxia and augmented FICO2 on respira-
tory compensation threshold and ventilatory response to
exercise during incremental cycling to exhaustion. A: group
data in normoxia (mean 6 SD); B: group data in hypoxia. * different
from control (P,0.05); { different from normoxia (P,0.05); 1 trend for a
difference (P,0.10).
doi:10.1371/journal.pone.0081130.g005
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therefore MCA) to global CBF remains relatively unchanged
(,65%) at high intensity exercise [43], we contend that MCAv is a
reasonable index of changes in global CBF during heavy exercise.
Further consideration when interpreting our MCAv data is the
potential influence of hypoxia and hypercapnia on the MCA
diameter. The cross-sectional area of the MCA was shown to
remain relatively unchanged within a wide range of changes in
PETCO2 [44–47] and during exposure to hypoxia similar to that
used in the present study (5,300 m) [48]. However, since no studies
have examined the effect of exercise on MCA diameter, nor when
superimposed with hypoxia and hypercapnia, we cannot exclude
the possibility MCA diameter might have increased in our study,
leading to an underestimation of the effect of augmented FICO2
or hypoxia on CBF. In addition, since we did not measure cerebral
tissue oxygenation, it is possible that we were unable to elevated
cerebral O2 delivery with our experimental setup. However, in the
present study, SpO2 was elevated with augmented FICO2
throughout exercise in hypoxia (Fig. 1D), while MCAv was
comparable between the control and augmented FICO2 condi-
tions (Fig. 1C). We would therefore expect cerebral O2 delivery,
which is the product of arterial O2 saturation and CBF, to be
elevated with augmented FICO2 in hypoxia, leading to increased
cerebral tissue oxygenation.
Another limitation of the present study is that we increased end-
tidal rather than arterial PCO2 during exercise, while it is known
that the end-tidal-arterial PCO2 gradient [49] varies with exercise
[50,51]. Using our setup, Siebenmann et al., [16] were successful
in clamping both end-tidal and arterial PCO2 at around
40 mmHg during incremental exercise in hypoxia. Therefore,
we believe it is likely that we were able to sufficiently elevate
PaCO2.
Finally, in the present study, we used a linear ramp protocol to
assess the effect of augmented FICO2 on the ventilatory response
during incremental exercise. It should be acknowledged that
during incremental exercise, lower peak V
:
O2 and work output is
obtained during ramp vs. step protocols [52], while the steepness
of the ramp (i.e., 10 W/min, 30 W/min or 50 W/min), pedaling
frequency and baseline workload can influence the onset of
ventilatory threshold, peak V
:
O2 and the V
:
O2-workload relation-
ship [53,54]. Therefore, our conclusions on the ventilatory
response to exercise should only be limited to the specific ramp
protocol (30 W/min) used in the present study. Furthermore, since
all the aforementioned studies [15,16] only looked at aerobic
capacity using incremental exercise tests until voluntary exhaus-
tion, which have limited ecological validity [55], it remains to be
investigated if increasing MCAv by augmenting FICO2 during
steady-state sub-maximal endurance exercise such as a time trial
could improve performance in hypoxia, as time trial exercise
provide a more accurate simulation of physiological responses
during actual competitions [56] and correlate well with actual race
performance [57].
Conclusions
We report two novel findings. Firstly, augmenting FICO2
increases cerebral blood flow during sub-maximal exercise in
normoxia, but not in hypoxia. This finding indicates that the
‘normal’ cerebrovascular response to hypercapnia is impaired
during exercise in hypoxia, possibly due to an exhaustion of
cerebral vasodilatory reserve. Secondly, above the ventilatory
recruitment threshold, both in normoxia and hypoxia, the
chemoreflex ventilatory responses are blunted.
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Abstract
During heavy exercise, hyperventilation-induced hypocapnia leads to cerebral
vasoconstriction, resulting in a reduction in cerebral blood flow (CBF). A
reduction in CBF would impair cerebral O2 delivery and potentially account
for reduced exercise performance in hypoxia. We tested the hypothesis that
end-tidal PCO2 (PETCO2) clamping in hypoxic exercise would prevent the
hypocapnia-induced reduction in CBF during heavy exercise, thus improving
exercise performance. We measured PETCO2, middle cerebral artery velocity
(MCAv; index of CBF), prefrontal cerebral cortex oxygenation (cerebral
O2Hb; index of cerebral oxygenation), cerebral O2 delivery (DO2), and leg
muscle oxygenation (muscle O2Hb) in 10 healthy men (age 27  7 years;
VO2max 63.3  6.6 mL/kg/min; mean  SD) during simulated 15-km time
trial cycling (TT) in normoxia and hypoxia (FIO2 = 0.10) with and without
CO2 clamping. During exercise, hypoxia elevated MCAv and lowered cerebral
O2Hb, cerebral DO2, and muscle O2Hb (P < 0.001). CO2 clamping elevated
PETCO2 and MCAv during exercise in both normoxic and hypoxic conditions
(P < 0.001 and P = 0.024), but had no effect on either cerebral and muscle
O2Hb (P = 0.118 and P = 0.124). Nevertheless, CO2 clamping elevated cere-
bral DO2 during TT in both normoxic and hypoxic conditions (P < 0.001).
CO2 clamping restored cerebral DO2 to normoxic values during TT in
hypoxia and tended to have a greater effect on TT performance in hypoxia
compared to normoxia (P = 0.097). However, post hoc analysis revealed no
effect of CO2 clamping on TT performance either in normoxia (P = 0.588) or
in hypoxia (P = 0.108). Our findings confirm that the hyperventilation-
induced hypocapnia and the subsequent drop in cerebral oxygenation are
unlikely to be the cause of the reduced endurance exercise performance in
hypoxia.
Introduction
Altitude hypoxia represents a formidable environmental
challenge to the human organism. Hypoxia limits oxygen
transport from the air to the muscle mitochondria, which
compromises aerobic capacity (Calbet and Lundby 2009).
Exercise capacity is a vital determinant of a population’s
ability to thrive at high altitude (Curran et al. 1998), and
permanent residence above 5000 m poses problems for
mining and other human endeavor. Despite more than a
century of research on the detrimental effects of hypoxia
on exercise performance, the exact underlying mecha-
nisms remain poorly understood [see (Amann and Kayser
2009; Verges et al. 2012) for reviews].
Even though the cessation of maximal exercise, or the
reduction in exercise intensity, when fatiguing, imply
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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reduced motor recruitment by the central nervous system,
the mechanisms that lead to the derecruitment of active
muscle remain elusive. During normoxia and moderate
hypoxia, leg muscle afferents appear to play an important
role (Amann 2006; Amann and Dempsey 2007; Amann
et al. 2011), whereas cerebral tissue oxygenation may play
a more pivotal role under severe hypoxic conditions (Kjaer
et al. 1999; Amann et al. 2006; Amann and Dempsey 2007;
Subudhi et al. 2007a, 2009; Rasmussen et al. 2010; Vogiatzis
et al. 2011). At rest, the brain protects itself against
hypoxia by increasing cerebral blood flow (CBF) to com-
pensate for the decreased arterial oxygen tension (Cohen
et al. 1967). But during high-intensity exercise, hyperventi-
lation-induced hypocapnia leads to cerebral vasoconstric-
tion, which counteracts the hypoxia-induced vasodilation,
thereby lowering CBF and cerebral oxygenation (Jorgensen
et al. 1992a; Madsen et al. 1993; Ide et al. 1999; Subudhi
et al. 2007b). As hypoxia per se enhances ventilatory drive,
this would further exacerbate the hyperventilation-induced
hypocapnia during heavy exercise and further lower CBF
and cerebral oxygenation. It was proposed that this reduc-
tion in cerebral oxygenation may account for the reduced
performance during heavy exercise in severe hypoxia
(Amann and Dempsey 2007; Nybo and Rasmussen 2007;
Amann and Kayser 2009; Subudhi et al. 2009; Rasmussen
et al. 2010). In support, reduced cerebral oxygenation has
been shown to coincide with both reduced cortical motor
output (Subudhi et al. 2009) and increased cerebral metab-
olism (Rasmussen et al. 2010).
Contrary to this hypothesis, Subudhi et al. (2011)
recently found exercise capacity to be reduced when they
prevented the normal hyperventilation-induced hypocap-
nia with end-tidal CO2 clamping during incremental
cycling in hypobaric hypoxia (equivalent of 4875 m),
despite elevated CBF and improved cerebral oxygenation.
They attributed this finding to limiting factors such as
increased respiratory muscle work and associated “steal”
of blood flow, and an elevated perceived effort related to
their experimental setup, which may have outweighed the
benefits of elevated cerebral O2 delivery. Siebenmann et al.
(2012) completed those observations by investigating, at a
more moderate altitude (3454 m), the impact of clamping
PETCO2 at 40 mmHg, on performance. Clamping
increased middle cerebral artery velocity (MCAv), attenu-
ated the decrease in cerebral oxygenation, but slightly
decreased peak power output while it did not affect maxi-
mal oxygen uptake. Siebenmann et al. (2012) concluded
that although hypocapnia decreases CBF and cerebral oxy-
genation, this does not limit maximum aerobic exercise
capacity. In contrast, using a similar approach but in non-
acclimatized subjects during incremental exercise to capac-
ity in more severe hypoxia (equivalent of 5000 m), we
were unable to improve CBF with inspired CO2, despite a
greater degree of hypercapnia (Fan and Kayser 2013). We
attributed these discrepant findings to the different accli-
matization states of the subjects in the different studies
(389 m vs. 1600 m resident) and the type of hypoxia used
(normobaric vs. hypobaric). However, all the aforemen-
tioned studies only looked at aerobic capacity using incre-
mental exercise tests until voluntary exhaustion, which
have limited ecological validity (Currell and Jeukendrup
2008). It thus remains unclear whether preventing a
reduction in CBF and cerebral oxygenation associated with
hyperventilation-induced hypocapnia would improve per-
formance during prolonged, submaximal exercise para-
digms such as time trial cycling, which are more
representative of usual human exercise behavior.
In this study, we therefore examined the effect of
clamping partial pressure of end-tidal CO2 (PETCO2) on
CBF and performance during a 15-km time trial cycling
in severe normobaric hypoxia, as time trial protocols
provide a more accurate simulation of physiological
responses during actual competitions (Foster et al. 1993)
and has been shown to correlate well with actual race per-
formance (Palmer et al. 1996). We tested the hypothesis
that by preventing hyperventilation-induced hypocapnia,
we would increase CBF and cerebral oxygen delivery
without altering muscle tissue oxygenation during high-
intensity exercise, improving exercise performance during
15-km time trial cycling at a simulated altitude of 5000 m
in nonacclimatized low-altitude residents.
Methods
Participants
A power calculation was employed using a difference
worth detecting of a 5% improvement in 15-km time trial
cycling performance based upon previous findings by Jeuk-
endrup et al. (2008), along with unpublished data from
our laboratory. A sample size of nine control volunteers
was sufficient to give a power of 0.80 and an a of 0.05. Ten
healthy males with a mean age of 27  7 year
(mean  SD), a body mass index of 22.3  1.3 kg/m2,
VO2max of 63.3  6.6 mL/min/kg, and maximal power
output of 385  30 W participated in this study. Partici-
pants were nonsmokers, had no previous history of cardio-
vascular, cerebrovascular, or respiratory disease and were
not taking any medication. All participants were informed
regarding the procedures of this study, and informed con-
sent was given prior to participation. All the participants
were residents of Geneva, Switzerland (<500 m), and were
trained cyclists. The study was approved by the Research
Ethical Committee of the University Hospitals of Geneva
and conformed to the standards set by the Declaration of
Helsinki.
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Experimental design
The participants visited the laboratory on five occasions.
Following full familiarization, which included a VO2max
test to assess the participant’s aerobic fitness (visit one),
the participants underwent four experimental trials (ran-
domized, balanced order, and in single-blind fashion)
which consisted of the following conditions: (i) control
normoxia (389 m); (ii) normoxia with CO2 clamping; (iii)
control normobaric hypoxia (FIO2 = 0.10; simulated alti-
tude of 5000 m); and (iv) normobaric hypoxia with CO2
clamping. Before each experimental session, the partici-
pants were asked to abstain from caffeine for 12 h, and
heavy exercise and alcohol for 24 h. Each experimental
testing session comprised of 20-min instrumentation with
the participants breathing room air while seated on a bicy-
cle fitted to a Computrainer Pro Model trainer, calibrated
according to the manufacturer’s instructions (RacerMate,
Seattle, WA). While breathing normal room air, 4-min
baseline data were collected (room air baseline), the partic-
ipants then performed a 5-min self-selected warmup exer-
cise (heart rate <120 bpm). They were then switched to
breathe from a modified gas mixing system (Altitrainer,
SMTec, Nyon, Switzerland) followed by an additional
4-min resting baseline collection (condition baseline). The
participants then did a 15-km time trial cycling as fast as
possible. They were free to shift gears during the time tri-
als, and constant feedback regarding the distance covered,
but not speed, was provided on a computer screen (Com-
putrainerTM 3D software version 3.0; Racermate). To pre-
vent excessive thermal stress during the time trial exercise,
two ventilators were placed ~60 cm in front of the partici-
pants and wind velocity was adjusted according to cycling
speed. Throughout each experimental session, the partici-
pants wore a nose clip and breathed through a mouthpiece
attached to a low-resistance one-way nonrebreathing valve
(Hans-Rudolph 2700, Kansas City, MO). The simulated
normobaric hypoxia and CO2 clamping were achieved
using the gas mixing system, which was attached to the
inspiratory valve of the mouthpiece using a piece of large-
bore low-resistance tubing. The device consists of a reser-
voir in which air and experimental gases are mixed and
from which the participant inspires. This setup enables
bleeding additional CO2 into the inspired gas mixture,
thereby increasing the fraction of inspired CO2 (FICO2)
while keeping the fraction of inspired O2 (FIO2) constant
at either 0.21 (as in ambient air) or 0.10 (in Geneva the
equivalent of an altitude of ~5000 m) during normoxia
and hypoxia conditions, respectively. PETCO2 clamping
was achieved under feedback of on-screen PETCO2 (Lab-
Chart 7.2; ADInstruments, Colorado Springs, CO), contin-
uously adapting FICO2 keeping PETCO2 to its target value
(45 mmHg). The participants breathed through the same
circuit in all four conditions and were unaware to what gas
mixture they were breathing and naive to the exact ratio-
nale of the study. For each participant, the experiments
were carried out at the same time of day under consistent
laboratory conditions (temperature 21  1°C, humidity
32  5%, barometric pressure 726  6 mmHg).
Measurements
Respiratory variables
Gas exchange was monitored on a breath-by-breath basis
(Medgraphics CPX, Loma Linda, CA) measuring flow at
the mouth with a Pitot tube and the fractions of inspired
and expired O2 and CO2 with fast responding gas analyzers
(infrared and paramagnetic) integrated in the system. Ven-
tilation (V’E) was derived from the flow signal and
expressed in body temperature, pressure, saturated and per
minute. The partial pressures of end-tidal O2 (PETO2) and
CO2 (PETO2) were derived from the expired O2 and CO2
signals. Prior to each experimental session, the system was
calibrated using a 3-L syringe (M9474; Medikro Oy, Fin-
land) and precision gas mixtures of known O2 and CO2
concentrations (Carbogas AG, G€umligen, Switzerland).
Cerebrovascular and cardiovascular variables
Middle cerebral artery velocity (as an index of CBF) was
measured bilaterally in the middle cerebral arteries using
a 2-MHz pulsed Doppler ultrasound system (ST3; Spen-
cer technology, Seattle, WA). The ultrasound probes were
positioned over the temporal windows and held firmly in
place with an adjustable headband (Marc 600 Head
Frame; Spencer Technology). The signals were obtained
by first locating the bifurcation of the middle and ante-
rior cerebral artery; the angle and depth of insonation
were then adjusted to obtain measurements from the
MCA. The insonation depth and the velocity of MCA sig-
nals were recorded and compared to ensure within-sub-
ject repeatability of MCAv measurements between trials.
In our hands, day-to-day reproducibility of MCAv has a
coefficient of variation of <10%. The bilateral MCAv was
averaged to represent global CBF during rest and exercise.
Cerebral O2 delivery (cerebral DO2) was calculated using
the equation: cerebral DO2 = mean MCAv 9 arterial
oxygen content (CaO2, see below). Cerebral DO2 was nor-
malized to the room air baseline values prior to 5-min
warmup during each trial and expressed as %.
Cerebral oxygenation in the left prefrontal lobe was
assessed by monitoring changes in oxy- (O2Hb), deoxy-
(HHb), and delta (delta Hb: O2Hb–HHb) hemoglobin
obtained with spatially resolved, continuous wave near-
infrared spectroscopy (NIRS; Artinis Oxymon, MKIII,
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Zetten, the Netherlands). Source detector spacing was set
at 4.1 cm and data obtained from the optode were used
to calculate changes in O2Hb and HHb with a differential
pathlength factor (DPF) calculated using the formula:
DPF = 4.99 + 0.067 9 (age0.814) (Duncan et al. 1995).
Muscle oxygenation in the left vastus lateralis (~15 cm
proximal and 5 cm lateral to the superior border of the
patella) was measured with an additional NIRS channel
on the same instrument using a source detector spacing
of 3.8 cm and DPF of 4.0 (Duncan et al. 1995). The cere-
bral and muscle O2Hb and HHb are expressed at absolute
changes from room air baseline prior to the 5-min
warmup period. Beat-to-beat mean arterial blood pressure
(MAP) was monitored using finger plethysmography
(Finometer MIDI, Finapress Medical Systems, Amster-
dam, the Netherlands). Peripheral O2 saturation (SpO2)
was measured using earlobe pulse oximetry (Radical-7;
Masimo Corporation, Irvine, CA).
Blood gas variables
Arterialized earlobe capillary blood samples were taken at
rest and every 5 km during exercise (Mollard et al. 2010).
Vasodilating cream was applied to the earlobe 5 min prior
to the sampling (Decontractyl, Sanofi Aventis, France). A
lancet was used to pierce the earlobe and 60-lL capillary
tubes (MultiCap; Siemens Healthcare Diagnostics Inc, Tar-
rytown, UK) were used to collect the samples. All samples
were analyzed immediately (<5 sec) using an arterial blood
gas analyzing system (RapidlabTM 248; Siemens Healthcare
Diagnostics Inc) for arterialized capillary pH, partial pres-
sure of arterialized capillary O2 (PcO2) and CO2 (PcCO2),
and arterialized O2 saturation (ScO2). Standard calibration
was performed prior to each blood sample analysis. Arteri-
alized hemoglobin concentration ([Hb]) was measured
using an azidemethemoglobin double wavelength photom-
eter method (HemoCue Hb201+; HemoCue AB, €Angel-
holm, Sweden). Arterialized capillary O2 content (CcO2;
index of CaO2) was calculated using the equation:
1.36 9 [Hb] 9 ScO2/100) + 0.003 9 PaO2.
Electromyography
Quadriceps electromyogram (EMG) was recorded from the
right vastus lateralis during exercise using electrodes with
full-surface solid adhesive hydrogel. Following careful
preparation of the skin (shaving, abrading, and cleaning
with alcohol) to lower impedance <5 kΩ, pairs of circular
silver chloride (recording diameter of 10 mm) surface elec-
trodes (Medi-TraceTM 100; Tyco Healthcare Group, Mans-
field, UK) with an interelectrode distance (center-to-
center) of 20 mm were placed along the line from the
superior lateral side of the patella to the anterior superior
iliac spine at ~100 mm from the patella as described by
Rainoldi et al. (2004). The position of the electrodes was
marked on the skin for identical placement between exer-
cise sessions. To minimize movement artifacts, the elec-
trodes and cables were secured to the participant’s leg
using elastic bandage and netting. The EMG signals were
amplified (Bio Amp Powerlab 26T; ADInstruments, Bella
Vista, Australia) and filtered using a band-pass filter with
low-pass cutoff frequency of 10 Hz and a high-pass cutoff
frequency of 999 Hz (LabChart version 7.2; ADInstru-
ments). The filtered EMG signals were sampled at 2 kHz
by an analog-to-digital converter (PowerLab 26T; ADIn-
struments). As an index of motor drive, the EMG root
mean square (RMS) was calculated for each single muscle
contraction (LabChart version 7.2; ADInstruments).
Rate of perceived exertion (RPE)
During exercise, the participants were asked to score their
RPE on the 0–10 Borg scale every 3 km (Borg 1982).
The scale with descriptors was mounted in front of the
subject at eye height. At regular intervals they were asked
to activate a handle bar mounted switch, activating the
appropriate led indicator next to the descriptor corre-
sponding to their RPE, resulting in a corresponding volt-
age signal being fed into the analog-to-digital converter.
Data and statistical analysis
Resting values were obtained by averaging the data obtained
in the last 30 sec of the 4 min resting period prior to exer-
cise. During the time trial exercise, a single time-weighted
mean value for each variable was obtained by averaging the
means of the last 20 sec of each km. The effects of hypoxia
and CO2 clamping on cardiorespiratory, cerebrovascular,
and blood gas responses at rest were assessed using a two-
way repeated measures ANOVA with a-level of 0.05 (IBM
SPSS Statistics version 20.0; IBM Corporation, Armonk,
NY). Likewise, we performed two-way repeated measures
ANOVA to isolate the effect of hypoxia and CO2 clamping
on the mean cardiorespiratory, cerebrovascular, and blood
gas responses during the 15-km time trial cycling with a a-
level of 0.05. Trends were considered when P < 0.10. For
significant interactions between hypoxia and CO2 clamping,
four pairwise comparisons (Bonferroni corrected) were per-
formed to isolate the effect of hypoxia and inspired CO2 on
the dependent measures within participants with a a level of
0.0125, indicated where appropriate with the superscript B.
With the exception of RPE, which is reported as median
and range, all data are reported as means  SD.
With the exception of missing data at the end of exer-
cise, which were replaced by repeated imputation using
the missing data analysis function from the SPSS
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program, individual missing data points were replaced by
values derived from a linear interpolation procedure.
Results
All 10 participants completed the experimental protocol.
Due to a technical problem, one participant could not
complete the final 2 km during the CO2 clamping in
hypoxia. Accordingly, comparison of exercise time was
carried out in nine participants. Due to technical issues,
blood sample analysis could not be carried out in all the
participants (see Table 2 for details). No participants
reported any side effects such as headache or dyspnea fol-
lowing the experiments.
Resting variables
Respiratory variables
CO2 clamping elevated resting V’E during normoxic and
hypoxic conditions (P < 0.001) (Table 1). Meanwhile,
acute hypoxia had a greater effect on V’E during the
clamped condition compared to the unclamped condition
(interaction: P = 0.028). Post hoc analysis showed that
acute hypoxia elevated V’E during CO2 clamping
(P = 0.001B vs. normoxia), but not during the unclamped
control condition (P = 0.210B vs. normoxia). There was an
interaction between the effect of hypoxia and CO2 clamp-
ing on both PETCO2 and SpO2 (interaction: P < 0.001 for
both). As such, CO2 clamping elevated PETCO2 during
both normoxic and hypoxic conditions (post hoc:
P = 0.001B and P < 0.001B, respectively), whereas acute
hypoxia lowered PETCO2 during the unclamped control
condition (P < 0.001B) and only tended to lower it during
the clamped condition (P = 0.098B). Post hoc analysis
revealed that resting SpO2 was lowered by acute hypoxia
during both control and clamped conditions (P < 0.001B
vs. normoxia), whereas CO2 clamping selectively elevated
SpO2 in hypoxia (P = 0.002
B), but not during normoxia
(P = 0.713B). Acute hypoxia lowered resting PETO2
(P < 0.001), whereas CO2 clamping elevated it (P < 0.001).
Cerebrovascular variables
Both acute exposure to hypoxia and CO2 clamping ele-
vated resting MCAv (main effects: P = 0.014 and
Table 1. Effect of hypoxia and CO2 clamping on resting respiratory, cerebrovascular, and cardiovascular variables.
Normoxia Hypoxia
Control CO2 clamp Control CO2 clamp
Respiratory
V’E (L/min) 15.7  2.6 22.3  3.31 16.6  5.9 30.4  4.41,2
PETCO2 (mmHg) 42  2 45  21 37  12 46  11
PETO2 (mmHg) 108  2 118  51 47  22 59  21,2
SpO2 (%) 97.1  1.6 97.2  1.5 83.5  3.72 89.1  3.11,2
Cerebrovascular
Middle cerebral artery velocity (cm/sec) 60  6 61  71 61  42 69  71,2
Cerebral O2Hb (Mlmol) 3.3  3.4 3.4  3.9 1.4  3.92 1.3  2.32
Cerebral HHb (Mlmol) 0.5  0.7 0.9  1.8 4.9  2.42 2.3  1.61,2
Cerebral DO2 (%) n = 8 101.7  4.3 106.0  8.31 91.5  8.7 109.3  9.71
Muscle oxygenation
Muscle O2Hb (Mlmol) 2.3  4.1 1.8  6.9 3.7  4.82 0.1  5.02
Muscle HHb (Mlmol) 5.5  2.7 4.8  3.9 0.4  6.42 2.2  3.22
Cardiovascular
Mean arterial blood pressure (mmHg) 97  6 101  13 100  8 106  11
HR (b/min) 80  10 81  111 92  162 86  101,2
Blood gases
pH 7.46  0.03 7.46  0.05 7.48  0.06 7.46  0.041
PcCO2 (mmHg) n = 9 34  3 36  31 29  32 37  561
PCO2 (mmHg) n = 9 98  5 107  81 46  42 57  51,2
ScO2 (%) n = 9 97.9  0.5 98.1  0.3 87.2  4.52 90.9  1.91,2
CcO2 (mL O2/dL) n = 9 19.9  1.2 19.9  1.3 17.8  1.72 18.5  1.12
Values are meanSD. Cerebral and muscle oxygenation data (O2Hb and HHb) are expressed as delta change from baseline room air breathing
values. Likewise, cerebral DO2 is expressed as % of baseline room air breathing values.
1Different from control (P < 0.05).
2Different from normoxia (P < 0.05).
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P < 0.001, respectively; interaction: P = 0.101). Hypoxia
at rest lowered cerebral O2Hb (P = 0.003), whereas CO2
clamping had no effect (P = 0.222). Hypoxia enhanced
the effect of CO2 clamping on resting cerebral HHb (inter-
action: P = 0.047). Post hoc tests showed that hypoxia ele-
vated cerebral HHb during control and clamped condition
(P < 0.001B and P = 0.001B, respectively), whereas CO2
clamp lowered resting cerebral HHb in hypoxia
(P = 0.001B) but not in normoxia (P = 0.579B). Resting
cerebral DO2 was unaltered with hypoxia (P = 0.227),
whereas CO2 clamping elevated it (P < 0.001) with a trend
for this increase to be greater in hypoxia compared to
normoxia (interaction: P = 0.090). As a result, CO2
clamping in hypoxia restored resting cerebral DO2 to
normoxic values (post hoc: P = 0.821B vs. normoxia).
Muscle oxygenation
Acute hypoxia lowered resting muscle O2Hb and elevated
muscle HHb (hypoxia: P = 0.024 and P = 0.007, respec-
tively), whereas no effect was observed with CO2 clamp-
ing (clamp: P = 0.301 and P = 0.602).
Cardiovascular variables
Resting HR was higher with acute hypoxia (P = 0.001)
and lower with CO2 clamping (P = 0.050, interaction:
P = 0.085), whereas no differences were observed in MAP
with either hypoxia or CO2 clamping (main effects:
P = 0.128 and P = 0.136, respectively).
Blood gas variables
No differences were observed in resting pH in hypoxia
(P = 0.508), whereas there was an interaction between the
effects of CO2 clamping and hypoxia on pH (interaction:
P = 0.016) despite a lack of effect of CO2 clamp per se
(P = 0.489). Post hoc analysis revealed that pH was lower
with CO2 clamping in hypoxia (P < 0.001
B vs. control),
but not during normoxia (P = 0.112B). There was an
interaction between hypoxia and CO2 clamp on PcCO2
(interaction: P = 0.018). Post hoc t-tests showed that
hypoxia lowered PcCO2 during the unclamped condition
(P = 0.010B vs. normoxia) but not during the clamped
condition (P = 0.630B), whereas CO2 clamping increased
Table 2. Effect of hypoxia and CO2 clamping on arterialized blood gas variables and cerebral O2 delivery during 15-km time trial.
Normoxia Hypoxia
Control CO2 clamp Control CO2 clamp
pH (n = 9)
5 km 7.42  0.08 7.38  0.07 7.40  0.10 7.40  0.06
10 km 7.41  0.07 7.39  0.10 7.41  0.08 7.43  0.04
15 km 7.39  0.06 7.37  0.07 7.39  0.09 7.35  0.07
PcCO2 (mmHg) n = 9
5 km 32.0  4.2 34.5  3.21 22.4  2.52 34.5  3.11
10 km 29.6  2.5 33.7  3.21 19.8  4.72 34.2  2.61
15 km 27.6  3.3 33.6  4.11 19.3  3.12 35.1  3.01
PcO2 (mmHg) n = 8
5 km 81.2  8.2 86.9  10.71 32.7  4.82 37.7  2.91,2
10 km 82.1  9.0 87.2  9.31 34.2  3.32 38.8  3.01,2
15 km 82.7  9.7 93.0  17.51 33.6  4.22 39.0  3.81,2
ScO2 (%) n = 7
5 km 95.4  1.6 95.5  2.2 64.4  5.32 68.6  7.31,2
10 km 95.5  1.8 96.4  2.0 65.3  3.42 69.7  6.01,2
15 km 95.7  1.8 96.6  2.1 65.8  6.72 68.4  8.51,2
CcO2 (mL O2/dL) n = 7
5 km 19.5  1.3 19.3  1.5 13.1  1.62 14.0  1.02
10 km 19.6  1.5 19.5  1.4 13.3  1.12 14.3  0.82
15 km 19.6  1.2 19.4  1.4 12.7  1.12 14.0  1.42
Cerebral DO2 (%) n = 7
5 km 115.5  10.7 122.1  13.21 94.5  9.72 111.8  11.81,2
10 km 116.4  11.4 137.8  38.81 102.0  11.12 117.8  9.61,2
15 km 117.4  12.9 150.3  37.31 99.5  7.72 122.9  13.61,2
Values are meanSD. Cerebral DO2 expressed as % of baseline room air breathing values.
1Different from control (P < 0.05).
2Different from normoxia (P < 0.05).
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PcCO2 in hypoxia (P = 0.001
B vs. control) but not in
normoxia (P = 0.035B). Meanwhile, both resting PcO2
and ScO2 were lowered with hypoxia (P = 0.001). CO2
clamping elevated PcO2 during both normoxia and
hypoxia (P < 0.002) and elevated ScO2 in hypoxia (post
hoc: P = 0.016B), but not in normoxia (P = 0.115B, inter-
action: P = 0.024). Resting CcO2 was lower with hypoxia
(P = 0.010), but unaffected with CO2 clamping
(P = 0.221).
Time trial
Cycling performance
Exercise performance was impaired by 19  7% in
hypoxia (1899  69 vs. 1584  62 sec, hypoxia vs. norm-
oxia, P < 0.001), while there was a nonsignificant trend
for CO2 clamping to exert a greater effect on exercise time
in hypoxia compared to normoxia (CO2: P = 0.262, inter-
action: P = 0.097). Nevertheless, post hoc analysis revealed
no significant improvement in the exercise time with CO2
clamping in hypoxia (1875  72 vs. 1924  5 sec, CO2
clamp vs. control; P = 0.108B) or normoxia (1589  62
vs. 1579  66 sec; P = 0.586B). Hypoxia lowered mean
power, speed, and cadence (P < 0.001, P < 0.001, and
P = 0.004, respectively) compared to normoxia, whereas
no difference was observed with CO2 clamping
(P = 0.468, P = 0.0694, and P = 0.656).
Rate of perceived exertion
The participants’ RPE during the time trial, as indicated
by the Borg score, was higher in hypoxia (hypoxia:
P = 0.009), but no difference was observed with CO2
clamping (clamp: P = 0.459).
Respiratory variables
V’E was elevated by both hypoxia and CO2 clamping
(hypoxia: P = 0.048, clamp: P = 0.023), whereas PETO2
was lowered with hypoxia and elevated with CO2 clamp-
ing throughout the exercise (main effects: P < 0.001 for
both) (Fig. 1). Meanwhile, PETCO2 was lower with
hypoxia during control only (P < 0.001B), whereas CO2
clamping restored PETCO2 to the values observed in the
normoxic clamped condition (P = 0.269B, interaction:
P < 0.001). SpO2 was lower during exercise in hypoxia
during both control and clamped conditions (P < 0.001B
for both), whereas SpO2 was higher with CO2 clamping
during exercise in hypoxia (P < 0.001B), but not normox-
ia (P = 0.713B, interaction: P < 0.001).
In normoxia, the participants began cycling at ~63%
VO2max at the start of time trial, which progressively
increased to 78% at the 14th km, before a final sprint
reaching 85% VO2max at the end of exercise. In con-
trast, during hypoxic conditions, the participants began
cycling at 46% (normoxic) VO2max, and progressively
increased to 57% at the end of the time trial. Overall,
both VO2 and VCO2 were lower in hypoxia (P < 0.001
for both), whereas CO2 clamping tended to elevate
VCO2 but not VO2 (P = 0.064 and P = 0.603, respec-
tively).
Cerebrovascular variables
Both hypoxia and CO2 clamping elevated MCAv during
exercise (by 26% and 9%, respectively; hypoxia:
P < 0.001, clamp: P = 0.024, interaction: P = 0.963)
(Fig. 2 and Table 1). Hypoxia elevated cerebral HHb dur-
ing exercise and lowered cerebral O2Hb and delta Hb
(P < 0.001 for all). In contrast, CO2 clamping lowered
HHb (P = 0.015) and elevated delta Hb during exercise
(P = 0.047), whereas no difference was observed in O2Hb
with clamping (P = 0.118). During the time trial cycling,
cerebral DO2 was lower with hypoxia (P = 0.004) and ele-
vated with CO2 clamping (P = 0.019, interaction:
P = 0.911).
Cardiovascular variables
There was a nonsignificant trend for MAP to be higher
with CO2 clamping (P = 0.062), whereas no effect was
observed with hypoxia (P = 0.535). No differences were
observed in HR with hypoxia (P = 0.206) or CO2 clamp-
ing (P = 0.196).
Muscle oxygenation
The effect of CO2 clamping on muscle O2Hb and delta
Hb was greater in hypoxia compared to normoxia (inter-
action: P = 0.039 and P = 0.007, respectively) and tended
to be greater for muscle HHb (interaction: P = 0.078)
(Fig. 3). As a result, post hoc analysis revealed that
hypoxia lowered muscle O2Hb and delta Hb during con-
trol condition (P < 0.001B vs. normoxia), and by a lesser
extend during CO2 clamped condition for muscle delta
Hb (P = 0.002B). Meanwhile hypoxia did not alter muscle
O2Hb in the CO2 clamped condition (P = 0.033
B vs. con-
trol). CO2 clamping did not alter muscle O2Hb in norm-
oxia (P = 0.554B), but tended to elevate it in hypoxia
(P = 0.013B). Hypoxia during exercise elevated muscle
HHb in both control and clamped conditions (P = 0.001B
and P = 0.008B vs. normoxia, respectively), whereas there
was a tendency for CO2 clamping to elevate muscle HHb
during normoxia (P = 0.067B vs. control) but not during
hypoxia (P = 0.460B).
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During exercise, EMG RMS increased slightly, in paral-
lel with power output, showing a more pronounced
increase during the end spurt (P < 0.001). EMG RMS
was lower in hypoxia compared to normoxic exercise
(P = 0.002), whereas no difference was observed with
CO2 clamping (P = 0.628).
Blood gas variables
CO2 clamping during exercise elevated PcCO2 by a
greater extent in hypoxia compared to normoxia (inter-
action: P < 0.001) (Table 2). Accordingly, post hoc
analysis revealed that CO2 clamping elevated PcCO2
during both normoxia (P < 0.001B vs. control) and
hypoxia (P = 0.004B), whereas hypoxia lowered PcCO2
during control (P = 0.001B vs. normoxia) but no differ-
ence was observed between clamped values of PcCO2
between normoxia and hypoxia (P = 0.526B). Hypoxia
lowered PcO2 and CcO2 during exercise (hypoxia:
P < 0.001 for both), whereas CO2 elevated PcO2
(P < 0.001) and tended to elevate CcO2 (P = 0.089).
The effect of CO2 clamping on ScO2 was greater in
hypoxia than normoxia (interaction: P = 0.006).
Accordingly, hypoxia lowered ScO2 during both control
and clamped conditions (post hoc: P < 0.001B vs.
normoxia), whereas CO2 clamp elevated ScO2 during
hypoxia (P = 0.005B vs. control) but not during norm-
oxia (P = 0.754B). No changes were observed in pH
with either hypoxia (P = 0.568) or CO2 clamping dur-
ing exercise (P = 0.182).
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Figure 1. Effect of hypoxia and CO2 clamping on respiratory variables during 15-km time trial cycling. Left panels, group data in normoxia
(mean  SD); right panels, group data in hypoxia. ●, normoxia control; ○, normoxia CO2 clamp; ■, hypoxia control; □, hypoxia CO2 clamp.
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Discussion
The well-documented detrimental effect of severe hypoxia
on exercise performance is not fully understood. Several
studies found a relationship between exercise capacity or
performance and a reduction in cerebral oxygenation dur-
ing various exercise modes in hypoxia, such as time trial
cycling (Amann 2006; Amann et al. 2006), repeated
sprints (Smith and Billaut 2010), incremental exercise
(Subudhi et al. 2007a; Peltonen et al. 2009), and static
maximal muscle contraction to exhaustion (Rasmussen
et al. 2006; Rupp and Perrey 2009; Vogiatzis et al. 2011;
Goodall et al. 2012). These observations led to the
hypothesis that the hyperventilation-induced hypocapnia
and associated reduction in CBF and cerebral oxygenation
may account for the impaired capacity and performance
in hypoxia.
In this study, we tested the hypothesis that prevent-
ing the usual hyperventilation-induced hypocapnia and
associated reduction in CBF and cerebral tissue oxygen-
ation would improve 15-km time trial performance in
severe normobaric hypoxia. Even though CBF was only
increased by 9% during the hypoxic time trial with
CO2 clamping, it resulted, with the concomitant 9%
increase in SpO2 (Figs. 1, 2), in significantly increased
cerebral DO2 by 20% compared to the nonclamped
control (Table 2). Importantly, this increase with CO2
clamping in hypoxia was sufficient to normalize cerebral
DO2 to levels similar as observed during nonclamped
normoxic exercise. As exercise performance in hypoxia
was not significantly improved with clamping, it follows
that the reduction in overall cerebral O2 delivery is not
a prime reason for the reduced exercise performance in
hypoxia.
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Figure 2. Effect of hypoxia and CO2 clamping on cerebral variables during 15-km time trial cycling. Cerebral O2Hb and HHb are expressed at
delta changes from normoxia (room air baseline). Left panels, group data in normoxia (mean  SD); right panels, group data in hypoxia.
●, normoxia control; ○, normoxia CO2 clamp; ■, hypoxia control; □, hypoxia CO2 clamp.
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Exercise in hypoxia
The detrimental effects of decreases in CaO2 on endur-
ance capacity of large muscle groups are well documented
(Adams and Welch 1980; Koskolou and McKenzie 1994;
Peltonen et al. 1995; Amann 2006; Amann et al. 2006,
2007). In this study, we found a 9–29% reduction in
exercise performance during 15-km time trial cycling in
severe hypoxia due to a decreased motor drive (~16%
reduction in right vastus lateralis EMG RMS). In agree-
ment with the results from Amann et al. (2006), we
found that markedly different strategies were employed
during time trial exercise in normoxia and hypoxia. Spe-
cifically, during the time trial in normoxia, the partici-
pants slightly increased their power output throughout
the 15 km, reaching maximal power at the end of exercise
in the form of an end spurt. In contrast, during the time
trial in hypoxia, participants began cycling at a relatively
high power output, slightly lowering work rate through-
out the exercise test, only increasing power output again
toward the end with a short sprint over the last 100 m.
Interestingly, this progressive decline in central motor
drive and power output occurred despite relatively stable
CcO2, ScO2, and muscle [O2Hb] during the time trial in
hypoxia (Table 2 and Fig. 3). Meanwhile, both cerebral
[O2Hb] and cerebral DO2 remained relatively stable
despite parallel increases in MCAv and cerebral [HHb]
(Fig. 2 and Table 2). As this decline in power coincided
with an increase in perceived exertion, we tentatively
interpret these findings as supporting the role of inhibi-
tory feedback of muscle afferents in limiting central
motor drive during exercise in severe hypoxia (Amann
et al. 2006).
CO2 clamping effects on CBF and prefrontal
cerebral oxygenation
Our aim was to improve CBF during exercise by adding
CO2 to the inspirate, clamping PETCO2 to 45 mmHg,
preventing the normal hyperventilation-induced hypocap-
nia and associated cerebral vasoconstriction, while not
influencing muscle oxygen supply. As expected, CO2
clamping in normoxia prevented the development of hyp-
ocapnia during the second half of the time trial, thereby
elevating CBF (Fig. 2). During CO2 clamping in hypoxia,
we were successful in elevating and maintaining PETCO2
stable at levels similar to those in normoxia (Fig. 1),
without any development of respiratory acidosis
(Table 2). However, despite a relatively greater hypercap-
nic stimulus, we observed only modest elevations in
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Figure 3. Effect of hypoxia and CO2 clamping on muscle oxygenation during 15-km time trial cycling. Muscle O2Hb and HHb are expressed at
delta changes from normoxia (room air baseline). Left panels, group data in normoxia (mean  SD); right panels, group data in hypoxia.
●, normoxia control; ○, normoxia CO2 clamp; ■, hypoxia control; □, hypoxia CO2 clamp.
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MCAv during exercise with CO2 clamping in hypoxia
(Fig. 2). In this study, MCAv increased despite relatively
stable MAP, cardiac output (not reported), pH, and PcO2
during exercise in hypoxia (Fig. 2, Table 2). Therefore, it
seems unlikely that changes in perfusion pressure or cir-
culating systemic stimuli (such as arterial hypoxemia)
could account for the progressive rise in CBF during time
trial cycling observed in hypoxia. Instead, we suspect that
the increase in CBF is likely driven by other factors such
as increased neural activity and cerebral metabolic
demand associated with prolonged aerobic exercise in
normobaric hypoxia.
Control of CBF during hypoxic exercise
The entire capillary network of the brain is covered by
extensions of astrocytes, which constitutes the blood–
brain barrier (Secher et al. 2007). As such, O2 diffusion
distance plays a vital role during increased neural acti-
vation and subsequent increased O2 consumption. As
there is no capillary recruitment in the brain, greater
CBF is required to elevate the O2 gradient (Secher et al.
2007). Acute hypoxic exposure at rest elevates right pre-
frontal cortex activity (Schneider and Str€uder 2009),
and enhances O2 extraction in the brain (Ho et al.
2008). Meanwhile, studies of dynamically exercising
humans have found that the increases in regional
MCAv (and CBF) are driven by increased cortical acti-
vation of sensorimotor areas associated with neural
input from the working limbs (Friedman et al. 1991,
1992; Jorgensen et al. 1992a). These observations sup-
port earlier findings in exercising dogs, of CBF redistri-
bution to sensorimotor cerebral cortex, spinal cord, and
cerebellum – primarily in cortical layers (Gross et al.
1980). Accordingly, we attribute the higher MCAv
observed in this study to greater sensorimotor cortex
activation associated with exercise in hypoxia. Despite a
considerably lower power output, we observed higher
rates of perceived effort during exercise in hypoxia
when compared to normoxia, thereby confirming
reports of a direct effect of hypoxia on effort percep-
tion during exercise in severe hypoxia (Amann et al.
2007). Taken together, we postulate that elevated cere-
bral metabolism associated with greater sensorimotor
cortex activation – as indicated by higher perceived
effort – could account for the elevated CBF observed
during exercise in severe hypoxia.
Cerebral oxygenation, oxygen delivery, and
performance
Mass cerebral oxygen delivery is the product of CBF and
CaO2. Therefore, it is important to consider the effect of
CO2 clamping on CaO2. In this study, increased respira-
tory drive associated with CO2 clamping elevated PcO2
and ScO2, which in term tended to elevate CcO2
(P = 0.089, Table 2). Combined with modest elevations
in MCAv during exercise (Fig. 2), we expected to see
elevated mass O2 delivery to the brain with CO2 clamp-
ing in hypoxia. Instead, CO2 clamping in hypoxia nor-
malized the cerebral DO2 to normoxic control values
during time trial cycling (Table 2), which is supported
by lower cerebral HHb and higher cerebral delta Hb
(Fig. 2). Accordingly, we contend that we were successful
in restoring cerebral DO2 during the time trial exercise
in hypoxia with our CO2 clamping setup. Our data
corroborate those of Subudhi et al. (2011), who found
significant increases in cerebral oxygenation with CO2
clamping during incremental exercise to capacity in
hypoxia. We also found muscle oxygenation to be ele-
vated with CO2 clamping in hypoxia (Fig. 3) – presum-
ably due to a higher SpO2 associated with increased
ventilation (Fig. 1). As the restoration of cerebral DO2
with CO2 clamping in our study was not accompanied
by improvements in exercise time, motor drive or mean
power output, it appears that cerebral deoxygenation
associated with hyperventilation-induced hypocapnia can-
not account for the impaired performance in hypoxia.
Intriguingly, this lack of improvement was observed
despite a tendency for improvement of muscle tissue
oxygenation with CO2 clamping in hypoxia. This lack of
effect of increased cerebral O2 delivery on performance
may be attributed, at least in part, to increased cerebral
nonoxidative glycolysis during exercise in hypoxia
(Overgaard et al. 2012). Furthermore, it is important to
acknowledge that changes in global cerebral DO2 may
not be representative of changes in local arterial and/or
capillary PO2 in the brain; therefore, it is possible that
we were unable to restore oxygen diffusion drive to the
mitochondria of especially active neuronal tissue with
our CO2 clamping setup.
Methodological considerations
Some technical considerations should be acknowledged
when interpreting our data. Prefrontal lobe oxygenation
was used to represent global changes in cerebrocortical
oxygenation. Subudhi et al. (2009) have reported good
correlations in oxygenation measurements between pre-
frontal, premotor, and motor cortices during maximal
exercise. Therefore, we considered prefrontal oxygena-
tion as an appropriate index of global changes in
cerebrocortical oxygenation. Another important issue
associated with NIRS is the influence of extracerebral
and fat layers on the brain and muscle measurements,
respectively (Cooper et al. 2010). Cerebral [O2Hb]
ª 2013 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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measurements may be influenced by external carotid
blood flow (Li et al. 2011) and forehead skin blood
flow (Takahashi et al. 2011) during rest or a verbal
fluency task, respectively. Nevertheless, Subudhi et al.
(2011) reported significant elevations in cerebral
[O2Hb] and CBF with CO2 clamping during exercise in
normoxia and hypoxia. Likewise, we found cerebral
[HHb] to be lower with CO2 clamping, whereas cere-
bral [O2Hb] tended to be elevated in the last 5 km of
exercise during CO2 clamping in normoxia and
throughout exercise in hypoxia, coinciding with a
higher MCAv (Fig. 2). Therefore, we contend that the
NIRS methodology used in this study was sensitive
enough to detect the changes in cerebral oxygenation
associated with CO2 clamping.
An important limitation of this study, as of many
other studies, is the assumption that MCAv represents
global CBF changes. Four lines of evidence support the
use of MCAv as an index of global CBF during exercise:
(i) MCAv reflects change in internal carotid blood flow
during dynamic exercise in both normoxia (Sato et al.
2011) and hypoxia (Huang et al. 1991); (ii) increases in
MCAv are matched by increases in cortical CBF during
dynamic exercise (Jorgensen et al. 1992a,b); (iii) whereas
cortical representation of leg muscle can be served from
measuring blood flow velocity of the anterior cerebral
artery (van der Zwan and Hillen 1991), cortical represen-
tation of muscle involved in cycling is served dominantly
by MCA (Jorgensen et al. 1992a); (iv) the cross-sectional
area of the MCA remains unchanged within a wide
range of changes in PETCO2 (Bradac et al. 1976; Giller
et al. 1993; Valdueza et al. 1997; Serrador et al. 2000);
and (v) the diameter of MCA, as measured using TCD,
remains relatively unchanged at 5300 m (5.23 mm) com-
pared to sea level (5.30 mm) (Wilson et al. 2011).
Accordingly, we contend that MCAv is a reasonable
index of changes in global CBF during heavy exercise in
hypoxia. Nevertheless, we acknowledge that changes in
CBF and cerebral metabolic activity during exercise and
with hypoxia are not homogeneous. In this study, the
assessment of CBF and cerebral tissue oxygenation was
limited to the MCA and the left prefrontal cortex,
respectively, which were taken as global indices. How-
ever, it is likely that certain brain regions are more met-
abolically active and others regions are less active during
exercise in hypoxia.
Another limitation of this study is that we clamped
end-tidal rather than arterial PCO2 during exercise. As the
end-tidal–arterial PCO2 gradient (Robbins et al. 1990) var-
ies with exercise (Jones et al. 1979; Liu et al. 1995), it is
possible that we did not clamp arterial PCO2 per se. In
this study, we measured arterialized capillary blood sam-
ples, as a surrogate of arterial measurements, and were
able to clamp and maintain capillary PCO2 within
1 mmHg throughout exercise under both normoxic and
hypoxic conditions. As Mollard et al. (2010) found good
correlations between prewarmed capillary earlobe samples
with radial artery measurements of PO2 (R
2 = 0.99), PCO2
(R2 = 0.86), and SO2 (R
2 = 0.99) during rest, submaxi-
mal, and near maximal exercise intensities, we are confi-
dent that our protocol was effective in clamping and
maintaining arterial PCO2.
Finally, lack of power could potentially limit the inter-
pretation of the tendency (P = 0.108) for performance to
be improved with CO2 clamping in hypoxia. However,
this seems unlikely as power calculation using Gaussian
approximation revealed a power of 0.95 for our post hoc
t-test. Furthermore, given the results from the earlier
studies using an incremental exercise paradigm (Subudhi
et al. 2011; Siebenmann et al. 2012) and the rather small
effect, if any, found in this study, the tested hypothesis
should be refuted.
Conclusion
We were unable to improve exercise performance in
severe hypoxia, despite a normalization of cerebral oxygen
delivery to normoxia values and higher cerebral and mus-
cle oxygenation. The hypothesis that the hyperventilation-
induced hypocapnia and the subsequent drop in cerebral
oxygenation are the cause of the reduced endurance exer-
cise performance in hypoxia is thus refuted. Our data
demonstrate that CBF is progressively elevated during
time trial cycling in normobaric hypoxia, which appears
to be independent of changes in perfusion pressure, car-
diac output, or partial pressure of arterial CO2 and O2.
We speculate that this increase in CBF during prolonged
submaximal exercise in hypoxia may be due to either
greater somatosensory input, increased motor drive out-
put, or both.
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We  tested  the  hypothesis  that  preventing  the  poikilocapnic  response  to high  intensity  exercise  would
increase  the ventilatory  response  to  exercise.  We  measured  ventilatory  variables  in 10  healthy  men
during  incremental  cycling  with  and  without  inspired  CO2 (randomised  order).  Inspired  CO2 elevated
resting  ventilation  (V˙E),  tidal  volume  (VT), PETCO2 and  PETO2 by  5 ±  5 L/min,  0.3 ± 0.2  L, 6 ±  3 mmHg  and
11  ± 7 mmHg,  respectively  (P  <  0.05);  resting  breathing  frequency  (f),  expired  CO2 (V˙CO2 )  and  O2 con-
sumption  (V˙ )  remained  similar  (P  > 0.05).  During  high  intensity  exercise,  inspired  CO elevated  P byentilatory control O2 2 ETCO2
7  ±  2, 10  ±  4  and  11  ±  4  mmHg  at 80%,  90%  and  100% V˙O2 max, respectively  (P < 0.01),  while  PETO2 remained
unchanged  (P > 0.05).  During  high  intensity  exercise,  inspired  CO2 elevated  VT  by 0.2  ±  0.3  L at  80%, 90%
and  100% V˙O2 max, respectively  (P <  0.05),  while  no  differences  were  observed  in V˙E, f, V˙O2 , or  power  output
(P >  0.05).  These  data  suggest  a progressively  diminishing  role  of  CO2 chemoreception  in the  control  of
al  inventilation  during  maxim
. Introduction
The regulation of exercise hyperpnoea has been extensively
tudied for more than a century but several aspects remain to be
ully elucidated (see Flenley and Warren, 1983; Poon and Greene,
985; Cunningham, 1987; Mateika and Dufﬁn, 1995; Forster, 2000;
ard, 2000; Peronnet and Aguilaniu, 2006; Poon et al., 2007; Babb
t al., 2010 for reviews). Among others, the role of chemoreception
n the regulation of exercise hyperpnoea, especially during heavy
xercise, remains controversial. Early animal studies found, using
ilateral carotid denervation and altering cerebrospinal [H+], that
xercise hyperpnoea would be independent of peripheral (Bisgard
t al., 1982; Mitchell et al., 1984; Pan et al., 1986) and central (Smith
t al., 1988) chemoreceptor input. On the other hand, Bisgard et al.
1982) found, in goats, that the peripheral chemoreceptors are
evertheless essential in modulating the neural drive for exercise
yperpnoea. Meanwhile, human studies reported either preserved
Lugliani et al., 1971; Wasserman et al., 1975) or blunted (Honda
t al., 1979) ventilatory responses to moderate steady-state exer-
ise in asthmatic patients with carotid body resection as compared
o control subjects. Wasserman et al. (1975) also reported a lack
f hyperventilation in response to metabolic acidosis during incre-
ental exercise in patients with carotid resection, which led them
o speculate that the peripheral chemoreceptors may  be essen-
ial for ventilatory compensation of exercise-induced metabolic
∗ Corresponding author. Tel.: +41 22 379 00 28; fax: +41 22 379 00 35.
E-mail address: Bengt.Kayser@unige.ch (B. Kayser).
569-9048/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.resp.2011.12.004cremental  exercise.
© 2011 Elsevier B.V. All rights reserved.
acidosis. However, these ﬁndings concerned asthmatic patients,
either 3–9 yrs (Lugliani et al., 1971; Wasserman et al., 1975) or
∼25 yrs (Honda et al., 1979) following bilateral or unilateral carotid
body resection, and the role of chemoreception during exercise in
healthy subjects remained to be better described. In intact humans,
several studies investigated the effect of peripheral chemoreceptor
inhibition by hyperoxia on ventilation (V˙E) during exercise below
and above the respiratory compensation threshold (Dejours et al.,
1958; Wasserman, 1976; Jeyaranjan et al., 1987; Miyamoto and
Niizeki, 1995; Pianosi and Marchione, 1995; Kobayashi et al., 1996;
St Croix et al., 1996). Those studies suggested that the peripheral
chemoreceptors serve a minor role in the control of exercise hyper-
pnoea, contributing to approximately 10–25% of the overall V˙E
response. However, the role of CO2 chemoception, which involves
activation of both peripheral and central chemoreceptors, in the
regulation of hyperpnoea during heavy and maximal exercise in
humans remains to be investigated in greater detail.
Increasing the partial pressure of arterial CO2 (PaCO2) by inhala-
tion of gas mixtures with a ﬁxed increased FICO2 constitutes a
stimulus for exercise hyperpnoea, particularly at low-to-moderate
exercise intensities (Weil et al., 1972; Clark et al., 1980). Only few
studies have examined the effect of inspired CO2 on the ventilatory
response to exercise. Most (Essfeld et al., 1990; St Croix et al., 1996;
Hayashi et al., 2011), but not all (Olin et al., 2011) of these studies,
only reported effects on V˙E during steady-state exercise below the
respiratory compensation threshold. Olin et al. (2011) did not study
the ventilatory response to exercise but reported similar maximal
V˙E in two  consecutive incremental exercise tests when end-tidal
PCO2 (PETCO2 ) was  clamped at ∼40 mmHg  up to maximal exercise
2 gy & Neurobiology 180 (2012) 283– 288
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Incremental cycling84 J.-L. Fan et al. / Respiratory Physiolo
apacity in otherwise healthy, highly trained cyclists, suggesting
hat maximum aerobic exercise hyperpnoea may  be independent
f arterial PCO2 tension. But their subjects reported increased res-
iratory effort to overcome an added inspiratory resistance from
he breathing circuit during the PETCO2 condition compared to con-
rol, which may  have limited the exercise performance and thus
˙ E. In addition, the authors were unable to calculate O2 uptake
nd expired CO2 because of the particularities of their rebreath-
ng circuit. As such, the effect of clamping of PETCO2 on V˙E and other
entilatory variables during high intensity exercise remained to be
escribed.
In the present study, we therefore examined the effect of
nspired CO2 on the ventilatory response to exercise during an
ncremental maximal exercise test. We  tested the hypothesis that
ncreasing FICO2 to prevent the normal decrease of PETCO2 above
he respiratory compensation point (i.e., hypocapnia from exer-
ise induced hyperventilation), would lead to increased V˙E during
ncremental exercise, especially beyond the ventilatory threshold.
. Methods
.1.1. Participants
Ten healthy male subjects with a mean age of 24 ± 3 yr
mean ± SD), a body mass index of 22.8 ± 1.8 kg/m2 and V˙O2 max
f 49.8 ± 5.5 ml/min/kg participated in this study. Participants
ere non-smokers, had no previous history of cardiovascular,
erebrovascular, or respiratory disease and were not taking any
edication. All the participants partook in regular exercise, but
one were especially trained. The study was approved by the
esearch Ethical Committee of the University Hospitals of Geneva
nd conformed to the standards set by the Declaration of Helsinki. All
articipants were informed regarding the purposes and procedures
f this study, and informed consent was given prior to participation.
.2. Experimental design
The participants visited the laboratory on three occasions. After
 full familiarisation with the experimental procedures outlined
elow (visit one), participants underwent two experimental tri-
ls, control and inspired CO2, in a randomised order. Before each
xperimental session, the participants were asked to abstain from
affeine for 12 h and heavy exercise and alcohol for 24 h. Each
xperimental testing session consisted of a 10 min  instrumenta-
ion followed by a four min  resting period data collection with
he participant seated on an electronically braked cycle ergome-
er (Ergoselect 100, Ergoline GmbH, Bitz, Germany). At the end of
he resting period, the participant was instructed to begin cycling at
 W at a pedalling rate of 70 rpm. The work rate was then increased
y 0.5 W every second until the participant reached exhaustion.
hroughout each experimental session, the participants breathed
hrough a leak-free respiratory mask (Hans-Rudolph 8980, Kansas
ity, MO,  USA) attached to a low resistance one-way non-
ebreathing valve (Hans-Rudolph 2700, Kansas City, MO,  USA).
uring the control trial, participants breathed normal room air and
ETCO2
was allowed to ﬂuctuate freely and drop during the latter part
f the trial leading to exercise hyperventilation-induced hypocap-
ia (Fig. 1). During the inspired CO2 trial, the participants’ PETCO2
uring rest and throughout the exercise was controlled to values
f ∼44 and ∼50 mmHg, at rest and during exercise, respectively,
hus preventing the normal hyperventilation-induced hypocapnia
t high intensity exercise (Fig. 1). We  did not increase PETCO2 to
0 mmHg  at rest to prevent an apparatus related overshoot at the
eginning of the exercise protocol and aimed at keeping PETCO2 closeFig. 1. Typical individual’s end-tidal PCO2 traces during control and inspired CO2 at
rest and during incremental cycling to exhaustion. (©) Control; () inspired CO2.
to the maximum value observed during a control run, leaving it drift
up slightly throughout the exercise test since end-tidal arterial dif-
ferences increase with exercise intensity (Fig. 1) (Jones et al., 1979).
The inspired CO2 was achieved using a modiﬁed gas mixing sys-
tem (Altitrainer, SMTec, Nyon, Switzerland), which was  attached
to the inspiratory valve of the facemask using a piece of large-bore
low resistance tubing. The device consists of a reservoir in which
air and experimental gases are mixed and from which the subject
inspires. This setup enabled for bleeding additional CO2 and O2 into
the inspired gas mixture, thereby increasing the FICO2 while keeping
FICO2
constant. Under feedback of on-screen PETCO2 (Datex infrared
CO2 analyser, Finland), FICO2 was continuously adapted as to keep
PETCO2
to its target value. The subjects breathed through the same
low resistance circuit in the control and inspired CO2 conditions
and were kept unaware to what gas mixture they were breathing.
2.3. Measurements
Gas exchange was  monitored on a breath-by-breath basis (Med-
graphics CPX, Zürich, Switzerland) measuring ﬂow at the mouth
with a Pitot tube and the fractions of inspired and expired O2 and
CO2 with fast responding gas analysers (infrared and paramagnetic)
integrated in the system. V˙E and its components tidal volume (VT)
and breathing frequency (f) were calculated from the ﬂow signal
and expressed in BTPS and per min, respectively. The partial pres-
sure of end-tidal O2 (PETCO2 ) and CO2 (PETCO2 ), O2 consumption
(V˙O2), expired CO2 (V˙CO2 ) and respiratory duty cycle (Ti/Ttot) were
calculated by the gas analysis system; alveolar ventilation (V˙A) was
estimated using the alveolar gas equation. Prior to each experimen-
tal session the system was calibrated using a 3-L syringe (Medikro
M9474, Medikro Oy, Finland) and gas mixtures of known concen-
trations of O2 and CO2. Heart rate was  measured using a thoracic
belt and a watch (S610, Polar electro, Finland).
During exercise, the participants were asked to score their per-
ceived sensation of respiratory and leg muscle exertion on the 0–10
Borg scale every minute (Borg, 1982).
2.4. Data and statistical analysis
Resting values were obtained by averaging the data obtained in
the last minute of the four min  resting period. During exercise, all
the V˙O2 data was normalised to the maximum value obtained for
the control trial and expressed as percentages of maximal exercise
aerobic capacity. Subsequently, we calculated 10–15 s averages at
20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 100% V˙O2 max for all
variables during the incremental exercise. All the ventilatory vari-
ables were plotted against percentage V˙O2 max with the exception
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Table 1
Respiratory variables during rest and exercise under control and inspired CO2 conditions.
Exercise PETCO2 (mmHg) PETO2 (mmHg) V˙E (L/min) V˙A (L/min) f (breaths/min) VT (L)
Control Inspired CO2 Control Inspired CO2 Control Inspired CO2 Control Inspired CO2 Control Inspired CO2 Control Inspired CO2
Baseline 37 ± 2 44 ± 2* 99 ± 4 110 ± 6 11.7 ± 2.9 16.2 ± 6.2* 8.2 ± 2.2 12.6 ± 5.5* 13 ± 3 13 ± 4 0.9 ± 0.2 1.2 ± 0.2*
20% 42 ± 2 48 ± 3* 90 ± 6 114 ± 6* 18.4 ± 3.0 34.2 ± 9.2* 13.8 ± 2.1 30.8 ± 8* 18 ± 4 20 ± 4 1.1 ± 0.2 1.7 ± 0.4*
30% 43 ± 3 49 ± 4* 88 ± 5 107 ± 6* 25.9 ± 4.7 38.2 ± 7.8* 20.9 ± 3.5 33.9 ± 7.9* 18 ± 5 21 ± 4 1.5 ± 0.3 1.9 ± 0.3*
40% 46 ± 2 49 ± 5* 88 ± 4 101 ± 8* 33.8 ± 7.6 43.3 ± 8.6* 28.1 ± 6.3 38.0 ± 8.6* 20 ± 4 22 ± 4 1.7 ± 0.3 2.0 ± 0.3
50%  44 ± 2 49 ± 5 89 ± 4 98 ± 7* 42.8 ± 7.3 51.8 ± 9.8* 36.6 ± 6.4 46.1 ± 9.1* 21 ± 4 23 ± 5 2.0 ± 0.3 2.2 ± 0.2*
60% 47 ± 3 51 ± 5* 92 ± 6 98 ± 8* 54.4 ± 11.8 62.7 ± 16.4* 47.7 ± 10.6 56.8 ± 15.3* 24 ± 5 26 ± 7 2.3 ± 0.2 2.4 ± 0.2
70% 48 ±  4 52 ± 5* 95 ± 6 99 ± 8* 69.7 ± 16.2 78.3 ± 20.8 61.3 ± 14.7 61.3 ± 14.7* 29 ± 7 30 ± 7 2.4 ± 0.3 2.6 ± 0.3*
80% 47 ± 5 53 ± 5* 98 ± 7 101 ± 10 87.6 ± 20.4 94.3 ± 27.5 77.2 ± 18.8 77.2 ± 18.8 35 ± 8 34 ± 9 2.5 ± 0.3 2.7 ± 0.4*
90% 46 ± 7 53 ± 6* 102 ± 8 104 ± 10 106.0 ± 27.7 112.8 ± 30.5 93.7 ± 25.7 106.5 ± 32.5* 41 ± 8 41 ± 10 2.6 ± 0.3 2.8 ± 0.4*
100% 42 ± 8 53 ± 5* 104 ± 6 106 ± 9 117.1 ± 29.2 127.0 ± 35.6 103.7 ± 26.8 121.0 ± 38.2* 47 ± 9 46 ± 11 2.5 ± 0.3 2.7 ± 0.2*
End 40 ± 8 54 ± 6* 109 ± 6 106 ± 5* 116.2 ± 26.1 129.4 ± 33.0* 101.0 ± 22.6 122.9 ± 33.3* 50 ± 9 52 ± 12 2.3 ± 0.2 2.5 ± 0.3*
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Values are mean ± SD.
* Different from Control (P < 0.05).
f V˙E which was plotted against mechanical power output on the
rgometer for the analysis of V˙E slopes.
.4.1. Respiratory compensation threshold and ventilatory
esponse to exercise
The respiratory compensation threshold was obtained using the
-slope method previously described by Beaver et al. (1986).  The
ssessment of the ventilatory response to exercise (i.e., the slope of
˙ E rise during exercise) has been previously described (Babb, 1997a,
997b) and will be outlined here. In brief, breath-by-breath V˙E
oints were plotted against mechanical power output and the least
quares regression was used to determine the ventilatory response
o exercise above and below the respiratory compensation thresh-
ld (Babb, 1997a, 1997b).
Comparison of resting baseline variables as well as at the
nd of incremental exercise between the control and inspired
O2 conditions was done using the paired t-test. Compari-
on of the ventilatory variables between control and inspired
O2 conditions during incremental exercise were assessed using
epeated-measures ANOVA with -level of P < 0.05 (PASW Statistics
8, Chicago, USA). Post hoc analysis (by paired t-test) of signiﬁcant
esults from the ANOVAs (either condition or exercise step effects)
as performed with Bonferroni correction, to isolate the effects of
ondition on the dependent measures within participants.
. ResultsAll 10 participants completed the control and the inspired CO2
rials. There were no differences in V˙O2 max [49.7 ± 4.3 (mean ± SD)
s. 49.8 ± 5.5 mL/min/kg] or maximal power output (327 ± 54 vs.
31 ± 49 W)  between inspired CO2 and control conditions (P > 0.05).
able 2
etabolic and respiratory variables during rest and exercise under control and inspired C
Exercise V˙CO2 (mL/min) V˙O2 (mL/min) V˙E/V˙CO2
Control Inspired CO2 Control Inspired CO2 Control 
Baseline 351 ± 84 283 ± 70* 368 ± 66 392 ± 80 33 ± 3 
20% 646 ± 86 617 ± 136 767 ± 92 759 ± 100 29 ± 3 
30%  991 ± 132 927 ± 212 1181 ± 149 1138 ± 161 26 ± 2 
40%  1386 ± 280 1379 ± 283 1561 ± 233 1509 ± 220 24 ± 2 
50%  1856 ± 287 1938 ± 352 1936 ± 265 1882 ± 264 23 ± 2 
60%  2373 ± 412 2411 ± 451 2287 ± 304 2250 ± 284 23 ± 2 
70%  2983 ± 516 2921 ± 389 2663 ± 357 2626 ± 339 23 ± 2 
80%  3603 ± 554 3447 ± 599 3008 ± 390 3010 ± 425 24 ± 3 
90%  4103 ± 616 3984 ± 645 3271 ± 473 3256 ± 459 26 ± 4 
100%  4391 ± 581 4307 ± 589 3434 ± 443 3423 ± 516 26 ± 4 
End  4172 ± 437 4308 ± 687 3196 ± 403 3228 ± 486 28 ± 4 
alues are mean ± SD.
* Different from Control (P < 0.05).The subjects did not report any side-effect from the inspired CO2
procedure such as headache or dyspnoea.
3.1. Effect of inspired CO2 on resting variables
During resting, inspired CO2 elevated PETCO2 and PETO2 (P < 0.05
vs. control; Table 1). PETCO2 clamping elevated resting V˙E, V˙A and
VT (P < 0.05), while f remained similar (P > 0.05 vs. control; Table 1).
Inspired CO2 also elevated Ti/Ttot, V˙E/V˙CO2 and V˙E/V˙O2 , while V˙CO2
was lowered (P < 0.05 vs. control; Table 1). No differences were
observed in resting V˙O2 between the PETCO2 clamped and control
trial (P > 0.05; Table 1).
3.2. Effect of inspired CO2 on ventilatory variables during
incremental exercise
During incremental exercise, inspired CO2 elevated PETCO2 at
20%, 30%, 40%, 60%, 70%, 80%, 90% and 100% V˙O2 max (P < 0.05 vs.
control), while no difference was  observed at 50% V˙O2 max (P > 0.05;
Table 2). Inspired CO2 elevated PETO2 at 20%, 30%, 40%, 50%, 60%
and 70% V˙O2 max (P < 0.05 vs. control); no difference was observed
between 80% and 100% V˙O2 max (P < 0.05; Table 1). During the
inspired CO2 trial, V˙E was higher at 20%, 30%, 40%, 50% and 60%
V˙O2 max (P < 0.05 vs. control), while no signiﬁcant differences were
observed between 70% and 100% V˙O2 max (P > 0.05; Table 1). Inspired
CO2 also elevated calculated V˙A at all exercise intensities except at
80% V˙O2 max (P < 0.05 vs. control; Table 1). Tidal volume was  ele-
vated at 20%, 30%, 50%, 70%, 80%, 90% and 100% V˙O2 max (P < 0.05 vs.
O2 conditions.
V˙E/V˙O2 Ti/Ttot
Inspired CO2 Control Inspired CO2 Control Inspired CO2
57 ± 11* 31 ± 4 41 ± 11* 0.28 ± 0.04 0.33 ± 05*
55 ± 9* 24 ± 3 45 ± 10* 0.34 ± 0.04 0.40 ± 0.05
42 ± 11* 22 ± 3 34 ± 5* 0.39 ± 0.03 0.41 ± 0.03
32 ± 6* 22 ± 3 29 ± 3* 0.40 ± 0.03 0.41 ± 0.05
27 ± 4* 22 ± 2 28 ± 4* 0.41 ± 0.03 0.43 ± 0.02
26 ± 5* 24 ± 3 28 ± 6* 0.43 ± 0.04 0.44 ± 0.03
27 ± 5* 26 ± 3 30 ± 7* 0.44 ± 0.04 0.45 ± 0.04
27 ± 5* 29 ± 5 31 ± 8 0.44 ± 0.04 0.46 ± 0.04
28 ± 6* 32 ± 6 35 ± 7 0.44 ± 0.04 0.44 ± 0.03
29 ± 6* 34 ± 6 37 ± 8* 0.44 ± 0.04 0.44 ± 0.04
30 ± 5* 36 ± 5 40 ± 7* 0.43 ± 0.03 0.43 ± 0.04
2 gy & Neurobiology 180 (2012) 283– 288
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Fig. 2. Effect of inspired CO2 on group end-tidal PCO2 , end-tidal PO2 and ventilation
during incremental cycling to exhaustion. (©) Control; () inspired CO2. Inspired
CO2 elevated PET during all exercise intensities except 50% V˙O max. As a result,86 J.-L. Fan et al. / Respiratory Physiolo
ontrol), while no difference was observed at 40% V˙O2 max during
he inspired CO2 trial (P > 0.05; Table 1).
Inspired CO2 elevated V˙E/V˙CO2 at all exercise intensities (P < 0.05
s. control; Table 2). Likewise, V˙E/V˙O2 was higher during the PETCO2
lamp trial at 20%, 30%, 40%, 50%, 60%, 70% and 100% V˙O2 max
P < 0.05 vs. control), but not at 90% V˙O2 max (P > 0.05; Table 2). No
ifferences were observed in f, V˙CO2 , V˙O2 and Ti/Ttot between PETCO2
lamp and control trials (P > 0.05; Table 2).
.3. Effect of inspired CO2 on ventilatory variables at end of
ncremental exercise
Inspired CO2 elevated PETCO2 , PETO2 , V˙E, V˙A, V˙T V˙E/V˙CO2 and
˙ E/V˙O2 at the end of incremental exercise (P < 0.05 vs. control),
hile no differences were observed in any other variables (P > 0.05
s. control; Tables 1 and 2).
.4. Respiratory compensation threshold and ventilatory
esponse to exercise
Inspired CO2 lowered the v-slope estimate of respiratory com-
ensation threshold by 43 ± 38 W (200 ± 37 vs. 242 ± 43 W;  P < 0.05
s. control; Fig. 3). The ventilatory response to exercise below
espiratory compensation threshold was lower with inspired CO2
0.15 ± 0.03 vs. 0.22 ± 0.04 L/min/W; P < 0.05 vs. control; Fig. 3). In
ontrast, the ventilatory response to high intensity exercise (i.e.,
bove respiratory compensation threshold) was the same in both
onditions (P > 0.05; Fig. 3).
.5. Heart rate and sensation of exertion at maximal exercise
No difference was observed in the maximal HR (185 ± 8 vs.
85 ± 7 b/min; P < 0.05) between inspired CO2 and control con-
itions. Likewise, no differences were observed in the sensation
f respiratory (8.7 ± 1.1 vs. 8.3 ± 1.5) or leg exertion (9.7 ± 0.5 vs.
.4 ± 1.1; P < 0.05 vs. control).
. Discussion
We tested the hypothesis that preventing the usual exercise
yperventilation-induced hypocapnia above the respiratory com-
ensation point during incremental exercise until exhaustion, by
ncreasing FICO2 in order to elevate PETCO2 above the highest level
bserved during an incremental exercise test in control conditions,
ould lead to an elevated ventilatory response. We  found that
nspired CO2 augmented V˙E during rest, as expected, and also at
ow and moderate exercise intensities, and tended to increase V˙E at
aximal exercise (Table 1). But the main ﬁnding of the study was
hat despite these effects, inspired CO2 did not augment ventila-
ion during high intensity exercise (Fig. 3). We  furthermore found
nspired CO2 reduced the respiratory compensation threshold dur-
ng incremental exercise (Fig. 3). These ﬁndings indicate that above
he respiratory compensation threshold CO2 chemoreception does
ot increase V˙E beyond an offset reached below the threshold.
.1. Limitations
Although the present study provides the opportunity to exam-
ne the effect of inspired CO2 on the ventilatory response during
ncremental exercise, there are limitations that should be taken
nto account when interpreting our ﬁndings. Firstly, we did not
irectly measure gases nor lactate concentration in arterial blood.
t would have been useful to have arterial PCO2 , PO2 , pH, [HCO3
−],
La−] and [K+] data to strengthen our results. As such, we  do notCO2 2
elevated PETO2 and V˙E at the lower to moderate exercise intensities and tended to
elevate V˙E at maximal exercise. *Different from Control (P < 0.05).
have direct evidence that our intervention led to increases in both
PaCO2 and [H
+]. Nevertheless, given the very large differences in
PETCO2
between the two conditions, especially during high exercise
intensities (Fig. 2), it seems very likely that we were able to elevate
the body’s CO2 stores (i.e., central chemoreceptor PCO2 ) compared
to control and exacerbate metabolic acidosis during incremental
exercise with our inspired CO2 protocol, thus potentially augment-
ing both central and peripheral chemoreceptor activation. In favour
of that contention, in the study of Clark et al. (1980),  the condition of
inspired PCO2 of 20 mmHg  led to the stabilisation of PaCO2 towards
peak exercise to similar levels as we found and was accompanied
by a drop in arterial pH from 7.32 in the control condition to 7.24
in the inspired CO2 condition.
We  opted to keep FIO2 constant throughout the protocol and did
not attempt to clamp PETO2 . Since during high intensity exercise
PETO2
was not different between the trials (Fig. 2), it seems unlikely
that this will have inﬂuenced our main ﬁnding of unaltered ventila-
tion with inspired CO2. We  are aware of other setups (Tansley et al.,
1997; Koehle et al., 2009), which allow clamping of both PACO2
and
J.-L. Fan et al. / Respiratory Physiology & 
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Fig. 3. Effect of inspired CO2 on the respiratory compensation threshold and venti-
latory response to exercise during incremental cycling to exhaustion. (©) Control;
()  inspired CO2. Inspired CO2 blunted the ventilatory response to exercise (slope)
below the respiratory compensation threshold, while no difference was  observed
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ibove the threshold. Inspired CO2 also lowered the respiratory compensation
hreshold and elevated V˙E during both the beginning and the end of exercise. *Dif-
erent from control (P < 0.05).
AO2
, but these have so far not been able to clamp at the very high
ates of ventilation as observed during maximal exercise, which
as the reason for the use of our setup.
.2. Chemoreception of CO2 and exercise hyperpnoea
Several studies have assessed the effect of chemoreceptor
timulation using inspired CO2 on the ventilatory response to
ncremental exercise. In young sedentary subjects, increased
nspired PCO2 (FICO2 = 0.03) has been shown to augment ven-
ilatory response to exercise (i.e., greater rise in V˙E) below the
espiratory compensation threshold (Babb, 1997a). Those authors
eported that hypercapnia caused an offset of the ventilatory
esponse to exercise to a higher value without any change in
lope during exercise above the threshold – presumably due to an
ncreasing inﬂuence of mechanical ventilatory constraints at high
˙ E levels (Babb, 1997a).  Since they found a higher maximal V˙E with
ypercapnia compared to room-air breathing, they concluded that
uring near-maximal and maximal exercise in hypercapnia, the
espiratory system, with regard to the expiratory airﬂow in par-
icular, was not limiting. Several studies have examined the effect
f PETCO2 clamping on the ventilatory response to exercise (Essfeld
t al., 1990; St Croix et al., 1996; Hayashi et al., 2011; Olin et al.,
011), but these studies focused primarily on the effect of inspired
O2 PETCO2 clamping during low and moderate intensity steady-
tate exercise, with the exception of Olin et al. (2011) who only
eported maximal ventilation.
In contrast to our starting hypothesis, inspired CO2 did not aug-
ent V˙E during high intensity exercise in the present study (Fig. 2).
evertheless, we found a tendency for V˙E to be higher with inspired
O2 at 100% V˙O2 max (Fig. 2), while this difference reached signif-
cance at the end of exercise (Table 1). We  observed a blunted V˙E
esponse to incremental exercise (i.e., a slower rise in V˙E) at lower
xercise intensities with inspired CO2 (Fig. 3). This attenuated V˙E
ncrease with inspired CO2 was abolished at the respiratory com-
ensation threshold (Fig. 3), whereby the slope of V˙E rise became
dentical to control condition above the threshold. We  attribute the
pparent blunting of the ventilatory response to exercise below
he compensatory threshold to the lack of rise in PETCO2 during the
ow and moderate exercise intensities with inspired CO2 (Fig. 1).
s a result, the difference in PETCO2 between the two conditions
radually decreased with increasing workload (Panel 3, Fig. 2).
eanwhile, since V˙E was  higher at the end of exercise with inspired
O2 despite a lack of difference in the slope of V˙E rise, it appears that
ncreased CO2 loading resulted in a ﬁxed offset of the ventilatoryNeurobiology 180 (2012) 283– 288 287
response to higher values during heavy exercise. Our  data agrees
with those by Wasserman et al. (2011),  which showed a dissoci-
ation between arterial [H+] and ventilation during exercise above
the respiratory compensation threshold. Accordingly, our ﬁndings
do not appear to support the role of CO2 chemoreception in the
control of exercise hyperpnoea during high intensity, sub-maximal
exercise.
An unexpected ﬁnding in the present study was a lowered res-
piratory compensation threshold with inspired CO2 (Fig. 3). We
speculate that this reduction could be attributed to either: (i)
greater activation of the peripheral and central chemoreceptors
(Takano, 2000); increased intramuscular metabo-receptor activa-
tion (Williamson et al., 1993; Smith et al., 1999); or (ii) altered
ventilatory strategy associated with greater ventilation at low
exercise intensities. Regardless of the mechanism(s), our data
demonstrates inspired CO2 leads to early onset of the respiratory
compensation threshold.
4.3. Hypercapnia and perceived exertion
During exercise above the respiratory compensation thresh-
old, cerebral blood ﬂow decreases towards baseline because of
the lower PaCO2 from a hyperventilation-induced cerebral vaso-
constriction (Madsen et al., 1993; Ide et al., 1999; Olin et al.,
2010). Cerebral blood ﬂow thus decreases during heavy exercise
despite an increased in cerebral demand and it is thought that this
may  accelerate, in some conditions, the advent of central fatigue
(Rasmussen et al., 2010). As an auxiliary hypothesis of our study
we therefore expected, by avoiding the hyperventilation induced
drop in PaCO2 , to potentially modify the sensation of fatigue and
exertion. In our set-up, such an effect seems not to have played any
role since maximum exercise capacity, heart rate and the levels
of perceived legs and respiratory exertion were the same between
conditions. In contrast, Olin et al. (2010) reported ∼6% reduction in
maximal exercise capacity with PETCO2 clamping compared to con-
trol condition despite higher cerebral blood ﬂow. However, this
reduction in exercise capacity may  have been due to the elevated
respiratory resistance and dyspnoea associated with their particu-
lar rebreathing setup. It remains open if inspired CO2 on cerebral
blood ﬂow would play a role in conditions of hypoxia, or during
other types of exercise challenges like time-trials (Subudhi et al.,
2008; Rasmussen et al., 2010).
To conclude, we  demonstrated that elevating end-tidal PCO2 dur-
ing incremental exercise does not alter ventilation and respiratory
rate beyond the ventilatory threshold. Our data add to the evidence
against the classical concept of chemoreception of CO2/pH in the
regulation of breathing during high intensity exercise and high-
lights the need to develop better models to describe the ventilatory
response to exercise, especially during high intensity exercise.
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